"doc1","doc2","distance"
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section H  Enhanced Medication Therapy Management MTM Model",0.756898698697837
"Section N  Encounter Data as a Diagnosis Source for 2019","Section B  Encounter Data as a Diagnosis Source for 2019",0.721642593817914
"Section III Low Enrollment Plans Standalone PDPs only","Section II Plans with Low Enrollment",0.715676818508317
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section I Validation Audits",0.70329500944112
"Section I Plan Corrections","Section I Incomplete and Inaccurate Bid Submissions",0.69080442373396
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section II Part C Cost Sharing Standards",0.669460492175301
"Section II Maximum OutofPocket MOOP Limits","Section II Part C Cost Sharing Standards",0.634415388240735
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section N  Encounter Data as a Diagnosis Source for 2019",0.623617057022916
"Section II Tiered Cost Sharing of Medical Benefits","Section II Part C Cost Sharing Standards",0.610499463890671
"Section III Tier Composition","Section III Improving Access to Part D Vaccines",0.60827548346309
"Section II Cost Plan Competition Requirements","Section II Cost Plan Transition to MA under MACRA",0.581022899067801
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section D  Retiree Drug Subsidy Amounts",0.571373733413088
"Section D  ESRD Rates","Section B  Calculation of Fee for Service Cost",0.562939593409948
"Section I  ESRD Risk Adjustment Model for CY 2019","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.551060812368333
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Health Related Supplemental Benefits",0.549498879201461
"Section II Outpatient Observation Services","Section II Part C Cost Sharing Standards",0.543692273064491
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Part C Cost Sharing Standards",0.523117708447809
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section III Improving Access to Part D Vaccines",0.522341736476725
"Section A  Update of the RxHCC Model","Section L  Normalization Factors",0.517962410725493
"Section II Tiered Cost Sharing of Medical Benefits","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.511118141570098
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section II Maximum OutofPocket MOOP Limits",0.510650762463669
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Incomplete and Inaccurate Bid Submissions",0.507919046158184
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Health Related Supplemental Benefits",0.498540983327534
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.498400496937027
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.494717058908911
"Section II Part C Optional Supplemental Benefits","Section II Health Related Supplemental Benefits",0.488584156237771
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.485159529850227
"Section I  ESRD Risk Adjustment Model for CY 2019","Section L  Normalization Factors",0.480636855802221
"Section A  Update of the RxHCC Model","Section I  ESRD Risk Adjustment Model for CY 2019",0.465845986479701
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.461496576935767
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Health Related Supplemental Benefits",0.460638799954908
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Tiered Cost Sharing of Medical Benefits",0.456608450102201
"Section A  Update of the RxHCC Model","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.45259100360955
"Section III Specialty Tiers","Section III Tier Composition",0.451925909280674
"Section B  FFS Growth Percentage","Section B  Calculation of Fee for Service Cost",0.446396134207739
"Section III Improving Access to Part D Vaccines","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.445938145179498
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Medicare Advantage MA Uniformity Flexibility",0.442654610858774
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Part C Cost Sharing Standards",0.441634500388996
"Section C  IME Phase Out","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.439165283965977
"Section N  Encounter Data as a Diagnosis Source for 2019","Section L  Normalization Factors",0.437680274011437
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Tiered Cost Sharing of Medical Benefits",0.434556686682849
"Section II Tiered Cost Sharing of Medical Benefits","Section II Maximum OutofPocket MOOP Limits",0.431434699372167
"Section III Specialty Tiers","Section III Improving Access to Part D Vaccines",0.430562799275148
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section G  MA Employer Group Waiver Plans",0.429058227484307
"Section A  MA Growth Percentage","Section B  FFS Growth Percentage",0.42675778082684
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Part C Cost Sharing Standards",0.412953570374327
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section H  Enhanced Medication Therapy Management MTM Model",0.408795922756555
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Health Related Supplemental Benefits",0.408460864438416
"Section II Part C Optional Supplemental Benefits","Section II Medicare Advantage MA Uniformity Flexibility",0.408138816671568
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Plan Corrections",0.407365302101287
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Medicare Advantage MA Uniformity Flexibility",0.407176716804888
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Total Beneficiary Cost TBC",0.405445173232845
"Section D  ESRD Rates","Section I  ESRD Risk Adjustment Model for CY 2019",0.401332836997079
"Section II Cost Plan Competition Requirements","Section II Part C Cost Sharing Standards",0.401135129226236
"Section G  MA Employer Group Waiver Plans","Section B  Calculation of Fee for Service Cost",0.399224879920017
"Section N  Encounter Data as a Diagnosis Source for 2019","Section A  Update of the RxHCC Model",0.398923899497913
"Section II Cost Plan Competition Requirements","Section D  Retiree Drug Subsidy Amounts",0.395781200209365
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Medicare Advantage MA Uniformity Flexibility",0.395665239785744
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.395527139133854
"Section C  IME Phase Out","Section B  Calculation of Fee for Service Cost",0.393986429933046
"Section II Outpatient Observation Services","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.392826360970484
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.389166580757651
"Section II Part C Cost Sharing Standards","Section E  Clinical Trials",0.382705107241038
"Section B  Calculation of Fee for Service Cost","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.38262545275739
"Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries","Section L  Normalization Factors",0.382047185298646
"Section III Benefit Review","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.381157452381161
"Section III Expanding the Part D OTC Program","Section III CY 2019 Formulary Submission Window",0.375581476009544
"Section G  MA Employer Group Waiver Plans","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.375520779864456
"Section D  ESRD Rates","Section B  FFS Growth Percentage",0.374780884813141
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Medicare Advantage MA Uniformity Flexibility",0.37419485347364
"Section II Part C Optional Supplemental Benefits","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.370819955760912
"Section II Cost Plan Competition Requirements","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.369585365263891
"Section II Outpatient Observation Services","Section II Tiered Cost Sharing of Medical Benefits",0.367073059842796
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section L  Normalization Factors",0.362178242925139
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.360389347965242
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.360314188610018
"Section III Benefit Review","Section III Improving Access to Part D Vaccines",0.355043587035828
"Section A  MA Benchmark Quality Bonus Payments and Rebate","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.354940189667852
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Tiered Cost Sharing of Medical Benefits",0.354906265975949
"Section I Annual Calendar","Section I Incomplete and Inaccurate Bid Submissions",0.354199297740498
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section III Tier Composition",0.351569907301237
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.350746129130709
"Section B  FFS Growth Percentage","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.349181566848853
"Section B  Encounter Data as a Diagnosis Source for 2019","Section L  Normalization Factors",0.347855410484487
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.346916558406764
"Section D  Retiree Drug Subsidy Amounts","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.346494808715218
"Section II Tiered Cost Sharing of Medical Benefits","Section E  Clinical Trials",0.346322030587302
"Section III Benefit Review","Section III Tier Composition",0.344794340435693
"Section A  MA Growth Percentage","Section H  Enhanced Medication Therapy Management MTM Model",0.34424609719196
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.34412281182766
"Section II Employer Group Waiver Plans","Section I Incomplete and Inaccurate Bid Submissions",0.342734973403572
"Section II Cost Plan Competition Requirements","Section II Tiered Cost Sharing of Medical Benefits",0.340835200867036
"Section B  Encounter Data as a Diagnosis Source for 2019","Section A  Update of the RxHCC Model",0.339356460230294
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.339122258058868
"Section II Cost Plan Competition Requirements","Section II Overview of CY 2019 Benefits and Bid Review",0.33775854455486
"Section D  Retiree Drug Subsidy Amounts","Section II Part C Cost Sharing Standards",0.335674989398188
"Section II Cost Plan Competition Requirements","Section II Medicare Advantage MA Uniformity Flexibility",0.333909639288735
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Part C Cost Sharing Standards",0.332958946601487
"Section II Part C Optional Supplemental Benefits","Section II Medicare Advantage MA Segmented Service Area Options",0.332564397284216
"Section II Tiered Cost Sharing of Medical Benefits","Section III Tier Composition",0.331057597547821
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.329278842193719
"Section D  Retiree Drug Subsidy Amounts","Section II Cost Plan Transition to MA under MACRA",0.32904657069328
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.327987886618158
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section E  Clinical Trials",0.32449877630177
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section III Expanding the Part D OTC Program",0.322908408215987
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Health Related Supplemental Benefits",0.321545964458759
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Health Related Supplemental Benefits",0.321465312421025
"Section III Coordination of Benefits COB User Fee","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.320683035101409
"Section II Part C Optional Supplemental Benefits","Section II Overview of CY 2019 Benefits and Bid Review",0.320682099106264
"Section II Outpatient Observation Services","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.3194873208509
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section C  IME Phase Out",0.317491453213878
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Medicare Advantage MA Segmented Service Area Options",0.317430722322411
"Section II Tiered Cost Sharing of Medical Benefits","Section III Improving Access to Part D Vaccines",0.31697988678496
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Cost Plan Competition Requirements",0.315596861538805
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Maximum OutofPocket MOOP Limits",0.315111534757026
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.315049761138443
"Section III Tier Composition","Section III CY 2019 Formulary Submission Window",0.313341664694563
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.312845676164449
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Special Needs Plan SNP Legislative Sunset Provision",0.310759438426942
"Section C  IME Phase Out","Section G  MA Employer Group Waiver Plans",0.310049543363457
"Section II Health Related Supplemental Benefits","Section II Part C Cost Sharing Standards",0.309676424423814
"Section III CY 2019 Formulary Submission Window","Section IV  MedicareMedicaid Plans",0.309254028235519
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.308060544316669
"Section A  MA Growth Percentage","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.306503019305673
"Section D  Retiree Drug Subsidy Amounts","Section II Maximum OutofPocket MOOP Limits",0.305919313846148
"Section II Part C Cost Sharing Standards","Section II Total Beneficiary Cost TBC",0.305786056541483
"Section A  MA Growth Percentage","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.305520350948451
"Section II Tiered Cost Sharing of Medical Benefits","Section II Health Related Supplemental Benefits",0.304733764306824
"Section H  Enhanced Medication Therapy Management MTM Model","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.303741165031644
"Section I Enforcement Actions for Provider Directories","Section II Transparency  Timeliness with Prior Authorization Processes",0.297783395755038
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I  ESRD Risk Adjustment Model for CY 2019",0.297622645824422
"Section II Total Beneficiary Cost TBC","Section B  Calculation of Fee for Service Cost",0.297070214721657
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.296843339380996
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Cost Plan Transition to MA under MACRA",0.293470318119034
"Section A  Update of the RxHCC Model","Section B  Calculation of Fee for Service Cost",0.291814901947539
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section III CY 2019 Formulary Submission Window",0.29054251731329
"Section III Expanding the Part D OTC Program","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.290024797326318
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Improving Access to Part D Vaccines",0.28933095742847
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Maximum OutofPocket MOOP Limits",0.288572010286575
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.28672715791804
"Section II Cost Plan Competition Requirements","Section E  Clinical Trials",0.286689348764614
"Section I Incomplete and Inaccurate Bid Submissions","Section G  MA Employer Group Waiver Plans",0.286056039396742
"Section II Employer Group Waiver Plans","Section II Overview of CY 2019 Benefits and Bid Review",0.285280397352707
"Section II Outpatient Observation Services","Section E  Clinical Trials",0.28493187813253
"Section II Employer Group Waiver Plans","Section I Plan Corrections",0.284079553413994
"Section D  Retiree Drug Subsidy Amounts","Section H  Enhanced Medication Therapy Management MTM Model",0.283865232425533
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section II Total Beneficiary Cost TBC",0.28368707966084
"Section C  IME Phase Out","Section B  FFS Growth Percentage",0.283510272560653
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.282606981917901
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section I Validation Audits",0.281992885976061
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Overview of CY 2019 Benefits and Bid Review",0.279296832382689
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Transparency  Timeliness with Prior Authorization Processes",0.279067176639729
"Section I Innovations in Health Plan Design","Section I  ESRD Risk Adjustment Model for CY 2019",0.278926585511286
"Section II Outpatient Observation Services","Section II Medicare Advantage MA Segmented Service Area Options",0.278886675511358
"Section II Medicare Advantage MA Uniformity Flexibility","Section E  Clinical Trials",0.278760917442759
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Total Beneficiary Cost TBC",0.278380171213363
"Section II Cost Plan Transition to MA under MACRA","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.277759402929029
"Section K  Medicare Advantage Coding Pattern Adjustment","Section B  Calculation of Fee for Service Cost",0.277025874846994
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Health Related Supplemental Benefits",0.275809376263381
"Section B  Calculation of Fee for Service Cost","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.275802070612317
"Section II Cost Plan Competition Requirements","Section II Outpatient Observation Services",0.275796761840366
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section H  Enhanced Medication Therapy Management MTM Model",0.275512964862608
"Section II Cost Plan Competition Requirements","Section II Maximum OutofPocket MOOP Limits",0.275100379654549
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Cost Plan Competition Requirements",0.273660941959293
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section H  Enhanced Medication Therapy Management MTM Model",0.273644887134818
"Section A  Update of the RxHCC Model","Section I Innovations in Health Plan Design",0.273311989080865
"Section II Cost Plan Transition to MA under MACRA","Section II Medicare Advantage MA Uniformity Flexibility",0.27324603263073
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Part C Cost Sharing Standards",0.272487799878068
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Medicare Advantage MA Uniformity Flexibility",0.272388111422586
"Section II Cost Plan Transition to MA under MACRA","Section II Part C Cost Sharing Standards",0.272110946348524
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Overview of CY 2019 Benefits and Bid Review",0.271924866662086
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section L  Normalization Factors",0.271610178631145
"Section D  Retiree Drug Subsidy Amounts","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.271584807805234
"Section II Maximum OutofPocket MOOP Limits","Section E  Clinical Trials",0.270695705003169
"Section I Innovations in Health Plan Design","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.270598732536278
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Tiered Cost Sharing of Medical Benefits",0.27044812241129
"Section III Benefit Review","Section II Tiered Cost Sharing of Medical Benefits",0.270343941799607
"Section III Tier Composition","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.26978126609031
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Tiered Cost Sharing of Medical Benefits",0.2694092191064
"Section D  ESRD Rates","Section L  Normalization Factors",0.268925265616431
"Section III Specialty Tiers","Section II Tiered Cost Sharing of Medical Benefits",0.268671695186439
"Section II Tiered Cost Sharing of Medical Benefits","Section II Total Beneficiary Cost TBC",0.268377257028886
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section A  Update of the RxHCC Model",0.26787359346349
"Section III Coordination of Benefits COB User Fee","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.26762294194878
"Section III Improving Access to Part D Vaccines","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.267098162508495
"Section III Specialty Tiers","Section III Medication Therapy Management MTM Annual Cost Threshold",0.266940592436545
"Section III CY 2019 Formulary Submission Window","Section I Incomplete and Inaccurate Bid Submissions",0.266506901429738
"Section D  ESRD Rates","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.266418289069018
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.265763779406486
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.265429508030918
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.26493824702551
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Medicare Advantage MA Uniformity Flexibility",0.264820448851425
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section I Innovations in Health Plan Design",0.264534972595129
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Medicare Advantage MA Uniformity Flexibility",0.264050060458839
"Section N  Encounter Data as a Diagnosis Source for 2019","Section B  Calculation of Fee for Service Cost",0.263839152355816
"Section I Annual Calendar","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.263014119098459
"Section II Cost Plan Transition to MA under MACRA","Section II Plans with Low Enrollment",0.262841136107264
"Section I Annual Calendar","Section IV  MedicareMedicaid Plans",0.262101411656493
"Section A  Update of the RxHCC Model","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.261830684591991
"Section II Overview of CY 2019 Benefits and Bid Review","Section E  Clinical Trials",0.260955366529483
"Section II Part C Optional Supplemental Benefits","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.260395899264506
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Maximum OutofPocket MOOP Limits",0.258888260579285
"Section II Part C Optional Supplemental Benefits","Section I Incomplete and Inaccurate Bid Submissions",0.258409705424053
"Section II Overview of CY 2019 Benefits and Bid Review","Section IV  MedicareMedicaid Plans",0.258355068073185
"Section II Overview of CY 2019 Benefits and Bid Review","Section G  MA Employer Group Waiver Plans",0.257965306781329
"Section II Employer Group Waiver Plans","Section II Cost Plan Competition Requirements",0.257433854318177
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Expanding the Part D OTC Program",0.257215989193886
"Section II Cost Plan Competition Requirements","Section IV  MedicareMedicaid Plans",0.256772086783533
"Section II Part C Cost Sharing Standards","Section IV  MedicareMedicaid Plans",0.256396468773432
"Section II Cost Plan Competition Requirements","Section II Medicare Advantage MA Segmented Service Area Options",0.25575531215694
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Medicare Advantage MA Segmented Service Area Options",0.255702834465481
"Section I Plan Corrections","Section I Validation Audits",0.255402524652417
"Section I Innovations in Health Plan Design","Section L  Normalization Factors",0.255284991378553
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.254909282502587
"Section II Outpatient Observation Services","Section II Maximum OutofPocket MOOP Limits",0.254901358519881
"Section A  Update of the RxHCC Model","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.254663087521464
"Section IV  MedicareMedicaid Plans","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.253894642980466
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section III Expanding the Part D OTC Program",0.253883549196129
"Section C  Part D Risk Sharing","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.253719380579657
"Section I Enforcement Actions for Provider Directories","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.253222252063417
"Section K  Medicare Advantage Coding Pattern Adjustment","Section G  MA Employer Group Waiver Plans",0.252673632273678
"Section I Plan Corrections","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.25253003383797
"Section III Improving Drug Utilization Review Controls in Medicare Part D","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.252388889641477
"Section I Annual Calendar","Section I Plan Corrections",0.252156217174102
"Section I Plan Corrections","Section III CY 2019 Formulary Submission Window",0.252151324208886
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.251522720403543
"Section III Benefit Review","Section II Health Related Supplemental Benefits",0.250013286211579
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section A  Update of the RxHCC Model",0.249995237142666
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section IV  MedicareMedicaid Plans",0.248712728276658
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section III CY 2019 Formulary Submission Window",0.247892595133461
"Section C  IME Phase Out","Section D  ESRD Rates",0.247426686650202
"Section II Cost Plan Transition to MA under MACRA","Section IV  MedicareMedicaid Plans",0.246443962774434
"Section II Cost Plan Transition to MA under MACRA","Section II Maximum OutofPocket MOOP Limits",0.245936806805363
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.245035372042834
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Medicare Advantage MA Uniformity Flexibility",0.24501073650176
"Section N  Encounter Data as a Diagnosis Source for 2019","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.243878800901347
"Section II Maximum OutofPocket MOOP Limits","Section II Total Beneficiary Cost TBC",0.243504877268726
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Medicare Advantage MA Uniformity Flexibility",0.243498102575754
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.243090957115965
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Tiered Cost Sharing of Medical Benefits",0.242769406839993
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section I Incomplete and Inaccurate Bid Submissions",0.242712931584694
"Section I  ESRD Risk Adjustment Model for CY 2019","Section B  Calculation of Fee for Service Cost",0.242603326473339
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Overview of CY 2019 Benefits and Bid Review",0.242524669468483
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section II Total Beneficiary Cost TBC",0.242227657610983
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Cost Plan Transition to MA under MACRA",0.241852617132725
"Section II Employer Group Waiver Plans","Section II Cost Plan Transition to MA under MACRA",0.241470694088065
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section B  Calculation of Fee for Service Cost",0.240619750108876
"Section II Outpatient Observation Services","Section II Medicare Advantage MA Uniformity Flexibility",0.240427887144316
"Section II Total Beneficiary Cost TBC","Section G  MA Employer Group Waiver Plans",0.240215414677007
"Section D  Retiree Drug Subsidy Amounts","Section C  Part D Risk Sharing",0.240154378334737
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Part C Cost Sharing Standards",0.239145575065846
"Section II Part C Optional Supplemental Benefits","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.239069374538175
"Section II Cost Plan Transition to MA under MACRA","Section II Tiered Cost Sharing of Medical Benefits",0.23905864105898
"Section III Expanding the Part D OTC Program","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.238841062791986
"Section II Total Beneficiary Cost TBC","Section I Incomplete and Inaccurate Bid Submissions",0.237445802218909
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.237310486941847
"Section III Benefit Review","Section II Part C Cost Sharing Standards",0.236735630962053
"Section II Medicare Advantage MA Uniformity Flexibility","Section III Expanding the Part D OTC Program",0.235772322630771
"Section A  Update of the RxHCC Model","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.235440196007321
"Section II Cost Plan Competition Requirements","Section II Transparency  Timeliness with Prior Authorization Processes",0.234525668909161
"Section III Expanding the Part D OTC Program","Section III Tier Composition",0.234418044937251
"Section II Transparency  Timeliness with Prior Authorization Processes","Section E  Clinical Trials",0.234333555356955
"Section I Annual Calendar","Section II Overview of CY 2019 Benefits and Bid Review",0.234111013564876
"Section D  ESRD Rates","Section G  MA Employer Group Waiver Plans",0.233932242070678
"Section III Improving Access to Part D Vaccines","Section III CY 2019 Formulary Submission Window",0.233792444653047
"Section I Annual Calendar","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.233771134371171
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Medication Therapy Management MTM Annual Cost Threshold",0.233713176221401
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section I Plan Corrections",0.233284543392441
"Section H  Enhanced Medication Therapy Management MTM Model","Section IV  MedicareMedicaid Plans",0.233279195245614
"Section II Medicare Advantage MA Uniformity Flexibility","Section IV  MedicareMedicaid Plans",0.232992592698158
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.232878864191149
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.232524055335904
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I  ESRD Risk Adjustment Model for CY 2019",0.232500860318348
"Section C  Part D Risk Sharing","Section II Maximum OutofPocket MOOP Limits",0.231919042460471
"Section H  Enhanced Medication Therapy Management MTM Model","Section II Total Beneficiary Cost TBC",0.231451317767468
"Section III Coordination of Benefits COB User Fee","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.231372547431251
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Outpatient Observation Services",0.231061556756425
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section E  Clinical Trials",0.230856320413353
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section II Part C Cost Sharing Standards",0.230139657157729
"Section II Cost Plan Competition Requirements","Section II Plans with Low Enrollment",0.23009419633857
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.229986462414145
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.229844208873727
"Section III Specialty Tiers","Section D  Retiree Drug Subsidy Amounts",0.229721904777619
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.229310030250703
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.229287238136092
"Section III Specialty Tiers","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.229201730743899
"Section II Part C Cost Sharing Standards","Section B  Calculation of Fee for Service Cost",0.228548335600783
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Cost Plan Transition to MA under MACRA",0.228270578822788
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Overview of CY 2019 Benefits and Bid Review",0.228099509815132
"Section I Plan Corrections","Section IV  MedicareMedicaid Plans",0.228010787191521
"Section III Benefit Review","Section II Part C Optional Supplemental Benefits",0.227691277769594
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Improving Access to Part D Vaccines",0.227324615265926
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Part C Cost Sharing Standards",0.227210529149149
"Section N  Encounter Data as a Diagnosis Source for 2019","Section D  ESRD Rates",0.227181079667418
"Section II Plans with Low Enrollment","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.226715033535998
"Section III CY 2019 Formulary Submission Window","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.226693998188154
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Expanding the Part D OTC Program",0.226284818927626
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.226227906933587
"Section C  IME Phase Out","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.225902131720704
"Section II Cost Plan Transition to MA under MACRA","Section III Low Enrollment Plans Standalone PDPs only",0.225418828614566
"Section B  FFS Growth Percentage","Section H  Enhanced Medication Therapy Management MTM Model",0.225016240767925
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Plans with Low Enrollment",0.2245730866343
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.224484795764816
"Section A  Update of the RxHCC Model","Section H  Enhanced Medication Therapy Management MTM Model",0.224457670059951
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Medicare Advantage MA Segmented Service Area Options",0.224307940120649
"Section II Part C Optional Supplemental Benefits","Section II Total Beneficiary Cost TBC",0.223774531689993
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.223167421625502
"Section III Benefit Review","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.222700892076202
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III Expanding the Part D OTC Program",0.222192253150767
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.221605840893869
"Section M  Medical Loss Ratio Credibility Adjustment","Section B  Calculation of Fee for Service Cost",0.221588268446829
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Benefit Review",0.221535470115151
"Section II Part C Cost Sharing Standards","Section I Incomplete and Inaccurate Bid Submissions",0.221250070964049
"Section I Annual Calendar","Section III CY 2019 Formulary Submission Window",0.220446535816538
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.219253071174787
"Section I Enforcement Actions for Provider Directories","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.218949447552634
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.218693377593381
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Part C Cost Sharing Standards",0.216883211720346
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III CY 2019 Formulary Submission Window",0.216873368568901
"Section C  Part D Risk Sharing","Section II Part C Cost Sharing Standards",0.216812194124787
"Section A  Update of the RxHCC Model","Section II Total Beneficiary Cost TBC",0.216296641777439
"Section D  Retiree Drug Subsidy Amounts","Section II Tiered Cost Sharing of Medical Benefits",0.216123495927107
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.216095447064357
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.215899987542758
"Section II Cost Plan Competition Requirements","Section B  Calculation of Fee for Service Cost",0.215740688487398
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.215483169109925
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Total Beneficiary Cost TBC",0.215458819132498
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Cost Plan Competition Requirements",0.215339757607312
"Section K  Medicare Advantage Coding Pattern Adjustment","Section D  ESRD Rates",0.215256591577394
"Section L  Normalization Factors","Section B  Calculation of Fee for Service Cost",0.214716820416643
"Section II Cost Plan Competition Requirements","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.214699672157415
"Section K  Medicare Advantage Coding Pattern Adjustment","Section M  Medical Loss Ratio Credibility Adjustment",0.213881934552011
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.213727175403016
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.213378531829685
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Transparency  Timeliness with Prior Authorization Processes",0.213109178540067
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.212873464928123
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Maximum OutofPocket MOOP Limits",0.212410991171606
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section IV  MedicareMedicaid Plans",0.212117411544292
"Section II Tiered Cost Sharing of Medical Benefits","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.211784737400751
"Section II Cost Plan Transition to MA under MACRA","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.211779879799108
"Section D  Retiree Drug Subsidy Amounts","Section II Overview of CY 2019 Benefits and Bid Review",0.211560728264088
"Section III Benefit Review","Section II Medicare Advantage MA Uniformity Flexibility",0.211123859047238
"Section I Innovations in Health Plan Design","Section II Total Beneficiary Cost TBC",0.210970518104978
"Section III Expanding the Part D OTC Program","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.210861518314866
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.210797640091428
"Section III Expanding the Part D OTC Program","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.210077508961549
"Section II Outpatient Observation Services","Section II Health Related Supplemental Benefits",0.209980262782904
"Section III Coordination of Benefits COB User Fee","Section III Expanding the Part D OTC Program",0.209884635809877
"Section M  Medical Loss Ratio Credibility Adjustment","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.209630105898268
"Section II Total Beneficiary Cost TBC","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.209511145205729
"Section I Plan Corrections","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.208264625645088
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section E  Clinical Trials",0.208051421763637
"Section D  Retiree Drug Subsidy Amounts","Section II Total Beneficiary Cost TBC",0.206874366460535
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.206719487079807
"Section III Expanding the Part D OTC Program","Section III Improving Access to Part D Vaccines",0.206286493494814
"Section I Incomplete and Inaccurate Bid Submissions","Section I Validation Audits",0.206260497708317
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.205841488378327
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section G  MA Employer Group Waiver Plans",0.205730161784209
"Section II Tiered Cost Sharing of Medical Benefits","Section IV  MedicareMedicaid Plans",0.205400442093956
"Section III Expanding the Part D OTC Program","Section II Health Related Supplemental Benefits",0.2053501270971
"Section II Part C Optional Supplemental Benefits","Section II Tiered Cost Sharing of Medical Benefits",0.205183191818737
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section III CY 2019 Formulary Submission Window",0.204248825925997
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I  ESRD Risk Adjustment Model for CY 2019",0.204135591486836
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.204014386108144
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Cost Plan Competition Requirements",0.203833162695929
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section K  Medicare Advantage Coding Pattern Adjustment",0.203827113785394
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Total Beneficiary Cost TBC",0.203529747200094
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.203478994695459
"Section II Cost Plan Transition to MA under MACRA","Section I Incomplete and Inaccurate Bid Submissions",0.203245357947882
"Section B  FFS Growth Percentage","Section G  MA Employer Group Waiver Plans",0.203026348936672
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Total Beneficiary Cost TBC",0.202930793937845
"Section D  ESRD Rates","Section A  Update of the RxHCC Model",0.202808773094829
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section B  Calculation of Fee for Service Cost",0.202594605518344
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section III Improving Access to Part D Vaccines",0.202278196513501
"Section I Annual Calendar","Section III Expanding the Part D OTC Program",0.202275000568372
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Coordination of Benefits COB User Fee",0.202238944425401
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section C  Part D Risk Sharing",0.202200654631111
"Section B  Encounter Data as a Diagnosis Source for 2019","Section B  Calculation of Fee for Service Cost",0.202152224521162
"Section II Part C Optional Supplemental Benefits","Section I Plan Corrections",0.202100347272242
"Section II Part C Cost Sharing Standards","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.201745987410125
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Outpatient Observation Services",0.201604094056229
"Section II Employer Group Waiver Plans","Section II Medicare Advantage MA Uniformity Flexibility",0.201145570320453
"Section D  ESRD Rates","Section II Total Beneficiary Cost TBC",0.200414957422753
"Section II Employer Group Waiver Plans","Section IV  MedicareMedicaid Plans",0.200045005735019
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.200000946752285
"Section I Plan Corrections","Section G  MA Employer Group Waiver Plans",0.199938080727709
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section A  Update of the RxHCC Model",0.199889594250488
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.199412151688382
"Section II Employer Group Waiver Plans","Section II Part C Optional Supplemental Benefits",0.199254192554687
"Section II Part C Optional Supplemental Benefits","Section II Part C Cost Sharing Standards",0.198936670446293
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section III Tier Composition",0.198862136685822
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.198778371567936
"Section II Overview of CY 2019 Benefits and Bid Review","Section B  Calculation of Fee for Service Cost",0.198645947388459
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Cost Plan Transition to MA under MACRA",0.198443173031979
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Plans with Low Enrollment",0.198308409301853
"Section G  MA Employer Group Waiver Plans","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.197966547459169
"Section A  MA Growth Percentage","Section II Total Beneficiary Cost TBC",0.197925405761411
"Section II Total Beneficiary Cost TBC","Section IV  MedicareMedicaid Plans",0.197825489210749
"Section I Incomplete and Inaccurate Bid Submissions","Section IV  MedicareMedicaid Plans",0.197777029680196
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.197776812263263
"Section D  ESRD Rates","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.197732598678674
"Section II Medicare Advantage MA Uniformity Flexibility","Section A  Update of the RxHCC Model",0.197365514467985
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section IV  MedicareMedicaid Plans",0.197345934990771
"Section K  Medicare Advantage Coding Pattern Adjustment","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.197294020414192
"Section II Employer Group Waiver Plans","Section G  MA Employer Group Waiver Plans",0.197176162044094
"Section II Cost Plan Competition Requirements","Section II Total Beneficiary Cost TBC",0.197123057142845
"Section IV  MedicareMedicaid Plans","Section B  Calculation of Fee for Service Cost",0.1971153484871
"Section III Benefit Review","Section II Overview of CY 2019 Benefits and Bid Review",0.196827132522049
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Transparency  Timeliness with Prior Authorization Processes",0.196459466599248
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Tiered Cost Sharing of Medical Benefits",0.196328623115567
"Section II Transparency  Timeliness with Prior Authorization Processes","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.196137033016142
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.195677866256554
"Section D  Retiree Drug Subsidy Amounts","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.19554374210667
"Section D  Retiree Drug Subsidy Amounts","Section IV  MedicareMedicaid Plans",0.195344334868324
"Section II Health Related Supplemental Benefits","Section IV  MedicareMedicaid Plans",0.195291195229433
"Section III Coordination of Benefits COB User Fee","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.1949807899
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.194386156553852
"Section II Health Related Supplemental Benefits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.194363617009025
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section II Part C Cost Sharing Standards",0.193873187064853
"Section II Employer Group Waiver Plans","Section II Part C Cost Sharing Standards",0.193555007073951
"Section II Part C Optional Supplemental Benefits","Section IV  MedicareMedicaid Plans",0.193190081919233
"Section II Maximum OutofPocket MOOP Limits","Section B  Calculation of Fee for Service Cost",0.193062936706179
"Section II Medicare Advantage MA Uniformity Flexibility","Section I Innovations in Health Plan Design",0.192977670577466
"Section III Benefit Review","Section III Specialty Tiers",0.19235116909125
"Section III Expanding the Part D OTC Program","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.19215189541702
"Section III Coordination of Benefits COB User Fee","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.192125264848939
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Transparency  Timeliness with Prior Authorization Processes",0.19200736982043
"Section C  Part D Risk Sharing","Section II Total Beneficiary Cost TBC",0.191612799337035
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section D  Retiree Drug Subsidy Amounts",0.191549793097986
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Plans with Low Enrollment",0.191409065348007
"Section D  ESRD Rates","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.191124272836622
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Overview of CY 2019 Benefits and Bid Review",0.190933994823356
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section I Innovations in Health Plan Design",0.190540675313129
"Section II Medicare Advantage MA Segmented Service Area Options","Section E  Clinical Trials",0.190503315570425
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.190456048708709
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Medicare Advantage MA Uniformity Flexibility",0.189754710857371
"Section A  Update of the RxHCC Model","Section IV  MedicareMedicaid Plans",0.189546211539468
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.189390072812737
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section IV  MedicareMedicaid Plans",0.189213439233172
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.18905371186265
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.188975973404711
"Section G  MA Employer Group Waiver Plans","Section L  Normalization Factors",0.188592404081604
"Section III Improving Access to Part D Vaccines","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.188137518431709
"Section III Low Enrollment Plans Standalone PDPs only","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.187707281757452
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section II Maximum OutofPocket MOOP Limits",0.187568034035489
"Section II Part C Cost Sharing Standards","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.187506922135725
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Cost Plan Transition to MA under MACRA",0.187371586656206
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.186920436678954
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section H  Enhanced Medication Therapy Management MTM Model",0.186728187262827
"Section D  ESRD Rates","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.186462388041133
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.186300549390128
"Section N  Encounter Data as a Diagnosis Source for 2019","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.186281094007043
"Section II Cost Plan Transition to MA under MACRA","Section E  Clinical Trials",0.186243002886688
"Section I Annual Calendar","Section II Health Related Supplemental Benefits",0.186193742290416
"Section II Cost Plan Transition to MA under MACRA","Section B  Calculation of Fee for Service Cost",0.185612036319131
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Plans with Low Enrollment",0.185223802730241
"Section III Benefit Review","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.185174279201544
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section I Incomplete and Inaccurate Bid Submissions",0.184459373178178
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Medicare Advantage MA Segmented Service Area Options",0.184336680445834
"Section II Medicare Advantage MA Uniformity Flexibility","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.184179240663751
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.183917275100261
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Innovations in Health Plan Design",0.183795931813026
"Section III Coordination of Benefits COB User Fee","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.183553250322494
"Section III Improving Access to Part D Vaccines","Section H  Enhanced Medication Therapy Management MTM Model",0.183529536769386
"Section II Part C Optional Supplemental Benefits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.183519380524499
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Tier Composition",0.182743955509149
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section A  Update of the RxHCC Model",0.182425787707768
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section III Low Enrollment Plans Standalone PDPs only",0.182059825472702
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section IV  MedicareMedicaid Plans",0.181973916301926
"Section II Total Beneficiary Cost TBC","Section I  ESRD Risk Adjustment Model for CY 2019",0.181765404811305
"Section A  Update of the RxHCC Model","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.181691066703305
"Section II Health Related Supplemental Benefits","Section II Total Beneficiary Cost TBC",0.181540205249243
"Section II Medicare Advantage MA Uniformity Flexibility","Section I Incomplete and Inaccurate Bid Submissions",0.181376861837856
"Section K  Medicare Advantage Coding Pattern Adjustment","Section O  Quality Payment Program",0.181332639379726
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.181261589460561
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section IV  MedicareMedicaid Plans",0.181216182426934
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Part C Cost Sharing Standards",0.181184340527658
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.18114405387919
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Part C Cost Sharing Standards",0.180561830232196
"Section II Employer Group Waiver Plans","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.180126583402889
"Section II Part C Optional Supplemental Benefits","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.18004677414389
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.179678527329805
"Section III Coordination of Benefits COB User Fee","Section III CY 2019 Formulary Submission Window",0.179669372184169
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section IV  MedicareMedicaid Plans",0.179566559992471
"Section II Part C Cost Sharing Standards","Section H  Enhanced Medication Therapy Management MTM Model",0.179504666866201
"Section I Plan Corrections","Section II Total Beneficiary Cost TBC",0.179286140206958
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section E  Clinical Trials",0.179149631358206
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.179026277969047
"Section A  Update of the RxHCC Model","Section III Improving Access to Part D Vaccines",0.178976444279303
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Medicare Advantage MA Uniformity Flexibility",0.178849267704649
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Tiered Cost Sharing of Medical Benefits",0.178740163476935
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Overview of CY 2019 Benefits and Bid Review",0.178599536980528
"Section I Annual Calendar","Section II Medicare Advantage MA Uniformity Flexibility",0.178541910193085
"Section B  Encounter Data as a Diagnosis Source for 2019","Section D  ESRD Rates",0.178465798281826
"Section III Specialty Tiers","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.178176159191678
"Section I Annual Calendar","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.178170018605044
"Section III Benefit Review","Section II Total Beneficiary Cost TBC",0.178158727782219
"Section II Cost Plan Transition to MA under MACRA","Section II Total Beneficiary Cost TBC",0.178051559206515
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section IV  MedicareMedicaid Plans",0.177761360167346
"Section III Coordination of Benefits COB User Fee","Section H  Enhanced Medication Therapy Management MTM Model",0.177684575626462
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Medicare Advantage MA Segmented Service Area Options",0.177649346699671
"Section III Coordination of Benefits COB User Fee","Section A  Update of the RxHCC Model",0.177648565219082
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.177617882608721
"Section II Cost Plan Competition Requirements","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.177617347903855
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.177482103317373
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.177343335831371
"Section II Overview of CY 2019 Benefits and Bid Review","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.177319528384658
"Section K  Medicare Advantage Coding Pattern Adjustment","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.177301006033006
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.177059319754533
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.176805319589672
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section II Total Beneficiary Cost TBC",0.176797044168678
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Tiered Cost Sharing of Medical Benefits",0.176617118648332
"Section N  Encounter Data as a Diagnosis Source for 2019","Section G  MA Employer Group Waiver Plans",0.17658243279443
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.176550971177352
"Section III Specialty Tiers","Section H  Enhanced Medication Therapy Management MTM Model",0.176150959329532
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Part C Cost Sharing Standards",0.17608771255909
"Section B  FFS Growth Percentage","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.176010685139536
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.175806270675573
"Section III Expanding the Part D OTC Program","Section H  Enhanced Medication Therapy Management MTM Model",0.175689308394547
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.175571632678889
"Section II Plans with Low Enrollment","Section II Medicare Advantage MA Uniformity Flexibility",0.175566617923834
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section B  Calculation of Fee for Service Cost",0.175264452763922
"Section O  Quality Payment Program","Section G  MA Employer Group Waiver Plans",0.175233888180815
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section M  Medical Loss Ratio Credibility Adjustment",0.174218286911142
"Section I Innovations in Health Plan Design","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.173772339683269
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.17369002043213
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section I Incomplete and Inaccurate Bid Submissions",0.173679250085833
"Section N  Encounter Data as a Diagnosis Source for 2019","Section K  Medicare Advantage Coding Pattern Adjustment",0.173467853193852
"Section O  Quality Payment Program","Section B  Calculation of Fee for Service Cost",0.173463106759169
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.173121594864601
"Section A  Update of the RxHCC Model","Section II Health Related Supplemental Benefits",0.173111070640258
"Section B  Encounter Data as a Diagnosis Source for 2019","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.173107592022124
"Section III Specialty Tiers","Section III CY 2019 Formulary Submission Window",0.173099326716411
"Section I Innovations in Health Plan Design","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.172759437491385
"Section I Annual Calendar","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.172751672001985
"Section H  Enhanced Medication Therapy Management MTM Model","Section G  MA Employer Group Waiver Plans",0.172654385072185
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section III CY 2019 Formulary Submission Window",0.172205502393567
"Section K  Medicare Advantage Coding Pattern Adjustment","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.171880405264832
"Section H  Enhanced Medication Therapy Management MTM Model","Section B  Calculation of Fee for Service Cost",0.17182021894738
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section M  Medical Loss Ratio Credibility Adjustment",0.171796067734069
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Expanding the Part D OTC Program",0.171490960441598
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD",0.171145343603423
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section I Incomplete and Inaccurate Bid Submissions",0.171132409254068
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Tiered Cost Sharing of Medical Benefits",0.171097292014246
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Innovations in Health Plan Design",0.170756674350042
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Special Needs Plan SNP Legislative Sunset Provision",0.17062167331048
"Section II Transparency  Timeliness with Prior Authorization Processes","Section IV  MedicareMedicaid Plans",0.170332647289035
"Section I Annual Calendar","Section II Part C Cost Sharing Standards",0.170228147175974
"Section II Health Related Supplemental Benefits","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.169804728572383
"Section B  FFS Growth Percentage","Section II Total Beneficiary Cost TBC",0.169747810159293
"Section III Tier Composition","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.169511409214756
"Section II Part C Cost Sharing Standards","Section G  MA Employer Group Waiver Plans",0.169478989018768
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.169210933228643
"Section H  Enhanced Medication Therapy Management MTM Model","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.169165052145554
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section E  Clinical Trials",0.169149509867515
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section B  Calculation of Fee for Service Cost",0.168577352297446
"Section II Tiered Cost Sharing of Medical Benefits","Section B  Calculation of Fee for Service Cost",0.167814776830458
"Section H  Enhanced Medication Therapy Management MTM Model","Section III CY 2019 Formulary Submission Window",0.167659958316128
"Section A  Update of the RxHCC Model","Section II Part C Cost Sharing Standards",0.167580949307157
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.167476283141468
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section I  ESRD Risk Adjustment Model for CY 2019",0.167217749608565
"Section D  Retiree Drug Subsidy Amounts","Section E  Clinical Trials",0.167093543073162
"Section II Transparency  Timeliness with Prior Authorization Processes","Section I Innovations in Health Plan Design",0.167083105671994
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section I  ESRD Risk Adjustment Model for CY 2019",0.166841248237035
"Section A  Update of the RxHCC Model","Section III CY 2019 Formulary Submission Window",0.166836664404398
"Section II Part C Optional Supplemental Benefits","Section G  MA Employer Group Waiver Plans",0.166400057998435
"Section II Overview of CY 2019 Benefits and Bid Review","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.166271992439069
"Section D  ESRD Rates","Section II Part C Cost Sharing Standards",0.16617273717407
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section C  Part D Risk Sharing",0.165829678674195
"Section II Part C Optional Supplemental Benefits","Section III Expanding the Part D OTC Program",0.165568346357975
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.165503494973938
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section III Expanding the Part D OTC Program",0.165432110405062
"Section IV  MedicareMedicaid Plans","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.165037231808741
"Section III Expanding the Part D OTC Program","Section II Part C Cost Sharing Standards",0.1648743296888
"Section II Employer Group Waiver Plans","Section II Tiered Cost Sharing of Medical Benefits",0.164760953182893
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Innovations in Health Plan Design",0.164734375401274
"Section II Cost Plan Competition Requirements","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.164334297178228
"Section B  Encounter Data as a Diagnosis Source for 2019","Section C  Part D Risk Sharing",0.164273692960968
"Section I Innovations in Health Plan Design","Section O  Quality Payment Program",0.164262943382314
"Section H  Enhanced Medication Therapy Management MTM Model","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.164233526706744
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.164133409490813
"Section K  Medicare Advantage Coding Pattern Adjustment","Section L  Normalization Factors",0.164102981697742
"Section II Employer Group Waiver Plans","Section III Benefit Review",0.164082530828473
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Part C Optional Supplemental Benefits",0.16407786322693
"Section II Medicare Advantage MA Segmented Service Area Options","Section III Expanding the Part D OTC Program",0.163889658713765
"Section II Cost Plan Competition Requirements","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.163718219070954
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.163630664888997
"Section II Part C Optional Supplemental Benefits","Section I Annual Calendar",0.163598344665591
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Cost Plan Transition to MA under MACRA",0.163226129642502
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.163168833291209
"Section III Benefit Review","Section II Medicare Advantage MA Segmented Service Area Options",0.163012665924157
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Health Related Supplemental Benefits",0.162862319290384
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Expanding the Part D OTC Program",0.162725365422339
"Section II Cost Plan Competition Requirements","Section D  ESRD Rates",0.162431316553481
"Section N  Encounter Data as a Diagnosis Source for 2019","Section B  FFS Growth Percentage",0.162352570321706
"Section III Low Enrollment Plans Standalone PDPs only","Section G  MA Employer Group Waiver Plans",0.162350812618189
"Section K  Medicare Advantage Coding Pattern Adjustment","Section C  IME Phase Out",0.162030901952128
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section G  MA Employer Group Waiver Plans",0.161978936483849
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section O  Quality Payment Program",0.161908133741007
"Section III Coordination of Benefits COB User Fee","Section III Tier Composition",0.161559015238023
"Section II Part C Optional Supplemental Benefits","Section H  Enhanced Medication Therapy Management MTM Model",0.161355263116004
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.161256814136292
"Section I Annual Calendar","Section III Coordination of Benefits COB User Fee",0.161145568477228
"Section II Total Beneficiary Cost TBC","Section L  Normalization Factors",0.161099177038826
"Section A  Update of the RxHCC Model","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.160878046406621
"Section III Coordination of Benefits COB User Fee","Section IV  MedicareMedicaid Plans",0.160859410625125
"Section II Maximum OutofPocket MOOP Limits","Section IV  MedicareMedicaid Plans",0.160814824493654
"Section I Innovations in Health Plan Design","Section II Part C Cost Sharing Standards",0.160773708233981
"Section III Benefit Review","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.160717946423488
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Special Needs Plan SNP Legislative Sunset Provision",0.160412260726458
"Section III Expanding the Part D OTC Program","Section IV  MedicareMedicaid Plans",0.160255174129422
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Medicare Advantage MA Uniformity Flexibility",0.160240249131245
"Section D  Retiree Drug Subsidy Amounts","Section II Medicare Advantage MA Segmented Service Area Options",0.160196628537233
"Section B  FFS Growth Percentage","Section I  ESRD Risk Adjustment Model for CY 2019",0.159942251469684
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Special Needs Plan SNP Legislative Sunset Provision",0.159766110561763
"Section II Employer Group Waiver Plans","Section II Meaningful Difference Substantially Duplicative Plan Offerings",0.159656494006449
"Section II Total Beneficiary Cost TBC","Section E  Clinical Trials",0.159414074762603
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Health Related Supplemental Benefits",0.159350082039907
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Medicare Advantage MA Uniformity Flexibility",0.15932367761353
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Plans with Low Enrollment",0.159202254221864
"Section II Cost Plan Transition to MA under MACRA","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.159118929428109
"Section II Employer Group Waiver Plans","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.158835069332725
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Total Beneficiary Cost TBC",0.158823982307912
"Section II Cost Plan Competition Requirements","Section C  IME Phase Out",0.158712664911984
"Section D  Retiree Drug Subsidy Amounts","Section B  Calculation of Fee for Service Cost",0.158643200110203
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section III CY 2019 Formulary Submission Window",0.158621943268616
"Section B  FFS Growth Percentage","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.158617899368822
"Section I Annual Calendar","Section G  MA Employer Group Waiver Plans",0.158261466293468
"Section II Transparency  Timeliness with Prior Authorization Processes","Section III Expanding the Part D OTC Program",0.15778612373518
"Section II Health Related Supplemental Benefits","Section E  Clinical Trials",0.157689054655892
"Section K  Medicare Advantage Coding Pattern Adjustment","Section B  FFS Growth Percentage",0.157581073455262
"Section A  Update of the RxHCC Model","Section G  MA Employer Group Waiver Plans",0.157412469493894
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Low Enrollment Plans Standalone PDPs only",0.157359158493889
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.156877529135623
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Medicare Advantage MA Uniformity Flexibility",0.156734538677054
"Section III Tier Composition","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.156682725843881
"Section II Employer Group Waiver Plans","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.156675454217948
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.156659895906887
"Section II Medicare Advantage MA Segmented Service Area Options","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.156450431039846
"Section II Tiered Cost Sharing of Medical Benefits","Section I Innovations in Health Plan Design",0.156333481569969
"Section III Expanding the Part D OTC Program","Section I Innovations in Health Plan Design",0.156316403244762
"Section III Coordination of Benefits COB User Fee","Section III Improving Access to Part D Vaccines",0.156281795193342
"Section C  IME Phase Out","Section II Medicare Advantage MA Uniformity Flexibility",0.156252488537471
"Section I Annual Calendar","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.156139145072956
"Section B  Encounter Data as a Diagnosis Source for 2019","Section B  FFS Growth Percentage",0.156083832154503
"Section II Overview of CY 2019 Benefits and Bid Review","Section A  Update of the RxHCC Model",0.156064772221569
"Section II Maximum OutofPocket MOOP Limits","Section G  MA Employer Group Waiver Plans",0.156057049928033
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section B  Calculation of Fee for Service Cost",0.155787831697597
"Section II Cost Plan Competition Requirements","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.155623375153192
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.155584429048035
"Section I Annual Calendar","Section H  Enhanced Medication Therapy Management MTM Model",0.155458566439913
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Innovations in Health Plan Design",0.155364923258649
"Section III Specialty Tiers","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.155284114717133
"Section C  Part D Risk Sharing","Section G  MA Employer Group Waiver Plans",0.155159422135734
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Overview of CY 2019 Benefits and Bid Review",0.154961362968399
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section C  IME Phase Out",0.154951710613002
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.154775342257043
"Section III Coordination of Benefits COB User Fee","Section II Overview of CY 2019 Benefits and Bid Review",0.154753396447063
"Section III CY 2019 Formulary Submission Window","Section II Total Beneficiary Cost TBC",0.154593323852882
"Section I Annual Calendar","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.154585686056722
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Validation Audits",0.15449059175317
"Section I Innovations in Health Plan Design","Section B  Calculation of Fee for Service Cost",0.154466451098546
"Section II Medicare Advantage MA Segmented Service Area Options","Section IV  MedicareMedicaid Plans",0.154361002832217
"Section II Transparency  Timeliness with Prior Authorization Processes","Section I Incomplete and Inaccurate Bid Submissions",0.154103635465151
"Section III Expanding the Part D OTC Program","Section I Validation Audits",0.154095228828493
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.154066506614562
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.154028403816941
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.153968602136666
"Section II Cost Plan Competition Requirements","Section H  Enhanced Medication Therapy Management MTM Model",0.153941856187016
"Section II Tiered Cost Sharing of Medical Benefits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.153851345946474
"Section II Outpatient Observation Services","Section IV  MedicareMedicaid Plans",0.15384363221211
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.15375582534338
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section III Expanding the Part D OTC Program",0.153694769421652
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Plans with Low Enrollment",0.15367785037837
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Total Beneficiary Cost TBC",0.15365952166279
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.153620463709374
"Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries","Section B  Calculation of Fee for Service Cost",0.153586088489969
"Section I Innovations in Health Plan Design","Section E  Clinical Trials",0.153476276598531
"Section IV  MedicareMedicaid Plans","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.153167868311119
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Maximum OutofPocket MOOP Limits",0.153031619227424
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section I  ESRD Risk Adjustment Model for CY 2019",0.152919129115169
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.152759504575334
"Section II Total Beneficiary Cost TBC","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.152717975579419
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section IV  MedicareMedicaid Plans",0.152541652099705
"Section II Medicare Advantage MA Uniformity Flexibility","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.152264607963715
"Section II Part C Optional Supplemental Benefits","Section II Cost Plan Transition to MA under MACRA",0.152255639294224
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.152235199882041
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Meaningful Difference Substantially Duplicative Plan Offerings",0.15209250036889
"Section II Cost Plan Competition Requirements","Section III Low Enrollment Plans Standalone PDPs only",0.151956109915526
"Section I Enforcement Actions for Provider Directories","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.151901411520994
"Section II Plans with Low Enrollment","Section II Part C Cost Sharing Standards",0.151837330685992
"Section III Expanding the Part D OTC Program","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.151810400108879
"Section C  IME Phase Out","Section II Part C Cost Sharing Standards",0.151735453749186
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.15168520472008
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Cost Plan Transition to MA under MACRA",0.151635152908388
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Coordination of Benefits COB User Fee",0.151401152707928
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.151378520830506
"Section III Low Enrollment Plans Standalone PDPs only","Section II Medicare Advantage MA Uniformity Flexibility",0.151357493732854
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section G  MA Employer Group Waiver Plans",0.151337181093973
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section III CY 2019 Formulary Submission Window",0.151253915781572
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.151246655317805
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Incomplete and Inaccurate Bid Submissions",0.151153983439774
"Section C  Part D Risk Sharing","Section H  Enhanced Medication Therapy Management MTM Model",0.151084174274578
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section B  Calculation of Fee for Service Cost",0.150928912946397
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Plans with Low Enrollment",0.150895714745729
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.150761624993104
"Section II Employer Group Waiver Plans","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.150691470849833
"Section III Expanding the Part D OTC Program","Section A  Update of the RxHCC Model",0.150619804183068
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section H  Enhanced Medication Therapy Management MTM Model",0.150603402899917
"Section A  MA Growth Percentage","Section B  Calculation of Fee for Service Cost",0.150343333509356
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.149816138603462
"Section II Medicare Advantage MA Uniformity Flexibility","Section H  Enhanced Medication Therapy Management MTM Model",0.1496845740815
"Section I  ESRD Risk Adjustment Model for CY 2019","Section G  MA Employer Group Waiver Plans",0.149615864126157
"Section III Coordination of Benefits COB User Fee","Section II Medicare Advantage MA Uniformity Flexibility",0.149610435598389
"Section II Plans with Low Enrollment","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.149503654276286
"Section III Low Enrollment Plans Standalone PDPs only","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.149470318888988
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.149325998718729
"Section III Tier Composition","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.149317614612527
"Section III Coordination of Benefits COB User Fee","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.149302951636709
"Section II Medicare Advantage MA Segmented Service Area Options","Section A  Update of the RxHCC Model",0.149224073985314
"Section C  IME Phase Out","Section II Total Beneficiary Cost TBC",0.149129579240252
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section I Plan Corrections",0.149072150158998
"Section A  MA Growth Percentage","Section II Cost Plan Competition Requirements",0.148955483041726
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.148903299692447
"Section C  IME Phase Out","Section C  Part D Risk Sharing",0.14887740465225
"Section H  Enhanced Medication Therapy Management MTM Model","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.148568267292721
"Section M  Medical Loss Ratio Credibility Adjustment","Section D  ESRD Rates",0.148517899366373
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.148456409964018
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.14839025213765
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Special Needs Plan SNP Legislative Sunset Provision",0.148293978751537
"Section C  IME Phase Out","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.148099701332015
"Section N  Encounter Data as a Diagnosis Source for 2019","Section C  Part D Risk Sharing",0.148057610878158
"Section II Cost Plan Competition Requirements","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.148050774696916
"Section II Transparency  Timeliness with Prior Authorization Processes","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.148023512825757
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Part C Cost Sharing Standards",0.147842353304989
"Section D  Retiree Drug Subsidy Amounts","Section II Medicare Advantage MA Uniformity Flexibility",0.147799264015166
"Section I Annual Calendar","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.147760926372222
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.147729214308108
"Section II Tiered Cost Sharing of Medical Benefits","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.147460673246995
"Section III Coordination of Benefits COB User Fee","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.147324754698937
"Section II Part C Optional Supplemental Benefits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.146915826985597
"Section I Innovations in Health Plan Design","Section II Health Related Supplemental Benefits",0.146901898039417
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Expanding the Part D OTC Program",0.146837000630673
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.146665031328092
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Incomplete and Inaccurate Bid Submissions",0.146571064893771
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I Innovations in Health Plan Design",0.146305327768126
"Section O  Quality Payment Program","Section II Total Beneficiary Cost TBC",0.146298071676002
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.14616278510807
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Improving Access to Part D Vaccines",0.146084503017249
"Section I Annual Calendar","Section II Transparency  Timeliness with Prior Authorization Processes",0.146076636867036
"Section C  IME Phase Out","Section II Tiered Cost Sharing of Medical Benefits",0.145855778824091
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section I  ESRD Risk Adjustment Model for CY 2019",0.145505317631043
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section I Innovations in Health Plan Design",0.145444215909609
"Section II Part C Optional Supplemental Benefits","Section III Tier Composition",0.145248907445799
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Total Beneficiary Cost TBC",0.145247582487771
"Section III Low Enrollment Plans Standalone PDPs only","Section II Maximum OutofPocket MOOP Limits",0.145225057518197
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.145136854623578
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section III Low Enrollment Plans Standalone PDPs only",0.144903183247772
"Section II Employer Group Waiver Plans","Section I Validation Audits",0.144813653236721
"Section II Transparency  Timeliness with Prior Authorization Processes","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.144576529030661
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section C  IME Phase Out",0.144538978993357
"Section III Specialty Tiers","Section III Expanding the Part D OTC Program",0.144431368122222
"Section II Plans with Low Enrollment","Section II Maximum OutofPocket MOOP Limits",0.144353065461542
"Section II Employer Group Waiver Plans","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.144272241398022
"Section III Expanding the Part D OTC Program","Section I Incomplete and Inaccurate Bid Submissions",0.144165053902964
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.144000512002731
"Section II Plans with Low Enrollment","Section II Tiered Cost Sharing of Medical Benefits",0.143906796319571
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section D  Retiree Drug Subsidy Amounts",0.143887771050565
"Section II Tiered Cost Sharing of Medical Benefits","Section I Incomplete and Inaccurate Bid Submissions",0.143862368501386
"Section I Validation Audits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.143832366595824
"Section C  Part D Risk Sharing","Section B  Calculation of Fee for Service Cost",0.143630958196123
"Section II Cost Plan Competition Requirements","Section II Health Related Supplemental Benefits",0.143556552543333
"Section O  Quality Payment Program","Section L  Normalization Factors",0.143479577536547
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.143473891566954
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Plan Corrections",0.143435047064498
"Section II Employer Group Waiver Plans","Section I Annual Calendar",0.143385635819773
"Section I Incomplete and Inaccurate Bid Submissions","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.143336648780197
"Section II Health Related Supplemental Benefits","Section I Incomplete and Inaccurate Bid Submissions",0.14320858971727
"Section I Enforcement Actions for Provider Directories","Section II Tiered Cost Sharing of Medical Benefits",0.1431872378695
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I Innovations in Health Plan Design",0.143126632539919
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section D  ESRD Rates",0.142985912617249
"Section III Tier Composition","Section H  Enhanced Medication Therapy Management MTM Model",0.142900641557731
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Tiered Cost Sharing of Medical Benefits",0.142761404649066
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.142757793113209
"Section A  Update of the RxHCC Model","Section C  Part D Risk Sharing",0.14270572420654
"Section II Plans with Low Enrollment","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.142629312870061
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section O  Quality Payment Program",0.142590968738955
"Section II Plans with Low Enrollment","Section G  MA Employer Group Waiver Plans",0.142540690277418
"Section III Specialty Tiers","Section C  Part D Risk Sharing",0.142405069184132
"Section I Annual Calendar","Section A  Update of the RxHCC Model",0.142329992930728
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section E  Clinical Trials",0.142268233800032
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Outpatient Observation Services",0.142220030997144
"Section II Overview of CY 2019 Benefits and Bid Review","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.14211258599367
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section M  Medical Loss Ratio Credibility Adjustment",0.142072785693378
"Section N  Encounter Data as a Diagnosis Source for 2019","Section C  IME Phase Out",0.142067243038226
"Section A  Update of the RxHCC Model","Section III Tier Composition",0.141936148250361
"Section II Cost Plan Competition Requirements","Section I Incomplete and Inaccurate Bid Submissions",0.141913302236596
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section A  Update of the RxHCC Model",0.141619824082963
"Section I Enforcement Actions for Provider Directories","Section II Overview of CY 2019 Benefits and Bid Review",0.141592165796524
"Section B  FFS Growth Percentage","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.141530914150614
"Section E  Clinical Trials","Section B  Calculation of Fee for Service Cost",0.1414690364027
"Section III Specialty Tiers","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.141467527502703
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section I Incomplete and Inaccurate Bid Submissions",0.14140410462032
"Section II Medicare Advantage MA Uniformity Flexibility","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.141157966216818
"Section III CY 2019 Formulary Submission Window","Section I Validation Audits",0.141093182715603
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Transparency  Timeliness with Prior Authorization Processes",0.141003384333516
"Section C  IME Phase Out","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.140787319445284
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Plans with Low Enrollment",0.140684726529853
"Section O  Quality Payment Program","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.140551085196026
"Section I Annual Calendar","Section II Total Beneficiary Cost TBC",0.140195127739745
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Plans with Low Enrollment",0.140185853363438
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Expanding the Part D OTC Program",0.140013710347073
"Section II Medicare Advantage MA Uniformity Flexibility","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.139957279982321
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section G  MA Employer Group Waiver Plans",0.139935819903125
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section K  Medicare Advantage Coding Pattern Adjustment",0.139718010523131
"Section D  ESRD Rates","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.139669861114566
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Incomplete and Inaccurate Bid Submissions",0.139563569284557
"Section D  ESRD Rates","Section IV  MedicareMedicaid Plans",0.139494849445012
"Section B  FFS Growth Percentage","Section L  Normalization Factors",0.139473389442709
"Section II Employer Group Waiver Plans","Section C  IME Phase Out",0.139427969558382
"Section C  Part D Risk Sharing","Section L  Normalization Factors",0.139024929363874
"Section II Plans with Low Enrollment","Section B  Calculation of Fee for Service Cost",0.138811112081342
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.138790221011933
"Section II Cost Plan Competition Requirements","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.138700380145943
"Section II Transparency  Timeliness with Prior Authorization Processes","Section I Plan Corrections",0.138277646770018
"Section A  MA Growth Percentage","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.138091288209105
"Section III Coordination of Benefits COB User Fee","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.137986578016064
"Section II Tiered Cost Sharing of Medical Benefits","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.137923639831471
"Section II Employer Group Waiver Plans","Section II Total Beneficiary Cost TBC",0.13787379465978
"Section II Health Related Supplemental Benefits","Section H  Enhanced Medication Therapy Management MTM Model",0.137651943887154
"Section A  MA Growth Percentage","Section D  ESRD Rates",0.137609262804236
"Section II Cost Plan Competition Requirements","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.137385516954598
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section IV  MedicareMedicaid Plans",0.137313884600096
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Total Beneficiary Cost TBC",0.137293415079761
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section B  FFS Growth Percentage",0.137125558534574
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.137120751701449
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Transparency  Timeliness with Prior Authorization Processes",0.136978044826691
"Section II Employer Group Waiver Plans","Section II Medicare Advantage MA Segmented Service Area Options",0.136947357603492
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section B  Calculation of Fee for Service Cost",0.136809703041647
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.136748584999564
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Total Beneficiary Cost TBC",0.13671905210599
"Section II Plans with Low Enrollment","Section E  Clinical Trials",0.136696584565486
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section L  Normalization Factors",0.136456318815236
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Cost Plan Transition to MA under MACRA",0.136295859896651
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Annual Calendar",0.136264570868277
"Section II Cost Plan Competition Requirements","Section III Expanding the Part D OTC Program",0.136186322109993
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.135665640702368
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section IV  MedicareMedicaid Plans",0.135639804233788
"Section III Improving Access to Part D Vaccines","Section I Incomplete and Inaccurate Bid Submissions",0.135553234328096
"Section III Benefit Review","Section III Expanding the Part D OTC Program",0.135495944180154
"Section II Overview of CY 2019 Benefits and Bid Review","Section O  Quality Payment Program",0.13544080284807
"Section I Annual Calendar","Section II Cost Plan Transition to MA under MACRA",0.135369797608291
"Section III Expanding the Part D OTC Program","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.135298087950983
"Section II Transparency  Timeliness with Prior Authorization Processes","Section III Low Enrollment Plans Standalone PDPs only",0.135232246216155
"Section H  Enhanced Medication Therapy Management MTM Model","Section L  Normalization Factors",0.135112092669742
"Section II Employer Group Waiver Plans","Section II Maximum OutofPocket MOOP Limits",0.135097135987291
"Section II Part C Optional Supplemental Benefits","Section II Plans with Low Enrollment",0.135054052416022
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section I Validation Audits",0.135043165192
"Section C  IME Phase Out","Section II Maximum OutofPocket MOOP Limits",0.134960401085861
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section D  ESRD Rates",0.134827966084056
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Cost Plan Transition to MA under MACRA",0.134819873573305
"Section III Benefit Review","Section H  Enhanced Medication Therapy Management MTM Model",0.134799090785601
"Section II Medicare Advantage MA Uniformity Flexibility","Section B  Calculation of Fee for Service Cost",0.134681916280398
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Validation Audits",0.134553381259253
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section L  Normalization Factors",0.134484710924303
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.134429207150017
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section H  Enhanced Medication Therapy Management MTM Model",0.134349591846369
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.134327423667046
"Section II Health Related Supplemental Benefits","Section II Maximum OutofPocket MOOP Limits",0.134245350369605
"Section D  Retiree Drug Subsidy Amounts","Section II Outpatient Observation Services",0.134030115482631
"Section I Plan Corrections","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.133986423198748
"Section I Annual Calendar","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.133948261337203
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.133804299755886
"Section I Annual Calendar","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.133757571754982
"Section II Employer Group Waiver Plans","Section II Plans with Low Enrollment",0.133687928065253
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Medicare Advantage MA Segmented Service Area Options",0.133646936275357
"Section M  Medical Loss Ratio Credibility Adjustment","Section B  FFS Growth Percentage",0.133639056966508
"Section II Tiered Cost Sharing of Medical Benefits","Section C  Part D Risk Sharing",0.133430772884015
"Section I Annual Calendar","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.133266716625036
"Section II Maximum OutofPocket MOOP Limits","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.133151024457095
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Total Beneficiary Cost TBC",0.133095672949416
"Section III Coordination of Benefits COB User Fee","Section II Transparency  Timeliness with Prior Authorization Processes",0.133089292127287
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section III CY 2019 Formulary Submission Window",0.133067236237383
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Total Beneficiary Cost TBC",0.132879587775072
"Section I Annual Calendar","Section III Improving Access to Part D Vaccines",0.132870479106654
"Section II Cost Plan Transition to MA under MACRA","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.132819459751052
"Section D  Retiree Drug Subsidy Amounts","Section A  Update of the RxHCC Model",0.132777759821287
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Maximum OutofPocket MOOP Limits",0.132674663678983
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.132653900765199
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section O  Quality Payment Program",0.132430836173822
"Section II Overview of CY 2019 Benefits and Bid Review","Section D  ESRD Rates",0.132241641218965
"Section B  Encounter Data as a Diagnosis Source for 2019","Section G  MA Employer Group Waiver Plans",0.132222086841184
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Total Beneficiary Cost TBC",0.132118467224081
"Section II Medicare Advantage MA Uniformity Flexibility","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.131952937761606
"Section II Employer Group Waiver Plans","Section II Health Related Supplemental Benefits",0.131949665727937
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Tiered Cost Sharing of Medical Benefits",0.131930442035081
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.1318705982111
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.131823089610682
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Maximum OutofPocket MOOP Limits",0.131811381056931
"Section II Employer Group Waiver Plans","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.131670998271923
"Section B  FFS Growth Percentage","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.131551795175368
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.13153972439072
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Maximum OutofPocket MOOP Limits",0.131531461519349
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section H  Enhanced Medication Therapy Management MTM Model",0.131354450634221
"Section K  Medicare Advantage Coding Pattern Adjustment","Section A  Update of the RxHCC Model",0.131352748600858
"Section III Improving Access to Part D Vaccines","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.131325436971584
"Section I Annual Calendar","Section II Tiered Cost Sharing of Medical Benefits",0.131246411280005
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.131196649735736
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section IV  MedicareMedicaid Plans",0.131139556800319
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.131082717904705
"Section B  Encounter Data as a Diagnosis Source for 2019","Section I  ESRD Risk Adjustment Model for CY 2019",0.131039647359809
"Section III Benefit Review","Section III CY 2019 Formulary Submission Window",0.130984648384828
"Section II Employer Group Waiver Plans","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.130920993358623
"Section III Specialty Tiers","Section III Coordination of Benefits COB User Fee",0.13091917053326
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section I Incomplete and Inaccurate Bid Submissions",0.130906048476492
"Section I Innovations in Health Plan Design","Section III CY 2019 Formulary Submission Window",0.130786904717938
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section IV  MedicareMedicaid Plans",0.13072869770857
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Health Related Supplemental Benefits",0.130643605338653
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.130609241353647
"Section II Part C Cost Sharing Standards","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.130543253068446
"Section III Expanding the Part D OTC Program","Section II Total Beneficiary Cost TBC",0.130516972072411
"Section II Tiered Cost Sharing of Medical Benefits","Section A  Update of the RxHCC Model",0.130495244087814
"Section II Medicare Advantage MA Uniformity Flexibility","Section I Validation Audits",0.130362534256449
"Section D  Retiree Drug Subsidy Amounts","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.130312603665052
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Specialty Tiers",0.130286820398926
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.130282571444299
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.130210549626528
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Health Related Supplemental Benefits",0.130108797156137
"Section II Overview of CY 2019 Benefits and Bid Review","Section C  IME Phase Out",0.13008524911951
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section I Validation Audits",0.13003800400128
"Section I Annual Calendar","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.13000350999634
"Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries","Section IV  MedicareMedicaid Plans",0.129852608658754
"Section II Cost Plan Transition to MA under MACRA","Section D  ESRD Rates",0.129805984775573
"Section II Overview of CY 2019 Benefits and Bid Review","Section III CY 2019 Formulary Submission Window",0.129781955891102
"Section II Total Beneficiary Cost TBC","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.12958434249177
"Section III Specialty Tiers","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.129540534803419
"Section M  Medical Loss Ratio Credibility Adjustment","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.129512429098879
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.129377493119466
"Section II Cost Plan Competition Requirements","Section I Innovations in Health Plan Design",0.129286606214593
"Section III Benefit Review","Section IV  MedicareMedicaid Plans",0.129205843525181
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I Innovations in Health Plan Design",0.128840012918338
"Section O  Quality Payment Program","Section I Incomplete and Inaccurate Bid Submissions",0.128832929546339
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.128831366018626
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.128788717180741
"Section III Benefit Review","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.128747820414296
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.128620467265245
"Section II Cost Plan Transition to MA under MACRA","Section II Special Needs Plan SNP Legislative Sunset Provision",0.128590174861325
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Total Beneficiary Cost TBC",0.128589923963239
"Section II Part C Optional Supplemental Benefits","Section III Low Enrollment Plans Standalone PDPs only",0.1285150926244
"Section C  IME Phase Out","Section B  Encounter Data as a Diagnosis Source for 2019",0.128393104829654
"Section II Part C Optional Supplemental Benefits","Section A  Update of the RxHCC Model",0.128381893321768
"Section II Tiered Cost Sharing of Medical Benefits","Section D  ESRD Rates",0.128281649803258
"Section II Tiered Cost Sharing of Medical Benefits","Section III Expanding the Part D OTC Program",0.128206776766328
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.128187093613346
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section III Low Enrollment Plans Standalone PDPs only",0.128092806161358
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.128089966163626
"Section III Coordination of Benefits COB User Fee","Section B  Calculation of Fee for Service Cost",0.12807829334623
"Section III Coordination of Benefits COB User Fee","Section II Total Beneficiary Cost TBC",0.128061939059946
"Section B  FFS Growth Percentage","Section A  Update of the RxHCC Model",0.127950341351451
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section E  Clinical Trials",0.127921494168852
"Section B  Encounter Data as a Diagnosis Source for 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.127837735483327
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Total Beneficiary Cost TBC",0.12775495035101
"Section III Specialty Tiers","Section II Total Beneficiary Cost TBC",0.127699057910284
"Section II Part C Cost Sharing Standards","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.127624918039721
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.127533439076131
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III Expanding the Part D OTC Program",0.127357782143179
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Innovations in Health Plan Design",0.127251695672605
"Section II Medicare Advantage MA Segmented Service Area Options","Section H  Enhanced Medication Therapy Management MTM Model",0.127239687286598
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.126827391170648
"Section II Overview of CY 2019 Benefits and Bid Review","Section H  Enhanced Medication Therapy Management MTM Model",0.126764566194899
"Section II Maximum OutofPocket MOOP Limits","Section H  Enhanced Medication Therapy Management MTM Model",0.126646146783097
"Section II Employer Group Waiver Plans","Section II Transparency  Timeliness with Prior Authorization Processes",0.126592420885458
"Section II Transparency  Timeliness with Prior Authorization Processes","Section I Validation Audits",0.126322645333198
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.126315789473684
"Section III Coordination of Benefits COB User Fee","Section II Health Related Supplemental Benefits",0.126308409242001
"Section II Transparency  Timeliness with Prior Authorization Processes","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.126020042397531
"Section III Improving Access to Part D Vaccines","Section IV  MedicareMedicaid Plans",0.125981707393725
"Section III Coordination of Benefits COB User Fee","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.125780011535894
"Section III Benefit Review","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.125691568209651
"Section III Low Enrollment Plans Standalone PDPs only","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.12565034463545
"Section II Employer Group Waiver Plans","Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.1255949812628
"Section M  Medical Loss Ratio Credibility Adjustment","Section G  MA Employer Group Waiver Plans",0.125568473546076
"Section II Outpatient Observation Services","Section B  Calculation of Fee for Service Cost",0.125478613195157
"Section IV  MedicareMedicaid Plans","Section G  MA Employer Group Waiver Plans",0.125406534147544
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.125377407678835
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Tier Composition",0.125080424612044
"Section II Part C Optional Supplemental Benefits","Section II Cost Plan Competition Requirements",0.125031013522373
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.125011155053444
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Transparency  Timeliness with Prior Authorization Processes",0.125
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.124972195790717
"Section III Coordination of Benefits COB User Fee","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.124956012342406
"Section D  Retiree Drug Subsidy Amounts","Section III Expanding the Part D OTC Program",0.12483305351079
"Section II Maximum OutofPocket MOOP Limits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.124794445269871
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Total Beneficiary Cost TBC",0.124789925687182
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section O  Quality Payment Program",0.124755455284294
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.124696039900726
"Section I Annual Calendar","Section I Validation Audits",0.12467703954194
"Section II Medicare Advantage MA Uniformity Flexibility","Section III Improving Access to Part D Vaccines",0.12464738572938
"Section E  Clinical Trials","Section IV  MedicareMedicaid Plans",0.124583556500317
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.124462645662858
"Section II Plans with Low Enrollment","Section II Total Beneficiary Cost TBC",0.124358088802337
"Section III Tier Composition","Section IV  MedicareMedicaid Plans",0.12431387283853
"Section III Benefit Review","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.124287834680674
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.124255830606543
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section II Total Beneficiary Cost TBC",0.124084715261574
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Overview of CY 2019 Benefits and Bid Review",0.124015267472305
"Section II Part C Optional Supplemental Benefits","Section III Coordination of Benefits COB User Fee",0.123978048541465
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section H  Enhanced Medication Therapy Management MTM Model",0.12395620281755
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section IV  MedicareMedicaid Plans",0.12395524247485
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.123951586982101
"Section II Cost Plan Transition to MA under MACRA","Section I Plan Corrections",0.123947303123845
"Section I Validation Audits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.123644259333612
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Total Beneficiary Cost TBC",0.123478792194959
"Section I Plan Corrections","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.123429885581509
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Overview of CY 2019 Benefits and Bid Review",0.123336863034465
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.123209172202554
"Section D  ESRD Rates","Section II Maximum OutofPocket MOOP Limits",0.122929056243723
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Incomplete and Inaccurate Bid Submissions",0.122866100637999
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Coordination of Benefits COB User Fee",0.122860307649964
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Total Beneficiary Cost TBC",0.122632080950934
"Section I Innovations in Health Plan Design","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.122619372288555
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I Incomplete and Inaccurate Bid Submissions",0.122578830076101
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.122556982534849
"Section III Specialty Tiers","Section IV  MedicareMedicaid Plans",0.1225226484445
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.122437894323747
"Section II Employer Group Waiver Plans","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.122334004400039
"Section II Transparency  Timeliness with Prior Authorization Processes","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.122316661380177
"Section I Enforcement Actions for Provider Directories","Section IV  MedicareMedicaid Plans",0.122316344459428
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.122282489601098
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.12225142361739
"Section II Medicare Advantage MA Uniformity Flexibility","Section G  MA Employer Group Waiver Plans",0.122194665841467
"Section II Cost Plan Competition Requirements","Section B  FFS Growth Percentage",0.122140963310492
"Section III Coordination of Benefits COB User Fee","Section I Incomplete and Inaccurate Bid Submissions",0.121859025899646
"Section II Cost Plan Transition to MA under MACRA","Section III Expanding the Part D OTC Program",0.121674259091431
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.121456190177527
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section B  FFS Growth Percentage",0.121396955293009
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section I Incomplete and Inaccurate Bid Submissions",0.121350465902159
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I Validation Audits",0.12121844240151
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Coordination of Benefits COB User Fee",0.121210543182024
"Section N  Encounter Data as a Diagnosis Source for 2019","Section M  Medical Loss Ratio Credibility Adjustment",0.121181514058843
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.121167523709524
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.121162324895142
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section B  Encounter Data as a Diagnosis Source for 2019",0.121134282128044
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Outpatient Observation Services",0.121124772703251
"Section III Improving Access to Part D Vaccines","Section II Part C Cost Sharing Standards",0.121123174495896
"Section I Annual Calendar","Section III Low Enrollment Plans Standalone PDPs only",0.1211060141639
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.12104550653376
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.121019565972248
"Section II Health Related Supplemental Benefits","Section III CY 2019 Formulary Submission Window",0.120788368479712
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Outpatient Observation Services",0.120684189544728
"Section O  Quality Payment Program","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.120554729854736
"Section C  IME Phase Out","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.120532338096618
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.120480209865169
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section C  Part D Risk Sharing",0.120247877039069
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.120177392577706
"Section II Medicare Advantage MA Uniformity Flexibility","Section I  ESRD Risk Adjustment Model for CY 2019",0.1201126723405
"Section II Employer Group Waiver Plans","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.12011077820905
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Maximum OutofPocket MOOP Limits",0.120068435229076
"Section I Plan Corrections","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.120057903816641
"Section III Benefit Review","Section A  Update of the RxHCC Model",0.119934867880628
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Transparency  Timeliness with Prior Authorization Processes",0.119911777385827
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.119884012003577
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.119802610551776
"Section II Transparency  Timeliness with Prior Authorization Processes","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.119467143739409
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section I Validation Audits",0.119431585296825
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I  ESRD Risk Adjustment Model for CY 2019",0.119356518890249
"Section I Plan Corrections","Section II Part C Cost Sharing Standards",0.119149603942
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.119136974533964
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.1188621112443
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.118844755450107
"Section I Enforcement Actions for Provider Directories","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.118759044821971
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I Incomplete and Inaccurate Bid Submissions",0.118696418474502
"Section II Cost Plan Competition Requirements","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.118682712624485
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.118679470359726
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Validation Audits",0.118630734378414
"Section I Annual Calendar","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.118629811014882
"Section III Benefit Review","Section C  Part D Risk Sharing",0.118582434739865
"Section II Cost Plan Competition Requirements","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.118503745566756
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.118442536845128
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.118342724980125
"Section III Low Enrollment Plans Standalone PDPs only","Section B  Calculation of Fee for Service Cost",0.118302119578898
"Section D  ESRD Rates","Section H  Enhanced Medication Therapy Management MTM Model",0.118291658787436
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section E  Clinical Trials",0.118071101831954
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.118037380832606
"Section II Medicare Advantage MA Segmented Service Area Options","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.117887154614221
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Low Enrollment Plans Standalone PDPs only",0.117851130197758
"Section I Annual Calendar","Section II Medicare Advantage MA Segmented Service Area Options",0.117759262341626
"Section II Overview of CY 2019 Benefits and Bid Review","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.117722519813093
"Section III Expanding the Part D OTC Program","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.117649613145317
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section B  Calculation of Fee for Service Cost",0.117616037538829
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Overview of CY 2019 Benefits and Bid Review",0.117589033541586
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section II Maximum OutofPocket MOOP Limits",0.117578693147047
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.117538256374123
"Section A  Update of the RxHCC Model","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.117195563724277
"Section A  MA Growth Percentage","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.11715040050775
"Section I Incomplete and Inaccurate Bid Submissions","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.1169670564141
"Section II Cost Plan Transition to MA under MACRA","Section H  Enhanced Medication Therapy Management MTM Model",0.116837973015524
"Section III Benefit Review","Section G  MA Employer Group Waiver Plans",0.116653314358628
"Section II Part C Optional Supplemental Benefits","Section II Maximum OutofPocket MOOP Limits",0.116647573239593
"Section I Annual Calendar","Section III Medication Therapy Management MTM Annual Cost Threshold",0.116608377046907
"Section III Coordination of Benefits COB User Fee","Section II Part C Cost Sharing Standards",0.116583924076864
"Section II Employer Group Waiver Plans","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.116581802434176
"Section I Annual Calendar","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.116387527649719
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section IV  MedicareMedicaid Plans",0.116370979667356
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.116267681094746
"Section B  FFS Growth Percentage","Section II Part C Cost Sharing Standards",0.11626598650246
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Part C Cost Sharing Standards",0.116106909633418
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.116030684387149
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section I Validation Audits",0.115912060033638
"Section IV  MedicareMedicaid Plans","Section I Validation Audits",0.115870109677598
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Improving Access to Part D Vaccines",0.115800786410057
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.115774943397445
"Section A  MA Growth Percentage","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.115745651877759
"Section II Tiered Cost Sharing of Medical Benefits","Section H  Enhanced Medication Therapy Management MTM Model",0.115689262076135
"Section I Annual Calendar","Section III Tier Composition",0.115543916162104
"Section III Specialty Tiers","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.115404996949324
"Section III CY 2019 Formulary Submission Window","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.115379590429474
"Section I Enforcement Actions for Provider Directories","Section I Plan Corrections",0.115370906106049
"Section II Employer Group Waiver Plans","Section D  Retiree Drug Subsidy Amounts",0.115177151119602
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.115154168549061
"Section II Plans with Low Enrollment","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.115128295500249
"Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.115067890683704
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Total Beneficiary Cost TBC",0.11497069263973
"Section I Innovations in Health Plan Design","Section I Validation Audits",0.114790724784392
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section I Incomplete and Inaccurate Bid Submissions",0.114741484649253
"Section II Transparency  Timeliness with Prior Authorization Processes","Section O  Quality Payment Program",0.114673657436761
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section I Validation Audits",0.114623727408726
"Section N  Encounter Data as a Diagnosis Source for 2019","Section IV  MedicareMedicaid Plans",0.114602867034539
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Part C Cost Sharing Standards",0.114584024066656
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.114513481221567
"Section II Transparency  Timeliness with Prior Authorization Processes","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.11448002676998
"Section III Benefit Review","Section I Annual Calendar",0.114434427054266
"Section I Innovations in Health Plan Design","Section IV  MedicareMedicaid Plans",0.114366317750748
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.114346729260894
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.114279641584657
"Section III Low Enrollment Plans Standalone PDPs only","Section III Expanding the Part D OTC Program",0.114268232311796
"Section I Annual Calendar","Section II Cost Plan Competition Requirements",0.114252409399597
"Section II Outpatient Observation Services","Section D  ESRD Rates",0.114215669877464
"Section III Coordination of Benefits COB User Fee","Section II Tiered Cost Sharing of Medical Benefits",0.114208798804088
"Section O  Quality Payment Program","Section I  ESRD Risk Adjustment Model for CY 2019",0.114096596115027
"Section II Employer Group Waiver Plans","Section H  CMSHCC Risk Adjustment Model for CY 2019",0.11400590984728
"Section I Annual Calendar","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.11399084453792
"Section D  Retiree Drug Subsidy Amounts","Section D  ESRD Rates",0.113929372248735
"Section II Medicare Advantage MA Uniformity Flexibility","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.11383361432013
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I  ESRD Risk Adjustment Model for CY 2019",0.113719562359268
"Section C  IME Phase Out","Section O  Quality Payment Program",0.11360383155756
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.11355167461567
"Section II Cost Plan Transition to MA under MACRA","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.113526372295641
"Section II Cost Plan Transition to MA under MACRA","Section G  MA Employer Group Waiver Plans",0.113499001672751
"Section I  ESRD Risk Adjustment Model for CY 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.113382827257226
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.113332577396681
"Section B  FFS Growth Percentage","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.113237265070003
"Section III Specialty Tiers","Section II Cost Plan Competition Requirements",0.113169503614462
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.113159038571417
"Section II Employer Group Waiver Plans","Section B  FFS Growth Percentage",0.113139439633281
"Section II Medicare Advantage MA Uniformity Flexibility","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.113094968240083
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.112952923281102
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Improving Access to Part D Vaccines",0.112951935322615
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.112891873152712
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Low Enrollment Plans Standalone PDPs only",0.112830389516714
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.112822703390632
"Section C  Part D Risk Sharing","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.112821908629665
"Section III Improving Access to Part D Vaccines","Section II Total Beneficiary Cost TBC",0.112740751167782
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section E  Clinical Trials",0.11273527510194
"Section C  IME Phase Out","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.112717092712288
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Cost Plan Transition to MA under MACRA",0.112703664267012
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Expanding the Part D OTC Program",0.112662088982129
"Section III Low Enrollment Plans Standalone PDPs only","Section II Total Beneficiary Cost TBC",0.112564462712216
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.112492054059066
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.11247310258165
"Section II Overview of CY 2019 Benefits and Bid Review","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.112384729902605
"Section II Overview of CY 2019 Benefits and Bid Review","Section B  FFS Growth Percentage",0.112368457557221
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Incomplete and Inaccurate Bid Submissions",0.112288064433488
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Transparency  Timeliness with Prior Authorization Processes",0.112268279877562
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Overview of CY 2019 Benefits and Bid Review",0.112268262746786
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Health Related Supplemental Benefits",0.112260753997963
"Section II Outpatient Observation Services","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.112234439281225
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section IV  MedicareMedicaid Plans",0.112195784173606
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.11215748442286
"Section II Outpatient Observation Services","Section I Innovations in Health Plan Design",0.111888665111782
"Section II Medicare Advantage MA Uniformity Flexibility","Section C  Part D Risk Sharing",0.111841602668647
"Section II Outpatient Observation Services","Section II Cost Plan Transition to MA under MACRA",0.111741190074622
"Section E  Clinical Trials","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.11164436395849
"Section III Tier Composition","Section I Incomplete and Inaccurate Bid Submissions",0.111536191427652
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Annual Calendar",0.111481291035147
"Section II Health Related Supplemental Benefits","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.111415690782269
"Section III Tier Composition","Section II Part C Cost Sharing Standards",0.11141465759819
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Part C Optional Supplemental Benefits",0.111342790297786
"Section II Medicare Advantage MA Segmented Service Area Options","Section B  Calculation of Fee for Service Cost",0.111322115888998
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section C  IME Phase Out",0.111302903930646
"Section III Benefit Review","Section C  IME Phase Out",0.111275859123071
"Section D  ESRD Rates","Section O  Quality Payment Program",0.111136215490343
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Innovations in Health Plan Design",0.111117970456805
"Section H  Enhanced Medication Therapy Management MTM Model","Section I Incomplete and Inaccurate Bid Submissions",0.111094791628505
"Section A  MA Growth Percentage","Section III Medication Therapy Management MTM Annual Cost Threshold",0.111045847604094
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section B  FFS Growth Percentage",0.110938356078387
"Section I Plan Corrections","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.110896885349106
"Section II Employer Group Waiver Plans","Section H  Enhanced Medication Therapy Management MTM Model",0.110741343629498
"Section A  Update of the RxHCC Model","Section II Maximum OutofPocket MOOP Limits",0.110465253699946
"Section I Annual Calendar","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.110431046645456
"Section II Plans with Low Enrollment","Section I Validation Audits",0.110298176633421
"Section B  Encounter Data as a Diagnosis Source for 2019","Section IV  MedicareMedicaid Plans",0.110296569679731
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section G  MA Employer Group Waiver Plans",0.110210934291585
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.110187618968957
"Section III Improving Access to Part D Vaccines","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.110044132022391
"Section A  MA Growth Percentage","Section II Overview of CY 2019 Benefits and Bid Review",0.109955027001021
"Section II Maximum OutofPocket MOOP Limits","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.109892185425635
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III CY 2019 Formulary Submission Window",0.109795965557781
"Section III Benefit Review","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.109778038218577
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section E  Clinical Trials",0.109721283627019
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.109693813682016
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.109693327432838
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Plans with Low Enrollment",0.109591489351024
"Section I Annual Calendar","Section M  Medical Loss Ratio Credibility Adjustment",0.109557477650277
"Section H  Enhanced Medication Therapy Management MTM Model","Section I  ESRD Risk Adjustment Model for CY 2019",0.109518562247098
"Section I Annual Calendar","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.109349554671466
"Section II Part C Optional Supplemental Benefits","Section III CY 2019 Formulary Submission Window",0.109281254190298
"Section D  Retiree Drug Subsidy Amounts","Section III CY 2019 Formulary Submission Window",0.109254693760912
"Section III Coordination of Benefits COB User Fee","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.109250555374114
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Specialty Tiers",0.109178184011343
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section I Validation Audits",0.109067652321139
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Cost Plan Transition to MA under MACRA",0.108960303469816
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Low Enrollment Plans Standalone PDPs only",0.108916229727434
"Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.108748577795428
"Section II Cost Plan Transition to MA under MACRA","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.108737868998122
"Section III Benefit Review","Section II Maximum OutofPocket MOOP Limits",0.108636284824937
"Section III Tier Composition","Section II Total Beneficiary Cost TBC",0.108592520404137
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Expanding the Part D OTC Program",0.108483576948226
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section II Health Related Supplemental Benefits",0.108451849655846
"Section C  Part D Risk Sharing","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.1083755706138
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section B  FFS Growth Percentage",0.108321100498543
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.108289888948403
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Plans with Low Enrollment",0.108212925174035
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.108206699972065
"Section A  Update of the RxHCC Model","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.108141064103459
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.108118238672211
"Section I Plan Corrections","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.108004359455269
"Section I Innovations in Health Plan Design","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.10798969188394
"Section II Plans with Low Enrollment","Section IV  MedicareMedicaid Plans",0.107927876907628
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section I Innovations in Health Plan Design",0.107891534420324
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section III CY 2019 Formulary Submission Window",0.10781861535472
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section B  FFS Growth Percentage",0.107797985779201
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.10777170857219
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Part C Cost Sharing Standards",0.107749937632575
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section H  Enhanced Medication Therapy Management MTM Model",0.107677449577716
"Section A  MA Growth Percentage","Section II Cost Plan Transition to MA under MACRA",0.107426915459087
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.107370934198483
"Section II Medicare Advantage MA Uniformity Flexibility","Section D  ESRD Rates",0.107349338956003
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.107345769320568
"Section C  Part D Risk Sharing","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.107197441591686
"Section II Employer Group Waiver Plans","Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD",0.107195980137526
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section A  Update of the RxHCC Model",0.107087142613038
"Section III Coordination of Benefits COB User Fee","Section D  Retiree Drug Subsidy Amounts",0.107084782693279
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.106928824361464
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Improving Access to Part D Vaccines",0.106905899186594
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section IV  MedicareMedicaid Plans",0.106881066410289
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Annual Calendar",0.106809173966911
"Section M  Medical Loss Ratio Credibility Adjustment","Section A  Update of the RxHCC Model",0.106754233594849
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section A  Update of the RxHCC Model",0.106694160947678
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.106673078034469
"Section II Part C Cost Sharing Standards","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.10664372942409
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section B  Calculation of Fee for Service Cost",0.106631893616404
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.106630404786617
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section B  Calculation of Fee for Service Cost",0.106613225634768
"Section I Plan Corrections","Section II Health Related Supplemental Benefits",0.106469212574819
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Plans with Low Enrollment",0.106371580889695
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section G  MA Employer Group Waiver Plans",0.106364704538781
"Section II Cost Plan Competition Requirements","Section II Special Needs Plan SNP Legislative Sunset Provision",0.10631548679075
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.106276402598775
"Section II Medicare Advantage MA Segmented Service Area Options","Section I Incomplete and Inaccurate Bid Submissions",0.10623607600769
"Section II Part C Optional Supplemental Benefits","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.106160232112609
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section I Incomplete and Inaccurate Bid Submissions",0.106157469947347
"Section I Annual Calendar","Section I Innovations in Health Plan Design",0.106120173942899
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.106115395668435
"Section A  Update of the RxHCC Model","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.105976422581138
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section B  Calculation of Fee for Service Cost",0.105947351678129
"Section B  FFS Growth Percentage","Section IV  MedicareMedicaid Plans",0.105848066354577
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section D  ESRD Rates",0.105685239760575
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.105620537270348
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Enforcement Actions for Provider Directories",0.10561655004328
"Section III Benefit Review","Section III Coordination of Benefits COB User Fee",0.105614350042237
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.105498136445294
"Section III Expanding the Part D OTC Program","Section B  FFS Growth Percentage",0.105483449482418
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section G  MA Employer Group Waiver Plans",0.10547823319236
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.105317197201081
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.105236903739836
"Section II Health Related Supplemental Benefits","Section III Improving Access to Part D Vaccines",0.105207281904383
"Section III Benefit Review","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.105202393688278
"Section C  Part D Risk Sharing","Section III Improving Access to Part D Vaccines",0.105077743620075
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section IV  MedicareMedicaid Plans",0.105074266025288
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section M  Medical Loss Ratio Credibility Adjustment",0.105010319860323
"Section III Coordination of Benefits COB User Fee","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.10497572328887
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section C  Part D Risk Sharing",0.104941386656791
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.104878344541856
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III CY 2019 Formulary Submission Window",0.104871649613355
"Section II Cost Plan Competition Requirements","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.104809829257297
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section E  Clinical Trials",0.104808349454598
"Section III Coordination of Benefits COB User Fee","Section I Plan Corrections",0.104732335548882
"Section II Plans with Low Enrollment","Section I Incomplete and Inaccurate Bid Submissions",0.104664894318925
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.104662975849259
"Section II Total Beneficiary Cost TBC","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.104642193485989
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.104578393689192
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section IV  MedicareMedicaid Plans",0.104577910351705
"Section II Part C Cost Sharing Standards","Section III CY 2019 Formulary Submission Window",0.10455685507675
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.104509952143743
"Section III Low Enrollment Plans Standalone PDPs only","Section II Part C Cost Sharing Standards",0.104509904542925
"Section I Annual Calendar","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.104490462976847
"Section I Annual Calendar","Section II Plans with Low Enrollment",0.104425020384389
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section IV  MedicareMedicaid Plans",0.104308907017674
"Section I Plan Corrections","Section III Tier Composition",0.104166723180746
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section A  Update of the RxHCC Model",0.104092361906068
"Section I Enforcement Actions for Provider Directories","Section II Medicare Advantage MA Uniformity Flexibility",0.104014913150398
"Section C  IME Phase Out","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.10401251553885
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Meaningful Difference Substantially Duplicative Plan Offerings",0.104010193498469
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Part C Optional Supplemental Benefits",0.103898294387537
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section I Innovations in Health Plan Design",0.103681386834654
"Section II Tiered Cost Sharing of Medical Benefits","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.103634523824405
"Section II Outpatient Observation Services","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.1035560746157
"Section II Medicare Advantage MA Segmented Service Area Options","Section I Innovations in Health Plan Design",0.103466749681422
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.103303177600024
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section O  Quality Payment Program",0.103251843750929
"Section N  Encounter Data as a Diagnosis Source for 2019","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.103112715304688
"Section III Coordination of Benefits COB User Fee","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.103081635886249
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Maximum OutofPocket MOOP Limits",0.102979394246729
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III CY 2019 Formulary Submission Window",0.102941522572203
"Section III Benefit Review","Section II Meaningful Difference Substantially Duplicative Plan Offerings",0.102916163427704
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section III Tier Composition",0.102882821774749
"Section III Coordination of Benefits COB User Fee","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.1027436788585
"Section A  MA Benchmark Quality Bonus Payments and Rebate","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.10261291272931
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section IV  MedicareMedicaid Plans",0.102609935625388
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.102543295376405
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.10253183166878
"Section III Coordination of Benefits COB User Fee","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.102525777012836
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section I Innovations in Health Plan Design",0.10251199331896
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.102469103818742
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.102204036819371
"Section II Medicare Advantage MA Uniformity Flexibility","Section O  Quality Payment Program",0.102190492697993
"Section II Part C Optional Supplemental Benefits","Section C  Part D Risk Sharing",0.102162866274943
"Section I Enforcement Actions for Provider Directories","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.102111537297514
"Section D  Retiree Drug Subsidy Amounts","Section III Improving Access to Part D Vaccines",0.102054314687821
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section B  Calculation of Fee for Service Cost",0.10182893530447
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section III Expanding the Part D OTC Program",0.101763001864527
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section I Plan Corrections",0.101711409358895
"Section III Specialty Tiers","Section A  Update of the RxHCC Model",0.101677179042429
"Section I Innovations in Health Plan Design","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.101605227767262
"Section M  Medical Loss Ratio Credibility Adjustment","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.101585430803382
"Section C  IME Phase Out","Section II Plans with Low Enrollment",0.101542727624326
"Section C  IME Phase Out","Section II Cost Plan Transition to MA under MACRA",0.101467397801814
"Section N  Encounter Data as a Diagnosis Source for 2019","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.101450218715943
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section IV  MedicareMedicaid Plans",0.101422476340799
"Section III Tier Composition","Section II Health Related Supplemental Benefits",0.101295208431614
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Total Beneficiary Cost TBC",0.10118990900855
"Section III Expanding the Part D OTC Program","Section I Plan Corrections",0.101186290472179
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Annual Calendar",0.101112475262151
"Section II Outpatient Observation Services","Section II Total Beneficiary Cost TBC",0.101094191097019
"Section M  Medical Loss Ratio Credibility Adjustment","Section C  IME Phase Out",0.10107026360553
"Section II Cost Plan Competition Requirements","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.101004121457507
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Medicare Advantage MA Uniformity Flexibility",0.100938918178232
"Section III Low Enrollment Plans Standalone PDPs only","Section II Health Related Supplemental Benefits",0.100925774234146
"Section B  Calculation of Fee for Service Cost","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.100898923045012
"Section II Tiered Cost Sharing of Medical Benefits","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.100862837981129
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section I Validation Audits",0.100762965292969
"Section II Transparency  Timeliness with Prior Authorization Processes","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.100662625528486
"Section III Improving Access to Part D Vaccines","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.100479988215925
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.100379574084114
"Section III Coordination of Benefits COB User Fee","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.100239329613486
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section C  IME Phase Out",0.100212587341593
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Overview of CY 2019 Benefits and Bid Review",0.100197033372671
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section I Plan Corrections",0.100120831381558
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section B  Calculation of Fee for Service Cost",0.100118121533577
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section II Part C Cost Sharing Standards",0.100068576098993
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.100053762333033
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III Low Enrollment Plans Standalone PDPs only",0.1
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0999748881289665
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0999692319334795
"Section D  Retiree Drug Subsidy Amounts","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0999606979224315
"Section II Health Related Supplemental Benefits","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0998768396845325
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section III CY 2019 Formulary Submission Window",0.099646140289859
"Section D  ESRD Rates","Section I Innovations in Health Plan Design",0.0995321678685036
"Section L  Normalization Factors","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0994757104619807
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section H  Enhanced Medication Therapy Management MTM Model",0.0993578639691827
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Cost Plan Transition to MA under MACRA",0.0993471691468751
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section E  Clinical Trials",0.0993375877072585
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Transparency  Timeliness with Prior Authorization Processes",0.0991972701286886
"Section D  Retiree Drug Subsidy Amounts","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0991211893281507
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III CY 2019 Formulary Submission Window",0.0990204122251609
"Section A  Update of the RxHCC Model","Section O  Quality Payment Program",0.0989307831100407
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section G  MA Employer Group Waiver Plans",0.0987817780823636
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section L  Normalization Factors",0.0987586266114303
"Section II Cost Plan Transition to MA under MACRA","Section A  Update of the RxHCC Model",0.0987443094751886
"Section III Coordination of Benefits COB User Fee","Section II Cost Plan Competition Requirements",0.0986318006924517
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0984695089949464
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0984067021936222
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section B  Calculation of Fee for Service Cost",0.0984052148156632
"Section I Annual Calendar","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0983965045202365
"Section I Plan Corrections","Section O  Quality Payment Program",0.0983769033274985
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Cost Plan Transition to MA under MACRA",0.0983127386782247
"Section III Low Enrollment Plans Standalone PDPs only","Section III Improving Access to Part D Vaccines",0.0982903388542043
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0982744466844929
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section III CY 2019 Formulary Submission Window",0.0982269313026743
"Section A  MA Growth Percentage","Section C  IME Phase Out",0.098213442402745
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0982101447092996
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I  ESRD Risk Adjustment Model for CY 2019",0.0981519619478218
"Section III Improving Access to Part D Vaccines","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0981400911843796
"Section A  MA Growth Percentage","Section M  Medical Loss Ratio Credibility Adjustment",0.098089251563383
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section O  Quality Payment Program",0.0980445534358668
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0980400664050104
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III CY 2019 Formulary Submission Window",0.0980259041880482
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Outpatient Observation Services",0.0979800535233292
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Tiered Cost Sharing of Medical Benefits",0.0979788297676722
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section B  FFS Growth Percentage",0.0979468275246955
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0978594919500171
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0977959108881374
"Section C  IME Phase Out","Section H  Enhanced Medication Therapy Management MTM Model",0.0976615865489591
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0975900072948533
"Section III Benefit Review","Section I Plan Corrections",0.0975392188410909
"Section I Enforcement Actions for Provider Directories","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0974939068212296
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section B  Calculation of Fee for Service Cost",0.0974430615738218
"Section III Expanding the Part D OTC Program","Section E  Clinical Trials",0.0973740580434993
"Section II Part C Optional Supplemental Benefits","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0973437540452026
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section B  Calculation of Fee for Service Cost",0.0972546054628558
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section B  Calculation of Fee for Service Cost",0.0972341453151143
"Section II Part C Optional Supplemental Benefits","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0972260905247102
"Section II Part C Optional Supplemental Benefits","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0972260905247101
"Section III Specialty Tiers","Section II Part C Cost Sharing Standards",0.0971442674796923
"Section III Benefit Review","Section I Incomplete and Inaccurate Bid Submissions",0.0969798254170754
"Section II Transparency  Timeliness with Prior Authorization Processes","Section III CY 2019 Formulary Submission Window",0.0969397192629795
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0969247651878485
"Section III Tier Composition","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0969228968491842
"Section D  ESRD Rates","Section E  Clinical Trials",0.0968627169113599
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Tiered Cost Sharing of Medical Benefits",0.0968024894149191
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0967268393619083
"Section III Expanding the Part D OTC Program","Section II Maximum OutofPocket MOOP Limits",0.0967115106355235
"Section II Plans with Low Enrollment","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.096701623791534
"Section II Medicare Advantage MA Uniformity Flexibility","Section III Tier Composition",0.0965880562155415
"Section II Medicare Advantage MA Uniformity Flexibility","Section I Plan Corrections",0.0964874960048147
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0964388761778149
"Section II Cost Plan Transition to MA under MACRA","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0964353928818627
"Section II Cost Plan Transition to MA under MACRA","Section II Health Related Supplemental Benefits",0.096424405192671
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0964197789330938
"Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries","Section G  MA Employer Group Waiver Plans",0.0963791498226452
"Section III Low Enrollment Plans Standalone PDPs only","Section A  Update of the RxHCC Model",0.0963706014180651
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0961837822555156
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Coordination of Benefits COB User Fee",0.0961796021021365
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section A  Update of the RxHCC Model",0.0961147845843442
"Section II Medicare Advantage MA Segmented Service Area Options","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0960860176943169
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III CY 2019 Formulary Submission Window",0.096065293366919
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Medicare Advantage MA Segmented Service Area Options",0.0960587354479127
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section G  MA Employer Group Waiver Plans",0.0960167012917196
"Section III Coordination of Benefits COB User Fee","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0959734777601523
"Section M  Medical Loss Ratio Credibility Adjustment","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0959294219086619
"Section III Tier Composition","Section I Validation Audits",0.0957985085100927
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs","Section G  MA Employer Group Waiver Plans",0.0957568441245545
"Section III Low Enrollment Plans Standalone PDPs only","Section I Incomplete and Inaccurate Bid Submissions",0.0957257558602774
"Section IV  MedicareMedicaid Plans","Section L  Normalization Factors",0.0957006345075966
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section I Incomplete and Inaccurate Bid Submissions",0.0955844040907487
"Section II Employer Group Waiver Plans","Section II Outpatient Observation Services",0.0954819832052577
"Section I Plan Corrections","Section H  Enhanced Medication Therapy Management MTM Model",0.0954809617808004
"Section II Medicare Advantage MA Uniformity Flexibility","Section B  FFS Growth Percentage",0.0954346653032407
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.095364322059878
"Section I Enforcement Actions for Provider Directories","Section I Incomplete and Inaccurate Bid Submissions",0.0953588340951386
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Expanding the Part D OTC Program",0.0953050954400128
"Section A  MA Growth Percentage","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0951821550892231
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Annual Calendar",0.095149870953075
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section H  Enhanced Medication Therapy Management MTM Model",0.0951238213762688
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0951023316690918
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0949782119249584
"Section II Part C Optional Supplemental Benefits","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0949722625866128
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section D  ESRD Rates",0.0949256172662005
"Section II Health Related Supplemental Benefits","Section G  MA Employer Group Waiver Plans",0.0945665315177895
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section N  Encounter Data as a Diagnosis Source for 2019",0.0945277272765569
"Section A  MA Growth Percentage","Section II Medicare Advantage MA Uniformity Flexibility",0.0944583259146015
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section D  ESRD Rates",0.0944127792770202
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section B  Calculation of Fee for Service Cost",0.0943411751716443
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section E  Clinical Trials",0.0942940619372305
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III CY 2019 Formulary Submission Window",0.0942928888454648
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0942294741897196
"Section O  Quality Payment Program","Section IV  MedicareMedicaid Plans",0.0941694997171744
"Section II Part C Optional Supplemental Benefits","Section III Improving Access to Part D Vaccines",0.0939389595080364
"Section B  FFS Growth Percentage","Section O  Quality Payment Program",0.0939335574372982
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0936175298385738
"Section N  Encounter Data as a Diagnosis Source for 2019","Section O  Quality Payment Program",0.0934206886107684
"Section III Improving Access to Part D Vaccines","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0934033240994186
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I Plan Corrections",0.0933786078098472
"Section A  Update of the RxHCC Model","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.093363907490056
"Section D  Retiree Drug Subsidy Amounts","Section B  FFS Growth Percentage",0.0933543649625042
"Section III Benefit Review","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0933411043497806
"Section I Incomplete and Inaccurate Bid Submissions","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0932945932030858
"Section III Specialty Tiers","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0931028309104454
"Section M  Medical Loss Ratio Credibility Adjustment","Section IV  MedicareMedicaid Plans",0.0930388409561957
"Section I Enforcement Actions for Provider Directories","Section II Cost Plan Competition Requirements",0.0930202373587402
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section H  Enhanced Medication Therapy Management MTM Model",0.0930164383060721
"Section II Overview of CY 2019 Benefits and Bid Review","Section L  Normalization Factors",0.0927473517458675
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0927437341708003
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Total Beneficiary Cost TBC",0.092496433031747
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0924886094939374
"Section II Outpatient Observation Services","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.092452909606996
"Section II Part C Cost Sharing Standards","Section I  ESRD Risk Adjustment Model for CY 2019",0.0923907158648871
"Section II Medicare Advantage MA Segmented Service Area Options","Section C  IME Phase Out",0.0923459062840501
"Section II Cost Plan Competition Requirements","Section A  Update of the RxHCC Model",0.0923423426758557
"Section II Tiered Cost Sharing of Medical Benefits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0922285838741101
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section H  Enhanced Medication Therapy Management MTM Model",0.0922140228057171
"Section N  Encounter Data as a Diagnosis Source for 2019","Section H  Enhanced Medication Therapy Management MTM Model",0.0921808306639769
"Section I Innovations in Health Plan Design","Section II Maximum OutofPocket MOOP Limits",0.0919622742181915
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0918915376744959
"Section I Innovations in Health Plan Design","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0918373404309659
"Section III Benefit Review","Section B  FFS Growth Percentage",0.0917516612761795
"Section C  IME Phase Out","Section I Innovations in Health Plan Design",0.09172541538812
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0916464787262221
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Medicare Advantage MA Segmented Service Area Options",0.0915583775955893
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III CY 2019 Formulary Submission Window",0.0914384584428481
"Section II Part C Optional Supplemental Benefits","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0913724454433986
"Section A  MA Growth Percentage","Section II Part C Cost Sharing Standards",0.0913107275604111
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section III Improving Access to Part D Vaccines",0.0911925244619617
"Section III Benefit Review","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0910083865602493
"Section E  Clinical Trials","Section I Incomplete and Inaccurate Bid Submissions",0.0909029093624467
"Section III CY 2019 Formulary Submission Window","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0908931092030519
"Section II Cost Plan Competition Requirements","Section G  MA Employer Group Waiver Plans",0.0908836051683752
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0908632453219109
"Section III Specialty Tiers","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0908111817055934
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0908055104436958
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.090795848060993
"Section II Plans with Low Enrollment","Section H  Enhanced Medication Therapy Management MTM Model",0.0907919273547222
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section H  Enhanced Medication Therapy Management MTM Model",0.0907851289748438
"Section II Cost Plan Competition Requirements","Section M  Medical Loss Ratio Credibility Adjustment",0.0907841299003204
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section III Improving Access to Part D Vaccines",0.0907524846407007
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Plans with Low Enrollment",0.0906225951209668
"Section II Transparency  Timeliness with Prior Authorization Processes","Section G  MA Employer Group Waiver Plans",0.0906164242085084
"Section II Medicare Advantage MA Uniformity Flexibility","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0905550274283282
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section C  IME Phase Out",0.0905306735450674
"Section II Cost Plan Transition to MA under MACRA","Section B  FFS Growth Percentage",0.0904477505655635
"Section II Tiered Cost Sharing of Medical Benefits","Section G  MA Employer Group Waiver Plans",0.0904334820447294
"Section II Overview of CY 2019 Benefits and Bid Review","Section I  ESRD Risk Adjustment Model for CY 2019",0.090278349740866
"Section III Low Enrollment Plans Standalone PDPs only","Section II Tiered Cost Sharing of Medical Benefits",0.0902593581859478
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section G  MA Employer Group Waiver Plans",0.0902363362392916
"Section II Transparency  Timeliness with Prior Authorization Processes","Section C  IME Phase Out",0.0901437486211483
"Section D  Retiree Drug Subsidy Amounts","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0900955683750092
"Section II Tiered Cost Sharing of Medical Benefits","Section I Plan Corrections",0.090094551080313
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Medicare Advantage MA Uniformity Flexibility",0.0900937462695559
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section O  Quality Payment Program",0.0900593527786024
"Section II Part C Cost Sharing Standards","Section I Validation Audits",0.0900588929661474
"Section III Coordination of Benefits COB User Fee","Section G  MA Employer Group Waiver Plans",0.0900110610137664
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Low Enrollment Plans Standalone PDPs only",0.09
"Section O  Quality Payment Program","Section H  Enhanced Medication Therapy Management MTM Model",0.0899996280200577
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section H  Enhanced Medication Therapy Management MTM Model",0.0899711226374388
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0899603462016545
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0898714633863105
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Total Beneficiary Cost TBC",0.0898654372225886
"Section I Innovations in Health Plan Design","Section III Improving Access to Part D Vaccines",0.0898483524023926
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section B  Calculation of Fee for Service Cost",0.0898420021544925
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0897122815226762
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0896625704413275
"Section I Enforcement Actions for Provider Directories","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0896463334557327
"Section II Cost Plan Competition Requirements","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0895571004585482
"Section II Cost Plan Transition to MA under MACRA","Section O  Quality Payment Program",0.0895410781130387
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0894065153239554
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section I  ESRD Risk Adjustment Model for CY 2019",0.0893561189530842
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0893481224557943
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Medicare Advantage MA Segmented Service Area Options",0.0892615902672771
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section III CY 2019 Formulary Submission Window",0.0892520641370196
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0891914258669814
"Section II Maximum OutofPocket MOOP Limits","Section I Incomplete and Inaccurate Bid Submissions",0.0891752108183015
"Section C  Part D Risk Sharing","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0891748408661416
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0891194679347462
"Section II Cost Plan Transition to MA under MACRA","Section I Validation Audits",0.0889040436315254
"Section A  MA Growth Percentage","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0888171599729474
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section G  MA Employer Group Waiver Plans",0.0887480904724044
"Section III Low Enrollment Plans Standalone PDPs only","Section I Innovations in Health Plan Design",0.0887385588975052
"Section B  Encounter Data as a Diagnosis Source for 2019","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0886768353993709
"Section D  Retiree Drug Subsidy Amounts","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0886745979512316
"Section II Total Beneficiary Cost TBC","Section I Validation Audits",0.0886020084527703
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section D  ESRD Rates",0.088500479165565
"Section II Medicare Advantage MA Uniformity Flexibility","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0884513167753527
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Part C Optional Supplemental Benefits",0.0883541261792749
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Part C Cost Sharing Standards",0.0883295550880117
"Section III Coordination of Benefits COB User Fee","Section C  IME Phase Out",0.0883205220937977
"Section I  ESRD Risk Adjustment Model for CY 2019","Section IV  MedicareMedicaid Plans",0.0883106078853804
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0882358904370445
"Section II Plans with Low Enrollment","Section II Health Related Supplemental Benefits",0.0882003871003532
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0881540744692269
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.088151817168341
"Section K  Medicare Advantage Coding Pattern Adjustment","Section H  Enhanced Medication Therapy Management MTM Model",0.0881272984971811
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0880019382368733
"Section E  Clinical Trials","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0879595139381618
"Section G  MA Employer Group Waiver Plans","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0879235196280536
"Section I Enforcement Actions for Provider Directories","Section III Low Enrollment Plans Standalone PDPs only",0.0878438127193422
"Section II Overview of CY 2019 Benefits and Bid Review","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0878034605437358
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section B  Calculation of Fee for Service Cost",0.0877961663905684
"Section O  Quality Payment Program","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0877718145743364
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0877145998418202
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Improving Access to Part D Vaccines",0.087671227008084
"Section II Plans with Low Enrollment","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0876539289975633
"Section II Overview of CY 2019 Benefits and Bid Review","Section C  Part D Risk Sharing",0.0875784703494435
"Section III Benefit Review","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0875553416249885
"Section III Expanding the Part D OTC Program","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0875098714437712
"Section II Medicare Advantage MA Uniformity Flexibility","Section III CY 2019 Formulary Submission Window",0.0874222734002952
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0873641024762313
"Section I Annual Calendar","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0872816145804978
"Section I Enforcement Actions for Provider Directories","Section I Validation Audits",0.0872679418508945
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Medicare Advantage MA Segmented Service Area Options",0.087166175916929
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Cost Plan Transition to MA under MACRA",0.0871386641945451
"Section A  Update of the RxHCC Model","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0871299278614504
"Section II Cost Plan Competition Requirements","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0870831260477986
"Section D  Retiree Drug Subsidy Amounts","Section I Incomplete and Inaccurate Bid Submissions",0.0870569977048389
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section G  MA Employer Group Waiver Plans",0.0870296078118305
"Section I Enforcement Actions for Provider Directories","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0869257454855845
"Section III Benefit Review","Section II Transparency  Timeliness with Prior Authorization Processes",0.0867956343536767
"Section O  Quality Payment Program","Section E  Clinical Trials",0.0867699896929456
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0866603332046147
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Transparency  Timeliness with Prior Authorization Processes",0.086637910010459
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Incomplete and Inaccurate Bid Submissions",0.086581208762985
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section O  Quality Payment Program",0.0865787051467779
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Innovations in Health Plan Design",0.0865484644815831
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0864974753356646
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Maximum OutofPocket MOOP Limits",0.0864614938021333
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Plans with Low Enrollment",0.0864247549094346
"Section A  MA Growth Percentage","Section IV  MedicareMedicaid Plans",0.0863853347497321
"Section II Transparency  Timeliness with Prior Authorization Processes","Section III Improving Access to Part D Vaccines",0.0863489452794717
"Section C  IME Phase Out","Section E  Clinical Trials",0.086323712647497
"Section III Coordination of Benefits COB User Fee","Section I  ESRD Risk Adjustment Model for CY 2019",0.0863174451687081
"Section II Transparency  Timeliness with Prior Authorization Processes","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0863063704004206
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Part C Cost Sharing Standards",0.0861596654469812
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0861199715205013
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section D  ESRD Rates",0.0860611100620842
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0860543135567406
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Improving Access to Part D Vaccines",0.0860218752650628
"Section II Cost Plan Competition Requirements","Section O  Quality Payment Program",0.0859283344555486
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Cost Plan Competition Requirements",0.0858288682449696
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I Validation Audits",0.0857209053448099
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0856617896223473
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0855830310623031
"Section III CY 2019 Formulary Submission Window","Section I  ESRD Risk Adjustment Model for CY 2019",0.0854162593224608
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Outpatient Observation Services",0.0854158015106748
"Section II Cost Plan Competition Requirements","Section I  ESRD Risk Adjustment Model for CY 2019",0.0853924469809956
"Section III Specialty Tiers","Section I Incomplete and Inaccurate Bid Submissions",0.0853787597258285
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Tier Composition",0.085333427025695
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Total Beneficiary Cost TBC",0.0851639027099006
"Section I Innovations in Health Plan Design","Section I Incomplete and Inaccurate Bid Submissions",0.0851570389649893
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0851106463997017
"Section II Medicare Advantage MA Segmented Service Area Options","Section D  ESRD Rates",0.0850586210616836
"Section III Benefit Review","Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.0850486511125124
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Low Enrollment Plans Standalone PDPs only",0.0850439434923102
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section A  Update of the RxHCC Model",0.0849495410679682
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Low Enrollment Plans Standalone PDPs only",0.0848874687627166
"Section O  Quality Payment Program","Section I Validation Audits",0.0848814240475501
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section IV  MedicareMedicaid Plans",0.0848480617812894
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section B  Calculation of Fee for Service Cost",0.0847732319767008
"Section II Part C Optional Supplemental Benefits","Section B  Calculation of Fee for Service Cost",0.0847644330003249
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.084743301768544
"Section II Cost Plan Transition to MA under MACRA","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.084740503389427
"Section III Coordination of Benefits COB User Fee","Section I Innovations in Health Plan Design",0.0846896551771807
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Total Beneficiary Cost TBC",0.0846778647868731
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section H  Enhanced Medication Therapy Management MTM Model",0.0846293626901374
"Section III Benefit Review","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0846189897615685
"Section III Improving Access to Part D Vaccines","Section G  MA Employer Group Waiver Plans",0.0845849365370502
"Section II Part C Optional Supplemental Benefits","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0845494030423683
"Section III Coordination of Benefits COB User Fee","Section II Medicare Advantage MA Segmented Service Area Options",0.0844755126368723
"Section III Low Enrollment Plans Standalone PDPs only","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0844164802576688
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Outpatient Observation Services",0.0844079340920505
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Tiered Cost Sharing of Medical Benefits",0.0844022585882576
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.084329746022238
"Section C  IME Phase Out","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0843194696258921
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section C  IME Phase Out",0.0842324263628656
"Section D  ESRD Rates","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0841814863652503
"Section III Specialty Tiers","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0841704591065502
"Section II Cost Plan Transition to MA under MACRA","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0840871934080073
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0840870720753061
"Section I Enforcement Actions for Provider Directories","Section C  IME Phase Out",0.0839673480210958
"Section II Employer Group Waiver Plans","Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI",0.0839362326855375
"Section II Tiered Cost Sharing of Medical Benefits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0837408707328412
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0837294779587331
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0837033785778331
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I Incomplete and Inaccurate Bid Submissions",0.0836187713866398
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section C  Part D Risk Sharing",0.0835504987323371
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section I Innovations in Health Plan Design",0.0833909955789761
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Maximum OutofPocket MOOP Limits",0.0833169432337957
"Section II Maximum OutofPocket MOOP Limits","Section I  ESRD Risk Adjustment Model for CY 2019",0.083244079425875
"Section O  Quality Payment Program","Section II Part C Cost Sharing Standards",0.0832359464889117
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I Plan Corrections",0.0830446326367534
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.083017051780908
"Section C  Part D Risk Sharing","Section E  Clinical Trials",0.0829738989068783
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0829652180380902
"Section III Coordination of Benefits COB User Fee","Section E  Clinical Trials",0.0829236319176802
"Section I Annual Calendar","Section I Enforcement Actions for Provider Directories",0.0828967326810359
"Section II Plans with Low Enrollment","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0828834799765913
"Section D  Retiree Drug Subsidy Amounts","Section C  IME Phase Out",0.0828436159371528
"Section III Low Enrollment Plans Standalone PDPs only","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0828256955810822
"Section II Medicare Advantage MA Segmented Service Area Options","Section III Low Enrollment Plans Standalone PDPs only",0.0828078671210825
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section C  IME Phase Out",0.0827971485411792
"Section II Cost Plan Competition Requirements","Section I Validation Audits",0.0827594227865651
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Tier Composition",0.0826790442256835
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Maximum OutofPocket MOOP Limits",0.0826239019563315
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Tiered Cost Sharing of Medical Benefits",0.0826079617094607
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD",0.0825733928463931
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Overview of CY 2019 Benefits and Bid Review",0.0824529769545218
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0823926088096257
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0823259141199538
"Section I Innovations in Health Plan Design","Section G  MA Employer Group Waiver Plans",0.0822800850023255
"Section II Health Related Supplemental Benefits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0822350072333924
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0821617617718564
"Section II Outpatient Observation Services","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0821485568715131
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section I Validation Audits",0.0820468583393671
"Section III Coordination of Benefits COB User Fee","Section D  ESRD Rates",0.0820069472748886
"Section II Part C Optional Supplemental Benefits","Section II Transparency  Timeliness with Prior Authorization Processes",0.0819782294729941
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Health Related Supplemental Benefits",0.0819750315774668
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section B  Calculation of Fee for Service Cost",0.0819235044460855
"Section C  IME Phase Out","Section IV  MedicareMedicaid Plans",0.0818276984066018
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section A  Update of the RxHCC Model",0.0818033943179583
"Section II Health Related Supplemental Benefits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0817207505381893
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section G  MA Employer Group Waiver Plans",0.0816705944993628
"Section III Benefit Review","Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD",0.0816631572510186
"Section I Innovations in Health Plan Design","Section H  Enhanced Medication Therapy Management MTM Model",0.0816630708351163
"Section II Plans with Low Enrollment","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0816026118842755
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Plans with Low Enrollment",0.0815926719128856
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section E  Clinical Trials",0.0815557235713196
"Section II Tiered Cost Sharing of Medical Benefits","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0815258836490478
"Section A  MA Growth Percentage","Section C  Part D Risk Sharing",0.0814938238676355
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section A  Update of the RxHCC Model",0.0814570487152403
"Section I  ESRD Risk Adjustment Model for CY 2019","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0813819584806966
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0813795326935554
"Section II Employer Group Waiver Plans","Section E  Clinical Trials",0.081366451384686
"Section D  ESRD Rates","Section C  Part D Risk Sharing",0.0812926301059697
"Section I Annual Calendar","Section II Outpatient Observation Services",0.0812208872320319
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section II Health Related Supplemental Benefits",0.0812061117681491
"Section I Enforcement Actions for Provider Directories","Section II Plans with Low Enrollment",0.0811546218751539
"Section I Plan Corrections","Section III Improving Access to Part D Vaccines",0.081072472227641
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Cost Plan Competition Requirements",0.0810498407140803
"Section III Low Enrollment Plans Standalone PDPs only","Section H  Enhanced Medication Therapy Management MTM Model",0.0810335965801973
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0810159138820864
"Section E  Clinical Trials","Section G  MA Employer Group Waiver Plans",0.0810087764343845
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section I Plan Corrections",0.0809670993420073
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.080967070188748
"Section II Employer Group Waiver Plans","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0809544117220238
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section E  Clinical Trials",0.0808979145035391
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0808828995672908
"Section III Coordination of Benefits COB User Fee","Section I Validation Audits",0.0808173680164126
"Section O  Quality Payment Program","Section III CY 2019 Formulary Submission Window",0.0808051593729501
"Section II Part C Optional Supplemental Benefits","Section D  Retiree Drug Subsidy Amounts",0.0808014710782801
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III Tier Composition",0.0806690459406523
"Section II Plans with Low Enrollment","Section I Plan Corrections",0.0806631470530167
"Section I Enforcement Actions for Provider Directories","Section E  Clinical Trials",0.0806068243838186
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0805962536723063
"Section II Plans with Low Enrollment","Section I Innovations in Health Plan Design",0.0804735334473939
"Section III Expanding the Part D OTC Program","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0803332557246303
"Section II Employer Group Waiver Plans","Section III Timely Updates to LIS Status Based on Best Available Evidence",0.0802209116794916
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0802052196642061
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Total Beneficiary Cost TBC",0.0802021796824542
"Section A  MA Growth Percentage","Section I  ESRD Risk Adjustment Model for CY 2019",0.0801301826341228
"Section III Specialty Tiers","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0801004122767401
"Section A  MA Growth Percentage","Section A  Update of the RxHCC Model",0.0800920983090553
"Section III Benefit Review","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0800640769025436
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0800355792768312
"Section C  IME Phase Out","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0799739007774844
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Specialty Tiers",0.0799680191872089
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Tier Composition",0.0799338293884441
"Section M  Medical Loss Ratio Credibility Adjustment","Section L  Normalization Factors",0.0798507493246956
"Section III Expanding the Part D OTC Program","Section B  Calculation of Fee for Service Cost",0.0798198781639962
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section III Improving Access to Part D Vaccines",0.0796630299494914
"Section II Cost Plan Transition to MA under MACRA","Section I  ESRD Risk Adjustment Model for CY 2019",0.0796471500591155
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0795799470331353
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section G  MA Employer Group Waiver Plans",0.079567918542279
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0795066780301169
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section B  FFS Growth Percentage",0.0794523421121432
"Section II Cost Plan Competition Requirements","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0794346094941247
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.079277323167277
"Section II Employer Group Waiver Plans","Section III Coordination of Benefits COB User Fee",0.0792204335850723
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Meaningful Difference Substantially Duplicative Plan Offerings",0.079211803438134
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0791379726033868
"Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0791033589846311
"Section III Tier Composition","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0790948141787883
"Section III Coordination of Benefits COB User Fee","Section II Cost Plan Transition to MA under MACRA",0.079076630839603
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section D  Retiree Drug Subsidy Amounts",0.0790364835237731
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section C  Part D Risk Sharing",0.0790352476010027
"Section II Plans with Low Enrollment","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.078969255687091
"Section B  FFS Growth Percentage","Section II Maximum OutofPocket MOOP Limits",0.0789350174982546
"Section A  MA Growth Percentage","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.078824656857168
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section III Low Enrollment Plans Standalone PDPs only",0.0786795792469443
"Section III Specialty Tiers","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0786304976730266
"Section C  IME Phase Out","Section L  Normalization Factors",0.0784475278969729
"Section II Employer Group Waiver Plans","Section B  Calculation of Fee for Service Cost",0.0783702141085844
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0782875935600137
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section L  Normalization Factors",0.0781473676950629
"Section II Outpatient Observation Services","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0781278944541126
"Section III Tier Composition","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0781102655663646
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0780497091037884
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0780344701182465
"Section A  MA Growth Percentage","Section L  Normalization Factors",0.078026290619606
"Section II Part C Optional Supplemental Benefits","Section B  FFS Growth Percentage",0.0779932645089033
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Cost Plan Competition Requirements",0.0779043920738005
"Section II Tiered Cost Sharing of Medical Benefits","Section III CY 2019 Formulary Submission Window",0.0778165592149014
"Section II Health Related Supplemental Benefits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0778031974777677
"Section II Cost Plan Transition to MA under MACRA","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0777340572201043
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.077733104409438
"Section II Medicare Advantage MA Uniformity Flexibility","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0776614412362862
"Section I Plan Corrections","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0775593697729233
"Section M  Medical Loss Ratio Credibility Adjustment","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0775537812556356
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Medicare Advantage MA Uniformity Flexibility",0.0775314886057106
"Section D  Retiree Drug Subsidy Amounts","Section III Tier Composition",0.0774629718664993
"Section II Employer Group Waiver Plans","Section O  Quality Payment Program",0.0774230181691165
"Section M  Medical Loss Ratio Credibility Adjustment","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0774225130326876
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0773370213670662
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0773120457838326
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section C  Part D Risk Sharing",0.077263481324142
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section I  ESRD Risk Adjustment Model for CY 2019",0.0771517937127374
"Section II Tiered Cost Sharing of Medical Benefits","Section O  Quality Payment Program",0.0771451840249377
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section I Incomplete and Inaccurate Bid Submissions",0.0771280702366302
"Section II Plans with Low Enrollment","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0770629274270874
"Section D  Retiree Drug Subsidy Amounts","Section I  ESRD Risk Adjustment Model for CY 2019",0.0770281910876501
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Plans with Low Enrollment",0.0770036469790835
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0769424760688284
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section H  Enhanced Medication Therapy Management MTM Model",0.0769308627726944
"Section I Enforcement Actions for Provider Directories","Section II Total Beneficiary Cost TBC",0.0768092828193788
"Section II Part C Optional Supplemental Benefits","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0768024577179711
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section IV  MedicareMedicaid Plans",0.076791054472211
"Section II Plans with Low Enrollment","Section D  ESRD Rates",0.0767604814860814
"Section II Employer Group Waiver Plans","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.076759236317628
"Section E  Clinical Trials","Section I  ESRD Risk Adjustment Model for CY 2019",0.0767330501401592
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0766822162726096
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section B  Calculation of Fee for Service Cost",0.0765755902306325
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III CY 2019 Formulary Submission Window",0.0765363907860154
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section II Part C Cost Sharing Standards",0.0765007331617742
"Section II Employer Group Waiver Plans","Section D  ESRD Rates",0.0764436316599002
"Section III Specialty Tiers","Section B  Calculation of Fee for Service Cost",0.0763971673677424
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section G  MA Employer Group Waiver Plans",0.0763387965689111
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0763357548930868
"Section II Employer Group Waiver Plans","Section I  ESRD Risk Adjustment Model for CY 2019",0.0762998948083713
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0762648332883011
"Section E  Clinical Trials","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.076201010214364
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI",0.076163231935151
"Section D  Retiree Drug Subsidy Amounts","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0761530673893271
"Section III Low Enrollment Plans Standalone PDPs only","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0761422360350593
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Validation Audits",0.075993275940123
"Section III Benefit Review","Section I Validation Audits",0.0759585441100268
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section D  ESRD Rates",0.0759083218232846
"Section B  FFS Growth Percentage","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.075872621496986
"Section II Employer Group Waiver Plans","Section A  MA Growth Percentage",0.0758587555442266
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section II Total Beneficiary Cost TBC",0.0758271133245756
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section I  ESRD Risk Adjustment Model for CY 2019",0.0757856090382547
"Section II Employer Group Waiver Plans","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0757595825541949
"Section I Annual Calendar","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0757112120539661
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section II Health Related Supplemental Benefits",0.0756825127656243
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.075640822144327
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section H  Enhanced Medication Therapy Management MTM Model",0.0755807124892109
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0755566361164586
"Section H  Enhanced Medication Therapy Management MTM Model","Section I Validation Audits",0.0755359278838038
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section I Incomplete and Inaccurate Bid Submissions",0.0754537325127361
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Maximum OutofPocket MOOP Limits",0.0753726541212863
"Section II Cost Plan Transition to MA under MACRA","Section I Innovations in Health Plan Design",0.075247681503274
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0751641113018944
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section E  Clinical Trials",0.0751318380810001
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section L  Normalization Factors",0.0751240084135793
"Section II Plans with Low Enrollment","Section III Improving Access to Part D Vaccines",0.0750966629569878
"Section II Part C Optional Supplemental Benefits","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0750719775534303
"Section II Employer Group Waiver Plans","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0750692363806564
"Section II Tiered Cost Sharing of Medical Benefits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0750580911926917
"Section II Tiered Cost Sharing of Medical Benefits","Section I  ESRD Risk Adjustment Model for CY 2019",0.075046513608703
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section L  Normalization Factors",0.0750309889422272
"Section III Coordination of Benefits COB User Fee","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0750213372270924
"Section II Part C Optional Supplemental Benefits","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0750004783209023
"Section III Low Enrollment Plans Standalone PDPs only","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0749322910116809
"Section O  Quality Payment Program","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0749191075340498
"Section III Benefit Review","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0749101616766789
"Section C  Part D Risk Sharing","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0748923842150483
"Section I Enforcement Actions for Provider Directories","Section I Innovations in Health Plan Design",0.0748793597542596
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section B  Calculation of Fee for Service Cost",0.0746109958707823
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section IV  MedicareMedicaid Plans",0.0745929086693691
"Section II Medicare Advantage MA Uniformity Flexibility","Section L  Normalization Factors",0.0745443402425389
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Tier Composition",0.0745400444836844
"Section II Plans with Low Enrollment","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0745126444183812
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0744533370697541
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Benefit Review",0.0744437500478198
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0743974547623466
"Section A  MA Growth Percentage","Section II Tiered Cost Sharing of Medical Benefits",0.074396195659136
"Section I Annual Calendar","Section II Maximum OutofPocket MOOP Limits",0.0743921128456045
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Plans with Low Enrollment",0.0743770969988401
"Section A  MA Growth Percentage","Section D  Retiree Drug Subsidy Amounts",0.0743701747143996
"Section C  IME Phase Out","Section III Expanding the Part D OTC Program",0.0743591315546685
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Overview of CY 2019 Benefits and Bid Review",0.0740767798280637
"Section A  MA Growth Percentage","Section II Maximum OutofPocket MOOP Limits",0.0740155044314473
"Section D  ESRD Rates","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0739898831023556
"Section III Improving Access to Part D Vaccines","Section I Validation Audits",0.0739800723387719
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section C  Part D Risk Sharing",0.0738839737369955
"Section A  Update of the RxHCC Model","Section E  Clinical Trials",0.0738838240098644
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Specialty Tiers",0.0737977669133593
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Outpatient Observation Services",0.0737681922137646
"Section III CY 2019 Formulary Submission Window","Section G  MA Employer Group Waiver Plans",0.073584880067422
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0735643049169157
"Section III Expanding the Part D OTC Program","Section O  Quality Payment Program",0.0735244674091985
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0734814369516441
"Section II Outpatient Observation Services","Section I Incomplete and Inaccurate Bid Submissions",0.0734364919365423
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section I  ESRD Risk Adjustment Model for CY 2019",0.0734031796669154
"Section I Plan Corrections","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0733921143092268
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section C  IME Phase Out",0.0733721986149642
"Section II Cost Plan Competition Requirements","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0733502422615802
"Section II Transparency  Timeliness with Prior Authorization Processes","Section H  Enhanced Medication Therapy Management MTM Model",0.0732950664154577
"Section C  IME Phase Out","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0732187534250282
"Section H  Enhanced Medication Therapy Management MTM Model","Section E  Clinical Trials",0.0732113699907227
"Section II Part C Optional Supplemental Benefits","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0731169854181451
"Section I Enforcement Actions for Provider Directories","Section III Expanding the Part D OTC Program",0.0731041140541067
"Section III Specialty Tiers","Section I Validation Audits",0.0730535738101648
"Section II Employer Group Waiver Plans","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0729930714521927
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0729513612027758
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section O  Quality Payment Program",0.0729002273831851
"Section II Health Related Supplemental Benefits","Section B  Calculation of Fee for Service Cost",0.0727898342410968
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0726861644212036
"Section III Expanding the Part D OTC Program","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0726680273149658
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0726596042571523
"Section II Cost Plan Transition to MA under MACRA","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0726514017147805
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section E  Clinical Trials",0.0726488241402433
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Part C Cost Sharing Standards",0.0726380723814318
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Maximum OutofPocket MOOP Limits",0.0726182022777818
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Plan Corrections",0.0725863161887757
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section O  Quality Payment Program",0.0724750674736296
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0724713794565561
"Section I Annual Calendar","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0723746864455746
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Improving Access to Part D Vaccines",0.0721677395628016
"Section D  ESRD Rates","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0721424680033615
"Section III Low Enrollment Plans Standalone PDPs only","Section I  ESRD Risk Adjustment Model for CY 2019",0.072140249942361
"Section III Tier Composition","Section I Innovations in Health Plan Design",0.0721319927207068
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section L  Normalization Factors",0.0720665981346495
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section H  Enhanced Medication Therapy Management MTM Model",0.0720624510100531
"Section III Coordination of Benefits COB User Fee","Section B  FFS Growth Percentage",0.0720409592347544
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section H  Enhanced Medication Therapy Management MTM Model",0.0720185131913509
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0720167098152406
"Section B  FFS Growth Percentage","Section E  Clinical Trials",0.0719818253390526
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Coordination of Benefits COB User Fee",0.0718588640737359
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Tier Composition",0.0718003636093632
"Section I Innovations in Health Plan Design","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0717448982026
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0717125715069118
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0716875911030382
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section I Validation Audits",0.0716793291142123
"Section II Employer Group Waiver Plans","Section III CY 2019 Formulary Submission Window",0.0716409753555344
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III Improving Access to Part D Vaccines",0.0715813059690444
"Section I Enforcement Actions for Provider Directories","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0714847427434377
"Section II Plans with Low Enrollment","Section III Expanding the Part D OTC Program",0.0714818715668934
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0714604805529813
"Section A  MA Growth Percentage","Section II Transparency  Timeliness with Prior Authorization Processes",0.0713376375006422
"Section L  Normalization Factors","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0713157719016696
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section O  Quality Payment Program",0.0712395788460429
"Section II Plans with Low Enrollment","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0711483639580122
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section A  Update of the RxHCC Model",0.0711294406317855
"Section I Plan Corrections","Section I Innovations in Health Plan Design",0.0710698135775347
"Section II Medicare Advantage MA Segmented Service Area Options","Section B  FFS Growth Percentage",0.0710669054518701
"Section D  ESRD Rates","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0710482923314903
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0710154198533209
"Section I Innovations in Health Plan Design","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.071012199576161
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III CY 2019 Formulary Submission Window",0.0709318607121185
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Health Related Supplemental Benefits",0.0709208143266975
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section C  IME Phase Out",0.0709132875115449
"Section III Benefit Review","Section III Low Enrollment Plans Standalone PDPs only",0.0708683386892301
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0706529146253206
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0706500860369373
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0706278312281457
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section B  FFS Growth Percentage",0.07061878636038
"Section II Employer Group Waiver Plans","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0704501430629678
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0703878436613736
"Section C  Part D Risk Sharing","Section I  ESRD Risk Adjustment Model for CY 2019",0.0703703145526009
"Section II Maximum OutofPocket MOOP Limits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0703477663248865
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section D  ESRD Rates",0.0702807666803109
"Section II Part C Cost Sharing Standards","Section L  Normalization Factors",0.070264556748939
"Section II Part C Optional Supplemental Benefits","Section E  Clinical Trials",0.0702546284773485
"Section II Medicare Advantage MA Segmented Service Area Options","Section C  Part D Risk Sharing",0.0702165128982794
"Section II Plans with Low Enrollment","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0701977221860144
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0701353913896955
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.070130170412733
"Section I Enforcement Actions for Provider Directories","Section II Part C Cost Sharing Standards",0.070066808375228
"Section II Employer Group Waiver Plans","Section I Enforcement Actions for Provider Directories",0.0700436828310926
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section H  Enhanced Medication Therapy Management MTM Model",0.0699166544358527
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section K  Medicare Advantage Coding Pattern Adjustment",0.06985354731357
"Section III Specialty Tiers","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0697667224480068
"Section III Expanding the Part D OTC Program","Section G  MA Employer Group Waiver Plans",0.069719841268313
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section B  FFS Growth Percentage",0.0695452569739824
"Section I Plan Corrections","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0694783419175472
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0694607437525486
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section O  Quality Payment Program",0.0694482134125792
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section O  Quality Payment Program",0.0694403275086664
"Section III Low Enrollment Plans Standalone PDPs only","Section IV  MedicareMedicaid Plans",0.0694211414574186
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I  ESRD Risk Adjustment Model for CY 2019",0.0694204639884261
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0694137609619641
"Section III Improving Access to Part D Vaccines","Section B  Calculation of Fee for Service Cost",0.0694131400969635
"Section I Incomplete and Inaccurate Bid Submissions","Section B  Calculation of Fee for Service Cost",0.069385482474958
"Section III Low Enrollment Plans Standalone PDPs only","Section I Plan Corrections",0.0693548387096774
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section C  IME Phase Out",0.0692407165765329
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section K  Medicare Advantage Coding Pattern Adjustment",0.0691653182407362
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0691612167177876
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section N  Encounter Data as a Diagnosis Source for 2019",0.069154904129672
"Section A  Update of the RxHCC Model","Section I Incomplete and Inaccurate Bid Submissions",0.0691248252881375
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Tier Composition",0.0690288680386333
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Enforcement Actions for Provider Directories",0.0690201385651975
"Section II Part C Cost Sharing Standards","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0689986287714052
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0689840248322693
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0689730494715005
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Incomplete and Inaccurate Bid Submissions",0.0689188539901668
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0688911079961671
"Section II Part C Optional Supplemental Benefits","Section C  IME Phase Out",0.0687925518896444
"Section II Outpatient Observation Services","Section C  IME Phase Out",0.0686774474683792
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0686486274317074
"Section III Benefit Review","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0686263516307516
"Section E  Clinical Trials","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.068607293721423
"Section D  ESRD Rates","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0685780676785002
"Section I Enforcement Actions for Provider Directories","Section G  MA Employer Group Waiver Plans",0.0684425355216523
"Section III Specialty Tiers","Section II Maximum OutofPocket MOOP Limits",0.0684323811661508
"Section II Plans with Low Enrollment","Section O  Quality Payment Program",0.0684317427217766
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Plan Corrections",0.0684296885019239
"Section A  MA Growth Percentage","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0684294103522456
"Section K  Medicare Advantage Coding Pattern Adjustment","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0684136149669813
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0683650868293412
"Section II Employer Group Waiver Plans","Section I Innovations in Health Plan Design",0.0683172223490538
"Section II Employer Group Waiver Plans","Section III Low Enrollment Plans Standalone PDPs only",0.0682191040240647
"Section II Maximum OutofPocket MOOP Limits","Section L  Normalization Factors",0.0680490516511694
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section O  Quality Payment Program",0.0679114076391574
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Cost Plan Transition to MA under MACRA",0.0678699993763661
"Section O  Quality Payment Program","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0678257411074468
"Section III Benefit Review","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0677982170084371
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0677801204680273
"Section A  Update of the RxHCC Model","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0677404592895772
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0677360844627324
"Section I Annual Calendar","Section E  Clinical Trials",0.0677089931966491
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section C  IME Phase Out",0.0676766599024113
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section A  MA Growth Percentage",0.0675713273761156
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section O  Quality Payment Program",0.0675629981756532
"Section II Plans with Low Enrollment","Section I  ESRD Risk Adjustment Model for CY 2019",0.0675079353611667
"Section M  Medical Loss Ratio Credibility Adjustment","Section I Plan Corrections",0.0674926609234612
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Cost Plan Transition to MA under MACRA",0.0673979120433075
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section D  ESRD Rates",0.0673908783318341
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0673880865585927
"Section III Specialty Tiers","Section B  FFS Growth Percentage",0.0673853319205979
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Incomplete and Inaccurate Bid Submissions",0.0673823909082796
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Overview of CY 2019 Benefits and Bid Review",0.0673641277992676
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section C  IME Phase Out",0.0672898812537302
"Section I Enforcement Actions for Provider Directories","Section M  Medical Loss Ratio Credibility Adjustment",0.067241411944686
"Section II Employer Group Waiver Plans","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0672182805250465
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0671732649869522
"Section II Tiered Cost Sharing of Medical Benefits","Section B  FFS Growth Percentage",0.067147550989751
"Section III Specialty Tiers","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.067145951654548
"Section G  MA Employer Group Waiver Plans","Section I Validation Audits",0.0671102283702745
"Section C  IME Phase Out","Section I  ESRD Risk Adjustment Model for CY 2019",0.0670537756792441
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section O  Quality Payment Program",0.0670511400597969
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Coordination of Benefits COB User Fee",0.0669126487548797
"Section III Benefit Review","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0669006974911935
"Section M  Medical Loss Ratio Credibility Adjustment","Section H  Enhanced Medication Therapy Management MTM Model",0.0668569862573432
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0667997675628703
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Validation Audits",0.0667551077426232
"Section C  IME Phase Out","Section A  Update of the RxHCC Model",0.0666843417708679
"Section B  FFS Growth Percentage","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0666206929531205
"Section II Transparency  Timeliness with Prior Authorization Processes","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0666133972481193
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section B  FFS Growth Percentage",0.0666072224580856
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Cost Plan Transition to MA under MACRA",0.0666010175452128
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0665716321683642
"Section II Cost Plan Transition to MA under MACRA","Section III CY 2019 Formulary Submission Window",0.0664147497254271
"Section II Outpatient Observation Services","Section II Plans with Low Enrollment",0.0663769002118155
"Section II Part C Optional Supplemental Benefits","Section I Innovations in Health Plan Design",0.0663609032616063
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0663378013218048
"Section II Health Related Supplemental Benefits","Section I Validation Audits",0.0663041084276828
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section H  Enhanced Medication Therapy Management MTM Model",0.0662796860620508
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Cost Plan Transition to MA under MACRA",0.0662692078702932
"Section III Tier Composition","Section C  Part D Risk Sharing",0.0662634008328374
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Medicare Advantage MA Uniformity Flexibility",0.0662051122128562
"Section B  Encounter Data as a Diagnosis Source for 2019","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0661532366679515
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section I  ESRD Risk Adjustment Model for CY 2019",0.0661226980486495
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section A  Update of the RxHCC Model",0.0661130473539203
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.066099462629675
"Section M  Medical Loss Ratio Credibility Adjustment","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0660189946647863
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.066012364293894
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0659195797060686
"Section II Part C Optional Supplemental Benefits","Section O  Quality Payment Program",0.0658947347165689
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section L  Normalization Factors",0.0657155567380273
"Section C  IME Phase Out","Section II Health Related Supplemental Benefits",0.0657052642012623
"Section II Health Related Supplemental Benefits","Section O  Quality Payment Program",0.0656739087882615
"Section II Cost Plan Competition Requirements","Section L  Normalization Factors",0.0656316076271146
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section A  Update of the RxHCC Model",0.0655666479481058
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.06555842867031
"Section III Benefit Review","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0655429786772708
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Expanding the Part D OTC Program",0.065541312676262
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section G  MA Employer Group Waiver Plans",0.0654109677663205
"Section II Part C Optional Supplemental Benefits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0653656136365165
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Total Beneficiary Cost TBC",0.0652921040842318
"Section III Benefit Review","Section I Enforcement Actions for Provider Directories",0.0652179007495467
"Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019","Section L  Normalization Factors",0.0652123312652128
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0651337576620488
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0651046735982357
"Section A  MA Growth Percentage","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0650120940947797
"Section III Improving Access to Part D Vaccines","Section E  Clinical Trials",0.0649543020436031
"Section III Low Enrollment Plans Standalone PDPs only","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0648704258271975
"Section II Plans with Low Enrollment","Section A  Update of the RxHCC Model",0.0648559087117145
"Section C  Part D Risk Sharing","Section I Validation Audits",0.0648096349647758
"Section A  MA Benchmark Quality Bonus Payments and Rebate","Section I Validation Audits",0.0647667568717802
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Medicare Advantage MA Uniformity Flexibility",0.0647577932865007
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I Plan Corrections",0.0646647496600515
"Section II Medicare Advantage MA Segmented Service Area Options","Section III Tier Composition",0.0646217994188271
"Section III CY 2019 Formulary Submission Window","Section B  Calculation of Fee for Service Cost",0.0645337809080422
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Part C Cost Sharing Standards",0.0644289474674949
"Section III Specialty Tiers","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0643421368772558
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I  ESRD Risk Adjustment Model for CY 2019",0.0643072902399838
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Innovations in Health Plan Design",0.064258956443021
"Section O  Quality Payment Program","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0642355825212441
"Section II Employer Group Waiver Plans","Section A  Update of the RxHCC Model",0.0641396691024454
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0641288671594761
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I Innovations in Health Plan Design",0.0641245150601885
"Section II Employer Group Waiver Plans","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0640900821525225
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Health Related Supplemental Benefits",0.0640124344074379
"Section II Medicare Advantage MA Segmented Service Area Options","Section O  Quality Payment Program",0.0639959407412555
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section I Incomplete and Inaccurate Bid Submissions",0.0639863084754521
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Total Beneficiary Cost TBC",0.0639540796781775
"Section B  Encounter Data as a Diagnosis Source for 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0639253825742239
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0638864375804964
"Section M  Medical Loss Ratio Credibility Adjustment","Section III Low Enrollment Plans Standalone PDPs only",0.0637887953849786
"Section I  ESRD Risk Adjustment Model for CY 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.063758514526199
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section D  ESRD Rates",0.0636660058795376
"Section III Specialty Tiers","Section III Low Enrollment Plans Standalone PDPs only",0.0636141697259978
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0635780488763287
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Part C Cost Sharing Standards",0.0635606355883318
"Section L  Normalization Factors","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0635001315920999
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Overview of CY 2019 Benefits and Bid Review",0.0634720530510127
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section O  Quality Payment Program",0.0634403678327232
"Section III Coordination of Benefits COB User Fee","Section II Maximum OutofPocket MOOP Limits",0.0633393671255726
"Section I Enforcement Actions for Provider Directories","Section II Health Related Supplemental Benefits",0.0633264629312784
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section C  IME Phase Out",0.063258049854982
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III CY 2019 Formulary Submission Window",0.0632484381591106
"Section III Tier Composition","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0632227058830051
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.063180189317447
"Section A  MA Growth Percentage","Section II Part C Optional Supplemental Benefits",0.0631598387445603
"Section II Maximum OutofPocket MOOP Limits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.062975929387203
"Section I Enforcement Actions for Provider Directories","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0629428365930321
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section II Total Beneficiary Cost TBC",0.0628104762592241
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0627694006356476
"Section II Transparency  Timeliness with Prior Authorization Processes","Section III Tier Composition",0.0626193681094447
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I Plan Corrections",0.0625927843311559
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Tiered Cost Sharing of Medical Benefits",0.0625724637924543
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0625690939191506
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Maximum OutofPocket MOOP Limits",0.0625274553203347
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Plans with Low Enrollment",0.0625184543508525
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0624281280630322
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Outpatient Observation Services",0.0623493887850573
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Plans with Low Enrollment",0.0622712452593942
"Section III Benefit Review","Section B  Calculation of Fee for Service Cost",0.0622439180637252
"Section I Enforcement Actions for Provider Directories","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0621973832522989
"Section III Specialty Tiers","Section II Plans with Low Enrollment",0.0621656363234018
"Section II Transparency  Timeliness with Prior Authorization Processes","Section B  Calculation of Fee for Service Cost",0.0620858770725634
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section O  Quality Payment Program",0.0620682274927648
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0620269106303989
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section B  FFS Growth Percentage",0.0619463038248947
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0618645793515068
"Section II Cost Plan Transition to MA under MACRA","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0618595049488939
"Section A  MA Growth Percentage","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0618591586940836
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section C  IME Phase Out",0.0617811861328394
"Section III Coordination of Benefits COB User Fee","Section O  Quality Payment Program",0.061699939085177
"Section M  Medical Loss Ratio Credibility Adjustment","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0616764636773986
"Section III Specialty Tiers","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0616016751776641
"Section K  Medicare Advantage Coding Pattern Adjustment","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0615312448846813
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0613631739064705
"Section II Part C Optional Supplemental Benefits","Section III Specialty Tiers",0.0613153568592068
"Section II Employer Group Waiver Plans","Section III Expanding the Part D OTC Program",0.0611394229547013
"Section II Maximum OutofPocket MOOP Limits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0610852228934418
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section B  FFS Growth Percentage",0.0610104861938031
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0609937545592833
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section D  Retiree Drug Subsidy Amounts",0.0608840863472962
"Section III Specialty Tiers","Section II Cost Plan Transition to MA under MACRA",0.0608356493093688
"Section II Employer Group Waiver Plans","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0608268478849969
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0608174312793839
"Section II Employer Group Waiver Plans","Section N  Encounter Data as a Diagnosis Source for 2019",0.0606407314553894
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Overview of CY 2019 Benefits and Bid Review",0.0606185864015041
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section E  Clinical Trials",0.0605227937547335
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section G  MA Employer Group Waiver Plans",0.0604913210376676
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section A  Update of the RxHCC Model",0.060401837759588
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Maximum OutofPocket MOOP Limits",0.0603344098868607
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0603259626232541
"Section II Outpatient Observation Services","Section A  Update of the RxHCC Model",0.0603139215942395
"Section A  MA Growth Percentage","Section II Medicare Advantage MA Segmented Service Area Options",0.0602913078559483
"Section A  MA Growth Percentage","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0602620331235325
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section II Total Beneficiary Cost TBC",0.0602533533479414
"Section II Medicare Advantage MA Segmented Service Area Options","Section III Improving Access to Part D Vaccines",0.0600996764070421
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section O  Quality Payment Program",0.0600787691598161
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I Validation Audits",0.0600706250639878
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section C  Part D Risk Sharing",0.0600524795542928
"Section D  Retiree Drug Subsidy Amounts","Section II Plans with Low Enrollment",0.0600513993051888
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Medicare Advantage MA Segmented Service Area Options",0.0600400400444964
"Section III Expanding the Part D OTC Program","Section C  Part D Risk Sharing",0.0600357685399832
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section H  Enhanced Medication Therapy Management MTM Model",0.0599666367817783
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section H  Enhanced Medication Therapy Management MTM Model",0.0598911290911087
"Section A  MA Growth Percentage","Section E  Clinical Trials",0.0597028650938967
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0596824934162947
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III CY 2019 Formulary Submission Window",0.0594976974358059
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0594627432487365
"Section B  FFS Growth Percentage","Section I Innovations in Health Plan Design",0.0594247436722587
"Section B  FFS Growth Percentage","Section II Health Related Supplemental Benefits",0.0593937974074761
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Specialty Tiers",0.059373225077598
"Section M  Medical Loss Ratio Credibility Adjustment","Section I  ESRD Risk Adjustment Model for CY 2019",0.0593588741494357
"Section II Transparency  Timeliness with Prior Authorization Processes","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0593286426605613
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Plan Corrections",0.0592996793560037
"Section A  MA Growth Percentage","Section III Specialty Tiers",0.05928528869411
"Section I Annual Calendar","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0592821811070166
"Section A  MA Growth Percentage","Section G  MA Employer Group Waiver Plans",0.0591027348278033
"Section B  Encounter Data as a Diagnosis Source for 2019","Section H  Enhanced Medication Therapy Management MTM Model",0.0590885920372169
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0590793674052216
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Health Related Supplemental Benefits",0.0590588694276483
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section G  MA Employer Group Waiver Plans",0.0589909860981345
"Section I Annual Calendar","Section O  Quality Payment Program",0.0589051154834448
"Section III Specialty Tiers","Section II Overview of CY 2019 Benefits and Bid Review",0.0588932229658805
"Section D  ESRD Rates","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0588146927688734
"Section II Transparency  Timeliness with Prior Authorization Processes","Section A  Update of the RxHCC Model",0.0587748027657034
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section III Low Enrollment Plans Standalone PDPs only",0.0587301232168675
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0586897638370201
"Section C  IME Phase Out","Section III Improving Access to Part D Vaccines",0.0586075679395688
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Plan Corrections",0.0585780248064807
"Section II Health Related Supplemental Benefits","Section I  ESRD Risk Adjustment Model for CY 2019",0.0585759744875132
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section O  Quality Payment Program",0.0585016136917668
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Cost Plan Competition Requirements",0.0583984821782857
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0583786695646328
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section B  Calculation of Fee for Service Cost",0.0582463673025899
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Innovations in Health Plan Design",0.0582204236195967
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I  ESRD Risk Adjustment Model for CY 2019",0.0582150206383011
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0581683187090907
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0581323588297346
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section G  MA Employer Group Waiver Plans",0.0581004969402392
"Section III Specialty Tiers","Section D  ESRD Rates",0.0580828716454129
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0580546953646125
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI",0.0580041893427398
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0579999371293372
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section H  Enhanced Medication Therapy Management MTM Model",0.0579962113472536
"Section III Specialty Tiers","Section E  Clinical Trials",0.0579593385846736
"Section III Part D Benefit Parameters for NonDefined Standard Plans","Section B  Encounter Data as a Diagnosis Source for 2019",0.0578065767302911
"Section II Medicare Advantage MA Segmented Service Area Options","Section G  MA Employer Group Waiver Plans",0.0577668631645135
"Section C  IME Phase Out","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0577582764114683
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0577350269189626
"Section C  IME Phase Out","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0576777219849613
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section III Tier Composition",0.057653435570224
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0576447275254085
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section G  MA Employer Group Waiver Plans",0.0574992461356086
"Section II Outpatient Observation Services","Section III Expanding the Part D OTC Program",0.0574926315338024
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Part C Cost Sharing Standards",0.0574654624814328
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Cost Plan Competition Requirements",0.057327420951716
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section L  Normalization Factors",0.0572837062095932
"Section III Low Enrollment Plans Standalone PDPs only","Section III CY 2019 Formulary Submission Window",0.0571170364115202
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0570171205131193
"Section B  Calculation of Fee for Service Cost","Section I Validation Audits",0.0569927925537467
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Innovations in Health Plan Design",0.0568979336185847
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section E  Clinical Trials",0.0568783845065235
"Section II Employer Group Waiver Plans","Section C  Part D Risk Sharing",0.0567942986060349
"Section A  MA Growth Percentage","Section III Low Enrollment Plans Standalone PDPs only",0.0567907636829675
"Section III Improving Access to Part D Vaccines","Section I  ESRD Risk Adjustment Model for CY 2019",0.0567756130240321
"Section III Low Enrollment Plans Standalone PDPs only","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0567281685442336
"Section C  Part D Risk Sharing","Section IV  MedicareMedicaid Plans",0.0567247498518729
"Section C  IME Phase Out","Section I Validation Audits",0.0566905242058357
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Coordination of Benefits COB User Fee",0.0565996106427945
"Section III Tier Composition","Section G  MA Employer Group Waiver Plans",0.0565215782219431
"Section II Transparency  Timeliness with Prior Authorization Processes","Section I  ESRD Risk Adjustment Model for CY 2019",0.0565050821230205
"Section M  Medical Loss Ratio Credibility Adjustment","Section I Incomplete and Inaccurate Bid Submissions",0.0564039450068527
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section M  Medical Loss Ratio Credibility Adjustment",0.0564027243404021
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section G  MA Employer Group Waiver Plans",0.0563968807897615
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0563687872386768
"Section C  IME Phase Out","Section III Low Enrollment Plans Standalone PDPs only",0.0562052113950799
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Maximum OutofPocket MOOP Limits",0.0561546298499648
"Section I Annual Calendar","Section III Specialty Tiers",0.0560295166535375
"Section III Tier Composition","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0559971457424927
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Outpatient Observation Services",0.0558466321423949
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.055829057645049
"Section E  Clinical Trials","Section I Validation Audits",0.0558027868805163
"Section II Medicare Advantage MA Segmented Service Area Options","Section III CY 2019 Formulary Submission Window",0.0558003029167523
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0555814843808205
"Section B  FFS Growth Percentage","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0555752154582248
"Section III Specialty Tiers","Section II Health Related Supplemental Benefits",0.0555269996268863
"Section M  Medical Loss Ratio Credibility Adjustment","Section O  Quality Payment Program",0.0555166119336701
"Section K  Medicare Advantage Coding Pattern Adjustment","Section IV  MedicareMedicaid Plans",0.0555140207535912
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0553607666039908
"Section I Enforcement Actions for Provider Directories","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0552858650997425
"Section D  ESRD Rates","Section III Expanding the Part D OTC Program",0.0552348671520222
"Section II Part C Optional Supplemental Benefits","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0552264266452734
"Section I Enforcement Actions for Provider Directories","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.055168485211272
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0551392338765456
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Innovations in Health Plan Design",0.0550834090820383
"Section III Tier Composition","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0550237909933339
"Section III Specialty Tiers","Section II Medicare Advantage MA Uniformity Flexibility",0.0550198931178481
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section N  Encounter Data as a Diagnosis Source for 2019",0.0550056832787376
"Section C  IME Phase Out","Section I Incomplete and Inaccurate Bid Submissions",0.0549386136263517
"Section III Low Enrollment Plans Standalone PDPs only","Section III Tier Composition",0.0548958631162533
"Section M  Medical Loss Ratio Credibility Adjustment","Section III Expanding the Part D OTC Program",0.0548821299948452
"Section III Low Enrollment Plans Standalone PDPs only","Section I Validation Audits",0.054867294981736
"Section A  Update of the RxHCC Model","Section I Validation Audits",0.0547354477788962
"Section III Benefit Review","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0547053842513355
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0547005864045369
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.054578646657537
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Overview of CY 2019 Benefits and Bid Review",0.0545386273095214
"Section II Outpatient Observation Services","Section I  ESRD Risk Adjustment Model for CY 2019",0.054529106752727
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section G  MA Employer Group Waiver Plans",0.0544282917679666
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Part C Optional Supplemental Benefits",0.0543551003769771
"Section II Plans with Low Enrollment","Section III Tier Composition",0.0542955411023394
"Section III Improving Access to Part D Vaccines","Section II Maximum OutofPocket MOOP Limits",0.0542058991655122
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Maximum OutofPocket MOOP Limits",0.0542050436060982
"Section III Low Enrollment Plans Standalone PDPs only","Section E  Clinical Trials",0.0539831114032204
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section O  Quality Payment Program",0.05395752042085
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section I Innovations in Health Plan Design",0.0538790769800575
"Section C  Part D Risk Sharing","Section O  Quality Payment Program",0.0538364467396719
"Section B  FFS Growth Percentage","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0538199687263016
"Section B  FFS Growth Percentage","Section I Validation Audits",0.0536895964046186
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section D  ESRD Rates",0.0536783057284054
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Validation Audits",0.0536720983915701
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section C  IME Phase Out",0.0535287727572189
"Section III CY 2019 Formulary Submission Window","Section L  Normalization Factors",0.0534920256565888
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section B  Calculation of Fee for Service Cost",0.0534892499673689
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0534799672109462
"Section II Medicare Advantage MA Segmented Service Area Options","Section L  Normalization Factors",0.0531988780802942
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section B  FFS Growth Percentage",0.0531715519646084
"Section D  Retiree Drug Subsidy Amounts","Section L  Normalization Factors",0.0531587819165215
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0531236138886316
"Section I Enforcement Actions for Provider Directories","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0530648017184201
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0530049876606566
"Section II Outpatient Observation Services","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0529325630378145
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0529210808543388
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0528799151686719
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0528742113333194
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Health Related Supplemental Benefits",0.0528285901166885
"Section II Cost Plan Competition Requirements","Section C  Part D Risk Sharing",0.0527972437541215
"Section III Benefit Review","Section N  Encounter Data as a Diagnosis Source for 2019",0.0527963677348455
"Section A  MA Growth Percentage","Section II Plans with Low Enrollment",0.0527352792424442
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0527264972921352
"Section B  FFS Growth Percentage","Section III Improving Access to Part D Vaccines",0.052717552715198
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Plan Corrections",0.0527133657485731
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0527076653351065
"Section III Expanding the Part D OTC Program","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0526447458312415
"Section III Specialty Tiers","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0526130888845596
"Section II Employer Group Waiver Plans","Section III Specialty Tiers",0.05260244438718
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0525742663708674
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section K  Medicare Advantage Coding Pattern Adjustment",0.05252331239346
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Transparency  Timeliness with Prior Authorization Processes",0.0525051599301613
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section IV  MedicareMedicaid Plans",0.0524828504686827
"Section II Cost Plan Transition to MA under MACRA","Section L  Normalization Factors",0.052400213634554
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section B  Calculation of Fee for Service Cost",0.0523248332273397
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Medicare Advantage MA Uniformity Flexibility",0.0522581471721608
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0522246931875488
"Section I Innovations in Health Plan Design","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0521289718869584
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section I  ESRD Risk Adjustment Model for CY 2019",0.0520376141642477
"Section II Plans with Low Enrollment","Section B  FFS Growth Percentage",0.0520117811827792
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.051970105777489
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section A  MA Growth Percentage",0.0519057554995008
"Section III Low Enrollment Plans Standalone PDPs only","Section L  Normalization Factors",0.051903860358473
"Section B  FFS Growth Percentage","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0518974448744599
"Section II Employer Group Waiver Plans","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0518874521662771
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0518478671499038
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Cost Plan Competition Requirements",0.0517710979474611
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section E  Clinical Trials",0.0517351853868745
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section O  Quality Payment Program",0.0517197871879656
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Tier Composition",0.0516666946976501
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0516532278782109
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section I  ESRD Risk Adjustment Model for CY 2019",0.051647588369719
"Section I Incomplete and Inaccurate Bid Submissions","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0514422291450723
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0514235678440099
"Section III Low Enrollment Plans Standalone PDPs only","Section D  ESRD Rates",0.0513590218048426
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section B  FFS Growth Percentage",0.0513193839595919
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section F  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0512820512820513
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Part C Cost Sharing Standards",0.0512087796296987
"Section III Benefit Review","Section D  Retiree Drug Subsidy Amounts",0.0511835958002358
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section G  MA Employer Group Waiver Plans",0.0511766571602509
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section D  ESRD Rates",0.0511118473535501
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Medicare Advantage MA Segmented Service Area Options",0.0509956349604631
"Section B  FFS Growth Percentage","Section III CY 2019 Formulary Submission Window",0.0509857052344785
"Section II Part C Optional Supplemental Benefits","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0509417527512017
"Section D  Retiree Drug Subsidy Amounts","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0509003418501811
"Section A  MA Growth Percentage","Section III Expanding the Part D OTC Program",0.05089709943286
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0508757555577355
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section E  Clinical Trials",0.0506414353017339
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section III CY 2019 Formulary Submission Window",0.0506256455726208
"Section III Low Enrollment Plans Standalone PDPs only","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0505823383202749
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0505721737424174
"Section III Coordination of Benefits COB User Fee","Section III Low Enrollment Plans Standalone PDPs only",0.0505633980641732
"Section D  Retiree Drug Subsidy Amounts","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0505055336104909
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Part C Optional Supplemental Benefits",0.0504893442107893
"Section III Coordination of Benefits COB User Fee","Section II Plans with Low Enrollment",0.0504828878192654
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Improving Access to Part D Vaccines",0.0504004952577161
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section III CY 2019 Formulary Submission Window",0.0503273320775277
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Innovations in Health Plan Design",0.0502888154764235
"Section III Coordination of Benefits COB User Fee","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0502412566732563
"Section II Cost Plan Competition Requirements","Section I Plan Corrections",0.0502136633867197
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0500982819069131
"Section II Outpatient Observation Services","Section C  Part D Risk Sharing",0.0500440385009595
"Section M  Medical Loss Ratio Credibility Adjustment","Section I Innovations in Health Plan Design",0.0499687792663908
"Section III Specialty Tiers","Section C  IME Phase Out",0.0499427637192307
"Section E  Clinical Trials","Section L  Normalization Factors",0.0498631212480481
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0497640770507754
"Section C  IME Phase Out","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0496793952099718
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.049663735392577
"Section II Employer Group Waiver Plans","Section II Special Needs Plan SNPSpecific Networks Research and Development",0.0496138938356834
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I  ESRD Risk Adjustment Model for CY 2019",0.0495970839194028
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Coordination of Benefits COB User Fee",0.0495723890387452
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I Validation Audits",0.0495177672606498
"Section II Cost Plan Competition Requirements","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0494837177079849
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0494244461621551
"Section II Employer Group Waiver Plans","Section III Improving Access to Part D Vaccines",0.0493829512606161
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Enforcement Actions for Provider Directories",0.0492975838564508
"Section C  Part D Risk Sharing","Section I Incomplete and Inaccurate Bid Submissions",0.0492041864005962
"Section II Health Related Supplemental Benefits","Section L  Normalization Factors",0.0491363752389149
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section III Improving Access to Part D Vaccines",0.0490783513052405
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section B  Encounter Data as a Diagnosis Source for 2019",0.0490514519596695
"Section III Expanding the Part D OTC Program","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0490152275564157
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Health Related Supplemental Benefits",0.048903799777247
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0488430238847525
"Section D  Retiree Drug Subsidy Amounts","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0487632431400331
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.048715066254927
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Plans with Low Enrollment",0.0486150797892423
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Validation Audits",0.0485303245983393
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Special Needs Plan SNPSpecific Networks Research and Development",0.0485071250072666
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0484195512729491
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section B  FFS Growth Percentage",0.0483869169509921
"Section M  Medical Loss Ratio Credibility Adjustment","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0482888302512042
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0482491233823638
"Section II Transparency  Timeliness with Prior Authorization Processes","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0481706197967111
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0481445526672844
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section M  Medical Loss Ratio Credibility Adjustment",0.0481125224324688
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section A  MA Growth Percentage",0.0480512715834056
"Section II Plans with Low Enrollment","Section L  Normalization Factors",0.0480454720840642
"Section B  FFS Growth Percentage","Section C  Part D Risk Sharing",0.0479046747196996
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI",0.047860587966723
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section B  FFS Growth Percentage",0.0478381459801517
"Section II Outpatient Observation Services","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.047770692035438
"Section K  Medicare Advantage Coding Pattern Adjustment","Section E  Clinical Trials",0.047733061095425
"Section III Coordination of Benefits COB User Fee","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0477116999616814
"Section D  ESRD Rates","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0476755076489249
"Section II Tiered Cost Sharing of Medical Benefits","Section I Validation Audits",0.0475888905602752
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III CY 2019 Formulary Submission Window",0.047386449084553
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0473773461579526
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section II Maximum OutofPocket MOOP Limits",0.0473536620902889
"Section I Plan Corrections","Section B  Calculation of Fee for Service Cost",0.047268808776026
"Section III Low Enrollment Plans Standalone PDPs only","Section O  Quality Payment Program",0.0472611848441754
"Section III Benefit Review","Section II Special Needs Plan SNPSpecific Networks Research and Development",0.0472455591261534
"Section III Low Enrollment Plans Standalone PDPs only","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0472184966543731
"Section I Annual Calendar","Section C  IME Phase Out",0.0471465913579049
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD",0.0471404520791032
"Section III Expanding the Part D OTC Program","Section I  ESRD Risk Adjustment Model for CY 2019",0.0471119532395687
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I  ESRD Risk Adjustment Model for CY 2019",0.0470927784201459
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Cost Plan Transition to MA under MACRA",0.0470892263621752
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0470823615430758
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section A  Update of the RxHCC Model",0.0470100494722268
"Section II Employer Group Waiver Plans","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0469478394103825
"Section II Outpatient Observation Services","Section O  Quality Payment Program",0.0469071936885627
"Section II Outpatient Observation Services","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0468365464014357
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0468051206210467
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Tiered Cost Sharing of Medical Benefits",0.0468034860534667
"Section C  Part D Risk Sharing","Section III CY 2019 Formulary Submission Window",0.0467995599021465
"Section II Outpatient Observation Services","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0467777426534333
"Section A  MA Growth Percentage","Section O  Quality Payment Program",0.0467459874576942
"Section I Enforcement Actions for Provider Directories","Section III CY 2019 Formulary Submission Window",0.0467107445389745
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section B  Encounter Data as a Diagnosis Source for 2019",0.0467067915170985
"Section III Low Enrollment Plans Standalone PDPs only","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0466874212448182
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section D  ESRD Rates",0.0466524419669277
"Section III CY 2019 Formulary Submission Window","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0466515477458263
"Section III Coordination of Benefits COB User Fee","Section B  Encounter Data as a Diagnosis Source for 2019",0.0466463126981871
"Section I Annual Calendar","Section B  Calculation of Fee for Service Cost",0.0466222719353568
"Section II Transparency  Timeliness with Prior Authorization Processes","Section B  FFS Growth Percentage",0.0465484355726039
"Section III Specialty Tiers","Section I Plan Corrections",0.046513586466321
"Section III Benefit Review","Section E  Clinical Trials",0.0464894390572783
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0462933506083277
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section E  Clinical Trials",0.0461284142993202
"Section A  MA Growth Percentage","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0461104616213049
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0460692196653913
"Section III Low Enrollment Plans Standalone PDPs only","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0459871865192922
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Validation Audits",0.045935409752151
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section M  Medical Loss Ratio Credibility Adjustment",0.0459279326771846
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section A  MA Growth Percentage",0.0458891852220919
"Section M  Medical Loss Ratio Credibility Adjustment","Section C  Part D Risk Sharing",0.0458678002021979
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Maximum OutofPocket MOOP Limits",0.0458390916438293
"Section I Annual Calendar","Section L  Normalization Factors",0.0457994513103635
"Section II Part C Optional Supplemental Benefits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.045773735234754
"Section III Specialty Tiers","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0456404651270548
"Section I Enforcement Actions for Provider Directories","Section II Maximum OutofPocket MOOP Limits",0.0455611526956577
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0454977120868857
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Incomplete and Inaccurate Bid Submissions",0.0454908524388161
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section III Low Enrollment Plans Standalone PDPs only",0.0454206698462679
"Section I Annual Calendar","Section B  FFS Growth Percentage",0.0453534228699872
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section L  Normalization Factors",0.0453463057102469
"Section II Maximum OutofPocket MOOP Limits","Section O  Quality Payment Program",0.0453250547279382
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0452104204266726
"Section I Enforcement Actions for Provider Directories","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0451241496998154
"Section II Medicare Advantage MA Segmented Service Area Options","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0450948968405578
"Section A  MA Growth Percentage","Section I Plan Corrections",0.0450944029244407
"Section I Enforcement Actions for Provider Directories","Section II Cost Plan Transition to MA under MACRA",0.0450037485550715
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I  ESRD Risk Adjustment Model for CY 2019",0.0449902709075637
"Section D  Retiree Drug Subsidy Amounts","Section I Innovations in Health Plan Design",0.0449893521183889
"Section III Specialty Tiers","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0448281778787851
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Expanding the Part D OTC Program",0.0448110714948221
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section O  Quality Payment Program",0.0448105525760893
"Section II Maximum OutofPocket MOOP Limits","Section III CY 2019 Formulary Submission Window",0.0447879122152568
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section I  ESRD Risk Adjustment Model for CY 2019",0.0447830548158769
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Tiered Cost Sharing of Medical Benefits",0.0447806127850588
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Health Related Supplemental Benefits",0.0446910487427046
"Section I Innovations in Health Plan Design","Section C  Part D Risk Sharing",0.0446283139475127
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0446073106310158
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section D  ESRD Rates",0.0445111522308635
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0444935725618114
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Cost Plan Competition Requirements",0.0444749589996661
"Section III Coordination of Benefits COB User Fee","Section II Outpatient Observation Services",0.0443867005012168
"Section II Employer Group Waiver Plans","Section III Tier Composition",0.0440581952519823
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Annual Calendar",0.0440385506050544
"Section II Part C Optional Supplemental Benefits","Section I  ESRD Risk Adjustment Model for CY 2019",0.0440198095214345
"Section II Part C Optional Supplemental Benefits","Section D  ESRD Rates",0.0440027296289861
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Incomplete and Inaccurate Bid Submissions",0.0438856982685971
"Section III Specialty Tiers","Section O  Quality Payment Program",0.0438681509382364
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0438354029659987
"Section M  Medical Loss Ratio Credibility Adjustment","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0437646770075861
"Section III Specialty Tiers","Section G  MA Employer Group Waiver Plans",0.043749759798047
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Plan Corrections",0.0436590672472235
"Section III Benefit Review","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0436350036054982
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section E  Clinical Trials",0.0435766210263525
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Transparency  Timeliness with Prior Authorization Processes",0.0435685422235579
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Validation Audits",0.0435616624192004
"Section D  ESRD Rates","Section III CY 2019 Formulary Submission Window",0.0435077208584626
"Section D  Retiree Drug Subsidy Amounts","Section I Validation Audits",0.043444973320454
"Section III Coordination of Benefits COB User Fee","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0434230035230007
"Section II Tiered Cost Sharing of Medical Benefits","Section L  Normalization Factors",0.0434163775580418
"Section III Coordination of Benefits COB User Fee","Section I Enforcement Actions for Provider Directories",0.0434149336165685
"Section III Tier Composition","Section B  Calculation of Fee for Service Cost",0.0434110759543169
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0433892159123611
"Section III Benefit Review","Section I Innovations in Health Plan Design",0.0433707189430523
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section O  Quality Payment Program",0.0433585799123591
"Section II Cost Plan Transition to MA under MACRA","Section III Improving Access to Part D Vaccines",0.0433441175865294
"Section III Benefit Review","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0431704154605097
"Section M  Medical Loss Ratio Credibility Adjustment","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0431531852002103
"Section II Medicare Advantage MA Segmented Service Area Options","Section I Validation Audits",0.0431451046385466
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section III Improving Access to Part D Vaccines",0.0431253585515417
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0431187040239491
"Section I Incomplete and Inaccurate Bid Submissions","Section I  ESRD Risk Adjustment Model for CY 2019",0.0430466743696302
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Part C Cost Sharing Standards",0.0429958081130535
"Section II Employer Group Waiver Plans","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0429739817585619
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section I Enforcement Actions for Provider Directories",0.0429311866673477
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0429154293528722
"Section II Medicare Advantage MA Segmented Service Area Options","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0427869330406883
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Health Related Supplemental Benefits",0.0427789729522465
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Health Related Supplemental Benefits",0.0427635431025337
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Low Enrollment Plans Standalone PDPs only",0.0426882789138483
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0426604195017964
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0426586598395302
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0426178615227991
"Section D  ESRD Rates","Section III Improving Access to Part D Vaccines",0.0425999633453033
"Section D  ESRD Rates","Section I Incomplete and Inaccurate Bid Submissions",0.042574847353721
"Section II Part C Optional Supplemental Benefits","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0425632199442581
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Validation Audits",0.0425571268822239
"Section II Medicare Advantage MA Segmented Service Area Options","Section I  ESRD Risk Adjustment Model for CY 2019",0.0424493427289378
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.0424266190048182
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section A  MA Growth Percentage",0.0423808718958129
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0423659272868162
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Annual Calendar",0.0422920546459836
"Section II Health Related Supplemental Benefits","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0422833245825068
"Section I Enforcement Actions for Provider Directories","Section B  Calculation of Fee for Service Cost",0.042175768005641
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0421678224991215
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Plans with Low Enrollment",0.0421560554720887
"Section I Plan Corrections","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0421455400231125
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Validation Audits",0.0421053107641298
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section O  Quality Payment Program",0.0420361060254432
"Section III Tier Composition","Section A  MA Benchmark Quality Bonus Payments and Rebate",0.0419983553729235
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section B  Encounter Data as a Diagnosis Source for 2019",0.0418755965133969
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III CY 2019 Formulary Submission Window",0.0418408887455898
"Section III Low Enrollment Plans Standalone PDPs only","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0418330013267038
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Expanding the Part D OTC Program",0.0417361640378043
"Section D  Retiree Drug Subsidy Amounts","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.041578600022212
"Section II Part C Optional Supplemental Benefits","Section I Validation Audits",0.0415082351182321
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0414767935601401
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0414646942380749
"Section III Coordination of Benefits COB User Fee","Section L  Normalization Factors",0.0414384560900957
"Section I Enforcement Actions for Provider Directories","Section O  Quality Payment Program",0.0414041236665231
"Section A  MA Growth Percentage","Section I Incomplete and Inaccurate Bid Submissions",0.0413868773057658
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I  ESRD Risk Adjustment Model for CY 2019",0.0413784725218293
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section G  MA Employer Group Waiver Plans",0.0412791689484681
"Section III Benefit Review","Section A  MA Growth Percentage",0.0412786366677391
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section M  Medical Loss Ratio Credibility Adjustment",0.0412561476240281
"Section D  Retiree Drug Subsidy Amounts","Section G  MA Employer Group Waiver Plans",0.0412226162987464
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Health Related Supplemental Benefits",0.0409473123360375
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section G  MA Employer Group Waiver Plans",0.0409316489978794
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0408791182463234
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0408697600237971
"Section I Plan Corrections","Section B  FFS Growth Percentage",0.0408146211491443
"Section M  Medical Loss Ratio Credibility Adjustment","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0407917336766595
"Section III Benefit Review","Section II Plans with Low Enrollment",0.0407380137880145
"Section III CY 2019 Formulary Submission Window","Section E  Clinical Trials",0.0406962559404338
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0406772199536931
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0406153847723333
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Enforcement Actions for Provider Directories",0.0405814362351624
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Validation Audits",0.040548945077413
"Section III Improving Access to Part D Vaccines","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0404920896010908
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Tiered Cost Sharing of Medical Benefits",0.0404406714707292
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0403601393590931
"Section II Outpatient Observation Services","Section III CY 2019 Formulary Submission Window",0.0403458247447625
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Outpatient Observation Services",0.0403238919272756
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section I Validation Audits",0.0403031364653001
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Advantage MA Uniformity Flexibility",0.0402714891865826
"Section II Transparency  Timeliness with Prior Authorization Processes","Section D  ESRD Rates",0.0401871962991362
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0400923365227831
"Section II Cost Plan Transition to MA under MACRA","Section C  Part D Risk Sharing",0.0399662129891674
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Advantage MA Uniformity Flexibility",0.0398948604393126
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section I  ESRD Risk Adjustment Model for CY 2019",0.0398676230121778
"Section II Outpatient Observation Services","Section H  Enhanced Medication Therapy Management MTM Model",0.0398433160763107
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Validation Audits",0.0397883190969396
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section C  Part D Risk Sharing",0.0397603260524253
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0396539648434765
"Section II Outpatient Observation Services","Section B  FFS Growth Percentage",0.0396392260007042
"Section II Medicare Advantage MA Segmented Service Area Options","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0396102536684282
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Total Beneficiary Cost TBC",0.0395906125986777
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section N  Encounter Data as a Diagnosis Source for 2019",0.0395253199433833
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0394913595173711
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0394903817755694
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Enforcement Actions for Provider Directories",0.0394410729208485
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Health Related Supplemental Benefits",0.0393984425354611
"Section II Employer Group Waiver Plans","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0393326365205747
"Section M  Medical Loss Ratio Credibility Adjustment","Section III CY 2019 Formulary Submission Window",0.0392998861876944
"Section C  Part D Risk Sharing","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0392102992674893
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0391245995439817
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI",0.03907800643602
"Section I Enforcement Actions for Provider Directories","Section III Improving Access to Part D Vaccines",0.0390334453816881
"Section II Cost Plan Competition Requirements","Section III CY 2019 Formulary Submission Window",0.0390080119685306
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0389433153481245
"Section B  FFS Growth Percentage","Section I Incomplete and Inaccurate Bid Submissions",0.0389108641798066
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Maximum OutofPocket MOOP Limits",0.0388354441331579
"Section III Benefit Review","Section O  Quality Payment Program",0.0387594455602519
"Section II Cost Plan Competition Requirements","Section III Improving Access to Part D Vaccines",0.0387344449800356
"Section III Benefit Review","Section II Cost Plan Transition to MA under MACRA",0.0387274130743918
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Plan Corrections",0.0387096774193548
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Low Enrollment Plans Standalone PDPs only",0.0386694595618265
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0386648335124033
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section III Improving Access to Part D Vaccines",0.0385457899186801
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Outpatient Observation Services",0.038490017945975
"Section A  MA Growth Percentage","Section I Annual Calendar",0.0384766603131085
"Section I Annual Calendar","Section K  Medicare Advantage Coding Pattern Adjustment",0.0384531122288902
"Section II Medicare Advantage MA Segmented Service Area Options","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0383879268967919
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0383714918139639
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Tiered Cost Sharing of Medical Benefits",0.0383206459774936
"Section I Enforcement Actions for Provider Directories","Section C  Part D Risk Sharing",0.0383074547379861
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Maximum OutofPocket MOOP Limits",0.0380842294128445
"Section III Coordination of Benefits COB User Fee","Section M  Medical Loss Ratio Credibility Adjustment",0.0380255120363678
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section D  ESRD Rates",0.0380017210602265
"Section D  Retiree Drug Subsidy Amounts","Section II Health Related Supplemental Benefits",0.0379939664743189
"Section II Tiered Cost Sharing of Medical Benefits","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0377913571124296
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section II Maximum OutofPocket MOOP Limits",0.0377009869288464
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section K  Medicare Advantage Coding Pattern Adjustment",0.0376488305748928
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section C  Part D Risk Sharing",0.0376334272686092
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.037589596862826
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Medication Therapy Management MTM Annual Cost Threshold",0.037579813412227
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0375652742008357
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III Tier Composition",0.0373903711627731
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0372717941585541
"Section D  Retiree Drug Subsidy Amounts","Section O  Quality Payment Program",0.0372618368451644
"Section II Outpatient Observation Services","Section I Plan Corrections",0.0372484044638468
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III CY 2019 Formulary Submission Window",0.0372223383355974
"Section D  ESRD Rates","Section I Validation Audits",0.0371355195261822
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Low Enrollment Plans Standalone PDPs only",0.0369961495807183
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0369961495807183
"Section A  MA Growth Percentage","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0369413553937281
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section C  Part D Risk Sharing",0.0368788807086421
"Section K  Medicare Advantage Coding Pattern Adjustment","Section C  Part D Risk Sharing",0.0368554435280442
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Plans with Low Enrollment",0.0368084477598297
"Section A  MA Growth Percentage","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0367875392278332
"Section III Benefit Review","Section L  Normalization Factors",0.0367834035516277
"Section B  Encounter Data as a Diagnosis Source for 2019","Section III Improving Access to Part D Vaccines",0.0367294805228304
"Section II Cost Plan Transition to MA under MACRA","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0367032351888607
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section L  Normalization Factors",0.0366916089885174
"Section A  MA Growth Percentage","Section N  Encounter Data as a Diagnosis Source for 2019",0.0366132829625309
"Section I Plan Corrections","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0365988184156346
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section C  Part D Risk Sharing",0.0365955189743141
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section I Validation Audits",0.036570073057873
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0365318806577329
"Section II Plans with Low Enrollment","Section III CY 2019 Formulary Submission Window",0.0365223279749147
"Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program","Section C  Part D Risk Sharing",0.036501869477494
"Section III Tier Composition","Section II Maximum OutofPocket MOOP Limits",0.0364743687254788
"Section II Medicare Advantage MA Segmented Service Area Options","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0364710980770454
"Section I Plan Corrections","Section A  Update of the RxHCC Model",0.0363948770107563
"Section I  ESRD Risk Adjustment Model for CY 2019","Section I Validation Audits",0.03632041554326
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0363056735678622
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Tiered Cost Sharing of Medical Benefits",0.0362198930338936
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Health Related Supplemental Benefits",0.0361916265089741
"Section M  Medical Loss Ratio Credibility Adjustment","Section I Validation Audits",0.0361386949277964
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Tier Composition",0.0360855848591163
"Section II Part C Optional Supplemental Benefits","Section II Outpatient Observation Services",0.0360685807813464
"Section II Health Related Supplemental Benefits","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0359895443967495
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Part C Cost Sharing Standards",0.035933942263544
"Section I Enforcement Actions for Provider Directories","Section H  Enhanced Medication Therapy Management MTM Model",0.035926407599313
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0359126946229384
"Section A  MA Growth Percentage","Section II Health Related Supplemental Benefits",0.0357483479878499
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Transparency  Timeliness with Prior Authorization Processes",0.0356416217820126
"Section III Specialty Tiers","Section L  Normalization Factors",0.0356078733382964
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Specialty Tiers",0.0355440507014918
"Section D  Retiree Drug Subsidy Amounts","Section M  Medical Loss Ratio Credibility Adjustment",0.0355401013278692
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section III Tier Composition",0.03551904045492
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0353972541173889
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0353705063196622
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section III Improving Access to Part D Vaccines",0.0353609480221654
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0353308122863031
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0352866017297775
"Section III Expanding the Part D OTC Program","Section L  Normalization Factors",0.0352300533132679
"Section D  Retiree Drug Subsidy Amounts","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0352205306654719
"Section III Specialty Tiers","Section B  Encounter Data as a Diagnosis Source for 2019",0.0352116341070476
"Section B  FFS Growth Percentage","Section III Tier Composition",0.0351561596790657
"Section II Maximum OutofPocket MOOP Limits","Section I Validation Audits",0.0351307002099192
"Section III Specialty Tiers","Section II Medicare Advantage MA Segmented Service Area Options",0.0351183580912561
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0351057324003605
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0350980193974331
"Section III Benefit Review","Section II Cost Plan Competition Requirements",0.0350207384175329
"Section I Plan Corrections","Section I  ESRD Risk Adjustment Model for CY 2019",0.0349967704146487
"Section D  Retiree Drug Subsidy Amounts","Section III Low Enrollment Plans Standalone PDPs only",0.0348220454640362
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section L  Normalization Factors",0.0347825352041778
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0347508940902425
"Section II Medicare Advantage MA Segmented Service Area Options","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0347507504623748
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section L  Normalization Factors",0.0347412049934673
"Section D  Retiree Drug Subsidy Amounts","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0346990815991754
"Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section L  Normalization Factors",0.0346401286883744
"Section III Specialty Tiers","Section II Transparency  Timeliness with Prior Authorization Processes",0.0346271680532222
"Section III Specialty Tiers","Section M  Medical Loss Ratio Credibility Adjustment",0.0346271680532222
"Section A  MA Growth Percentage","Section I Validation Audits",0.0345597935886134
"Section D  ESRD Rates","Section II Health Related Supplemental Benefits",0.0345563269304143
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Transparency  Timeliness with Prior Authorization Processes",0.0345334954109188
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Cost Plan Competition Requirements",0.0345192628083584
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Medicare Advantage MA Segmented Service Area Options",0.0345032779671177
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.034488864998115
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section M  Medical Loss Ratio Credibility Adjustment",0.0344486409130969
"Section C  Part D Risk Sharing","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0343091702344429
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Health Related Supplemental Benefits",0.0342808695212255
"Section C  IME Phase Out","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.034273650684815
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section L  Normalization Factors",0.0342115692106678
"Section III Improving Access to Part D Vaccines","Section O  Quality Payment Program",0.034171433123464
"Section A  MA Growth Percentage","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0341420624080233
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0340949118277275
"Section I Annual Calendar","Section D  Retiree Drug Subsidy Amounts",0.0340780535853214
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Medication Therapy Management MTM Annual Cost Threshold",0.034046708715649
"Section III Tier Composition","Section E  Clinical Trials",0.0339814759570974
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section B  FFS Growth Percentage",0.0339608040053053
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section L  Normalization Factors",0.03393967827261
"Section A  MA Growth Percentage","Section K  Medicare Advantage Coding Pattern Adjustment",0.033906293144461
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section C  Part D Risk Sharing",0.0338711756488663
"Section III Benefit Review","Section M  Medical Loss Ratio Credibility Adjustment",0.0337538578042076
"Section III Specialty Tiers","Section I Innovations in Health Plan Design",0.0337404076828977
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Medicare Advantage MA Uniformity Flexibility",0.033564628094385
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Transparency  Timeliness with Prior Authorization Processes",0.0335035167136811
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.0334200906220406
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section B  FFS Growth Percentage",0.0334105475515332
"Section A  MA Growth Percentage","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.033351255441676
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Incomplete and Inaccurate Bid Submissions",0.033309244244968
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section A  Update of the RxHCC Model",0.0332836054536873
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0332652319466544
"Section III Specialty Tiers","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0332155195359361
"Section II Outpatient Observation Services","Section I Validation Audits",0.0331510264821752
"Section III Low Enrollment Plans Standalone PDPs only","Section C  Part D Risk Sharing",0.0330698531219107
"Section D  Retiree Drug Subsidy Amounts","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0330311416926612
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.0330034507248481
"Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0329989150883634
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Enforcement Actions for Provider Directories",0.0329555934199267
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Low Enrollment Plans Standalone PDPs only",0.0328266082149306
"Section III Tier Composition","Section O  Quality Payment Program",0.0328264775656636
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section III Tier Composition",0.0328065530653253
"Section B  Encounter Data as a Diagnosis Source for 2019","Section I Plan Corrections",0.032734978349412
"Section D  Retiree Drug Subsidy Amounts","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0327182629255633
"Section III Improving Access to Part D Vaccines","Section L  Normalization Factors",0.0326687810821223
"Section III Specialty Tiers","Section II Outpatient Observation Services",0.0326468071249594
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III Improving Access to Part D Vaccines",0.0324818631182545
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0324687059715949
"Section D  Retiree Drug Subsidy Amounts","Section I Plan Corrections",0.0324506516869154
"Section III Benefit Review","Section D  ESRD Rates",0.0323531426845612
"Section II Outpatient Observation Services","Section L  Normalization Factors",0.0323170377695486
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0322860623893266
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Part C Cost Sharing Standards",0.03222393292086
"Section I Enforcement Actions for Provider Directories","Section II Outpatient Observation Services",0.0322010469334319
"Section III Benefit Review","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0321888741415701
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.03211884428228
"Section I Annual Calendar","Section I  ESRD Risk Adjustment Model for CY 2019",0.032015795830018
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Coordination of Benefits COB User Fee",0.031934777724741
"Section III Specialty Tiers","Section I Enforcement Actions for Provider Directories",0.0319320640668972
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.0319051910179973
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0318810496918301
"Section II Part C Optional Supplemental Benefits","Section L  Normalization Factors",0.0318807288529154
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0318249850794966
"Section I Plan Corrections","Section E  Clinical Trials",0.031741804990052
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Part C Optional Supplemental Benefits",0.0316403594646502
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Incomplete and Inaccurate Bid Submissions",0.0315796307992668
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0315482530035242
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Part C Cost Sharing Standards",0.0314961356156759
"Section L  Normalization Factors","Section I Validation Audits",0.0314585255363978
"Section II Outpatient Observation Services","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0314018566080123
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Medicare Advantage MA Segmented Service Area Options",0.0313432399431692
"Section A  MA Growth Percentage","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0313422777512946
"Section II Cost Plan Competition Requirements","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0313409949666278
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0313304179995183
"Section A  MA Growth Percentage","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0313282825383837
"Section II Employer Group Waiver Plans","Section L  Normalization Factors",0.0312426604327517
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I Plan Corrections",0.0312375500732285
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section D  ESRD Rates",0.0311983839156525
"Section II Medicare Advantage MA Segmented Service Area Options","Section I Plan Corrections",0.0311642510670741
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section C  Part D Risk Sharing",0.0310751447778164
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Outpatient Observation Services",0.0310080873436638
"Section I Enforcement Actions for Provider Directories","Section A  Update of the RxHCC Model",0.0309715648632398
"Section II Cost Plan Competition Requirements","Section B  Encounter Data as a Diagnosis Source for 2019",0.0307721532397478
"Section II Transparency  Timeliness with Prior Authorization Processes","Section L  Normalization Factors",0.0307717521787851
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section IV  MedicareMedicaid Plans",0.0307685915814789
"Section III Tier Composition","Section I  ESRD Risk Adjustment Model for CY 2019",0.0306992347752569
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Plan Corrections",0.030688050343453
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0306561666461758
"Section I Annual Calendar","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.030644610484487
"Section B  FFS Growth Percentage","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0306150838184739
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section L  Normalization Factors",0.0306020159501761
"Section I Enforcement Actions for Provider Directories","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.030540763034668
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section D  Retiree Drug Subsidy Amounts",0.0304823904984111
"Section C  Part D Risk Sharing","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0304798405663571
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0304722550399436
"Section III Specialty Tiers","Section I  ESRD Risk Adjustment Model for CY 2019",0.0303571157261181
"Section II Medicare Advantage MA Segmented Service Area Options","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0303366956633737
"Section III Benefit Review","Section II Outpatient Observation Services",0.0303080403105545
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0302323640821916
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I  ESRD Risk Adjustment Model for CY 2019",0.0301982441619185
"Section M  Medical Loss Ratio Credibility Adjustment","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0301694245015924
"Section II Health Related Supplemental Benefits","Section C  Part D Risk Sharing",0.0300684732444896
"Section M  Medical Loss Ratio Credibility Adjustment","Section E  Clinical Trials",0.0299891157153245
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Improving Access to Part D Vaccines",0.0298603561076064
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section B  Encounter Data as a Diagnosis Source for 2019",0.0298328910873079
"Section K  Medicare Advantage Coding Pattern Adjustment","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0298249933646646
"Section II Part C Optional Supplemental Benefits","Section B  Encounter Data as a Diagnosis Source for 2019",0.0296397959121829
"Section I Enforcement Actions for Provider Directories","Section B  FFS Growth Percentage",0.0295401116357545
"Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries","Section I Validation Audits",0.0295237136734847
"Section N  Encounter Data as a Diagnosis Source for 2019","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0295222976366043
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0294605588592933
"Section II Medicare Advantage MA Segmented Service Area Options","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0294558916165098
"Section A  MA Growth Percentage","Section I Innovations in Health Plan Design",0.029408400958657
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.0293625297665549
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Tier Composition",0.0293157245184479
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0292796640971025
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I Enforcement Actions for Provider Directories",0.0292200091809283
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I  ESRD Risk Adjustment Model for CY 2019",0.0291937445364368
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I Incomplete and Inaccurate Bid Submissions",0.0291062746176746
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0289571171083153
"Section I Enforcement Actions for Provider Directories","Section B  Encounter Data as a Diagnosis Source for 2019",0.0289423780949421
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Annual Calendar",0.0289127249413104
"Section III Coordination of Benefits COB User Fee","Section C  Part D Risk Sharing",0.02888419579728
"Section II Employer Group Waiver Plans","Section K  Medicare Advantage Coding Pattern Adjustment",0.0288808873371779
"Section II Medicare Advantage MA Segmented Service Area Options","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0288315961688547
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0287717668824218
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Specialty Tiers",0.0286286130744699
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0285922326938048
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section L  Normalization Factors",0.028579572704651
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Medicare Advantage MA Uniformity Flexibility",0.0283817474855534
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Tiered Cost Sharing of Medical Benefits",0.0282793838750471
"Section I Annual Calendar","Section D  ESRD Rates",0.0282722110097332
"Section III Benefit Review","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0282346219657891
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0282184490455335
"Section II Outpatient Observation Services","Section G  MA Employer Group Waiver Plans",0.0282067756895245
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0281904591440964
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section H  Enhanced Medication Therapy Management MTM Model",0.0281434048003081
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Low Enrollment Plans Standalone PDPs only",0.0281271975231506
"Section A  MA Growth Percentage","Section II Outpatient Observation Services",0.0280240706836288
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section B  Encounter Data as a Diagnosis Source for 2019",0.0279346569485058
"Section A  MA Growth Percentage","Section III Coordination of Benefits COB User Fee",0.0279015448466747
"Section III Specialty Tiers","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0278959745967211
"Section II Tiered Cost Sharing of Medical Benefits","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.027712316087655
"Section C  IME Phase Out","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0276650124931767
"Section C  IME Phase Out","Section III Tier Composition",0.0276565475958712
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0276434595494153
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section L  Normalization Factors",0.0274785143074269
"Section III Tier Composition","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0273553313836729
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Plans with Low Enrollment",0.0273431531452526
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Part C Optional Supplemental Benefits",0.0271107704621437
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0268947449440553
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Tiered Cost Sharing of Medical Benefits",0.0268338891070297
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0267050426980767
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section B  Encounter Data as a Diagnosis Source for 2019",0.0267048507587309
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section I Enforcement Actions for Provider Directories",0.0266806580180458
"Section F  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0266070422108387
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section D  ESRD Rates",0.0266005012903833
"Section A  MA Growth Percentage","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.0265368708656012
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Maximum OutofPocket MOOP Limits",0.0265187302627472
"Section II Cost Plan Competition Requirements","Section III Tier Composition",0.026329807720405
"Section II Plans with Low Enrollment","Section C  Part D Risk Sharing",0.0263214019694084
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Special Needs Plan SNPSpecific Networks Research and Development",0.0262612865719445
"Section I Plan Corrections","Section C  Part D Risk Sharing",0.0262589404441971
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section C  Part D Risk Sharing",0.0262414292940662
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section A  MA Growth Percentage",0.0262111216998311
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Outpatient Observation Services",0.0261891400439462
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section D  Retiree Drug Subsidy Amounts",0.0261185746913887
"Section K  Medicare Advantage Coding Pattern Adjustment","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0260174896315244
"Section C  IME Phase Out","Section I Plan Corrections",0.0259010190760737
"Section M  Medical Loss Ratio Credibility Adjustment","Section B  Encounter Data as a Diagnosis Source for 2019",0.0258927479646931
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0258760145415997
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section L  Normalization Factors",0.0258265801555931
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs","Section L  Normalization Factors",0.0257261768323489
"Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice","Section B  Encounter Data as a Diagnosis Source for 2019",0.0256599246943814
"Section D  ESRD Rates","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0255993615581125
"Section C  IME Phase Out","Section III CY 2019 Formulary Submission Window",0.0254211190826086
"Section M  Medical Loss Ratio Credibility Adjustment","Section III Improving Access to Part D Vaccines",0.0253967486116093
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section II Maximum OutofPocket MOOP Limits",0.0253489820686909
"Section II Employer Group Waiver Plans","Section M  Medical Loss Ratio Credibility Adjustment",0.0253184841770917
"Section N  Encounter Data as a Diagnosis Source for 2019","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0252131546130645
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Improving Access to Part D Vaccines",0.0251966440305078
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Improving Access to Part D Vaccines",0.0251074753482551
"Section K  Medicare Advantage Coding Pattern Adjustment","Section B  Encounter Data as a Diagnosis Source for 2019",0.0250608078732241
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Cost Plan Transition to MA under MACRA",0.0250471675906619
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Expanding the Part D OTC Program",0.0250379279343042
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Cost Plan Competition Requirements",0.0250191191323526
"Section III Low Enrollment Plans Standalone PDPs only","Section B  FFS Growth Percentage",0.0250108201693012
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Outpatient Observation Services",0.0248950397193456
"Section A  MA Growth Percentage","Section III CY 2019 Formulary Submission Window",0.0246713371051333
"Section II Part C Optional Supplemental Benefits","Section M  Medical Loss Ratio Credibility Adjustment",0.0245934688418982
"Section I Enforcement Actions for Provider Directories","Section III Part D Benefit Parameters for NonDefined Standard Plans",0.0245730658140035
"Section III Part D MailOrder Refill Consent Policy Solicitation for Comments","Section C  Part D Risk Sharing",0.0243923442134894
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Plans with Low Enrollment",0.024252991851715
"Section II Transparency  Timeliness with Prior Authorization Processes","Section C  Part D Risk Sharing",0.0242320453898404
"Section B  Encounter Data as a Diagnosis Source for 2019","Section D  Medicare Part D Benefit Parameters Annual Adjustments for Defined Standard Benefit in 2019",0.0242241235456623
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section L  Normalization Factors",0.0242047434660351
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0241889723423448
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.024147620427474
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Advantage MA Segmented Service Area Options",0.024098134635594
"Section I Plan Corrections","Section II Maximum OutofPocket MOOP Limits",0.0240740462731778
"Section K  Medicare Advantage Coding Pattern Adjustment","Section D  Retiree Drug Subsidy Amounts",0.0240241323494058
"Section B  FFS Growth Percentage","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0239406239373046
"Section A  MA Growth Percentage","Section III Improving Access to Part D Vaccines",0.023915021409179
"Section N  Encounter Data as a Diagnosis Source for 2019","Section E  Clinical Trials",0.0238629370024768
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0238410805149695
"Section B  Encounter Data as a Diagnosis Source for 2019","Section I Validation Audits",0.023836977590599
"Section II Outpatient Observation Services","Section B  Encounter Data as a Diagnosis Source for 2019",0.0236721618351692
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Medicare Advantage MA Uniformity Flexibility",0.0236597768912486
"Section I Enforcement Actions for Provider Directories","Section D  ESRD Rates",0.0236320453436215
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0234765070757921
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section E  Clinical Trials",0.0233286803314776
"Section M  Medical Loss Ratio Credibility Adjustment","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0232651885796466
"Section III Benefit Review","Section I  ESRD Risk Adjustment Model for CY 2019",0.0232504625639071
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section E  Clinical Trials",0.0232332378191075
"Section D  ESRD Rates","Section III Tier Composition",0.0232185703711566
"Section J  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III Tier Composition",0.0231835843080289
"Section II Cost Plan Transition to MA under MACRA","Section III Tier Composition",0.0231609433465668
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.023143242522381
"Section D  Retiree Drug Subsidy Amounts","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0231223916523105
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0230994012568421
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Transparency  Timeliness with Prior Authorization Processes",0.0229657606087313
"Section II Employer Group Waiver Plans","Section B  Encounter Data as a Diagnosis Source for 2019",0.0228851827076249
"Section I Enforcement Actions for Provider Directories","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0227802056396061
"Section II Outpatient Observation Services","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0225705207164011
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Part C Cost Sharing Standards",0.0225580648176025
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.0225017580185205
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section D  Retiree Drug Subsidy Amounts",0.0224424946488605
"Section II Outpatient Observation Services","Section III Improving Access to Part D Vaccines",0.0223479986032912
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Specialty Tiers",0.0222745325494766
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section L  Normalization Factors",0.0221962231776403
"Section K  Medicare Advantage Coding Pattern Adjustment","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0221877897088627
"Section D  Retiree Drug Subsidy Amounts","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0221212594550198
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section N  Encounter Data as a Diagnosis Source for 2019",0.0219495465922131
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.0217532705441796
"Section I Enforcement Actions for Provider Directories","Section II Medicare Advantage MA Segmented Service Area Options",0.0216492820567635
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Timely Updates to LIS Status Based on Best Available Evidence",0.0212309918432827
"Section II Medicare Diabetes Prevention Program MDPP Services Clarification","Section I Plan Corrections",0.0212186251622231
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Tier Composition",0.0212005293075024
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Enforcement Actions for Provider Directories",0.0211782880418022
"Section M  Medical Loss Ratio Credibility Adjustment","Section II Medicare Advantage MA Segmented Service Area Options",0.0211288563682129
"Section I Plan Corrections","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0210802303047442
"Section D  ESRD Rates","Section I Plan Corrections",0.0209854067589679
"Section II Part C Optional Supplemental Benefits","Section J  Frailty Adjustment for PACE organizations and FIDE SNPs",0.020969657723835
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Low Enrollment Plans Standalone PDPs only",0.0209529088730873
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section N  Encounter Data as a Diagnosis Source for 2019",0.0209529088730873
"Section D  Retiree Drug Subsidy Amounts","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0209231601206601
"Section B  Encounter Data as a Diagnosis Source for 2019","Section III Tier Composition",0.0208530604949987
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.020819281847095
"Section B  Encounter Data as a Diagnosis Source for 2019","Section III Low Enrollment Plans Standalone PDPs only",0.0207569521806499
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD",0.0206328153530058
"Section III Specialty Tiers","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.0206095232590019
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section II Tiered Cost Sharing of Medical Benefits",0.0204360810987051
"Section III Specialty Tiers","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0202755934974844
"Section II Part C Optional Supplemental Benefits","Section I Enforcement Actions for Provider Directories",0.020159385228762
"Section B  Encounter Data as a Diagnosis Source for 2019","Section III CY 2019 Formulary Submission Window",0.0201296230605785
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Part D MailOrder Refill Consent Policy Solicitation for Comments",0.0198800871187087
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Part C Cost Sharing Standards",0.0198110236621167
"Section B  Encounter Data as a Diagnosis Source for 2019","Section O  Quality Payment Program",0.0197433590704182
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section I  ESRD Risk Adjustment Model for CY 2019",0.0196758112544114
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section C  Part D Risk Sharing",0.0196737438155887
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section A  MA Growth Percentage",0.0196598772627864
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Parts A and B Costsharing for Individuals Enrolled in the Qualified Medicare Beneficiary QMB Program",0.0196264143917182
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section B  Encounter Data as a Diagnosis Source for 2019",0.0196139229813753
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Improving Access to Part D Vaccines",0.0196042842220541
"Section II Outpatient Observation Services","Section I Plan Finder Civil Money Penalty CMP Icon or Other Type of Notice",0.0194652387491261
"Section A  MA Growth Percentage","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.019212730238153
"Section II Outpatient Observation Services","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0191684877595098
"Section I Incomplete and Inaccurate Bid Submissions","Section L  Normalization Factors",0.0191329322510583
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0191321628232639
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0191190959310264
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Health Related Supplemental Benefits",0.0190541171503341
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.018996719169973
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section I Enforcement Actions for Provider Directories",0.0189876764401242
"Section I Annual Calendar","Section C  Part D Risk Sharing",0.0186711333360382
"Section II Outpatient Observation Services","Section III Tier Composition",0.0186436125573916
"Section N  Encounter Data as a Diagnosis Source for 2019","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0184565940671405
"Section N  Encounter Data as a Diagnosis Source for 2019","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0184301575717375
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section K  Medicare Advantage Coding Pattern Adjustment",0.0182940433316151
"Section III Benefit Review","Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI",0.0182696023810467
"Section II Meaningful Difference Substantially Duplicative Plan Offerings","Section B  Encounter Data as a Diagnosis Source for 2019",0.0182688401789821
"Section I Enforcement Actions for Provider Directories","Section III Tier Composition",0.0182354442301921
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Enforcement Actions for Provider Directories",0.0181975326627175
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Medicare Advantage MA Segmented Service Area Options",0.0181220094073187
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0177645458040951
"Section III Benefit Review","Section B  Encounter Data as a Diagnosis Source for 2019",0.0174342010938602
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Cost Plan Transition to MA under MACRA",0.017291999776034
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Maximum OutofPocket MOOP Limits",0.0172205771128235
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs",0.0172045954794678
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section C  Part D Risk Sharing",0.0169588990368773
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section L  Normalization Factors",0.016952621030732
"Section N  Encounter Data as a Diagnosis Source for 2019","Section III Medication Therapy Management MTM Annual Cost Threshold",0.0169083697859905
"Section N  Encounter Data as a Diagnosis Source for 2019","Section II Maximum OutofPocket MOOP Limits",0.0169049299792647
"Section III Tier Composition","Section L  Normalization Factors",0.0167606306673168
"Section I Enforcement Actions for Provider Directories","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0165810348729867
"Section II Encounter Data Listening Forums Monitoring and Compliance Activities","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0165100793845507
"Section A  MA Growth Percentage","Section I Enforcement Actions for Provider Directories",0.0164463204697418
"Section A  MA Growth Percentage","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0164200790088895
"Section B  Encounter Data as a Diagnosis Source for 2019","Section I Incomplete and Inaccurate Bid Submissions",0.016387422159574
"Section A  MA Growth Percentage","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.0163163957346562
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Cost Plan Transition to MA under MACRA",0.0162460299384444
"Section B  Encounter Data as a Diagnosis Source for 2019","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0162291504552441
"Section N  Encounter Data as a Diagnosis Source for 2019","Section D  Retiree Drug Subsidy Amounts",0.0162138476751656
"Section I Enforcement Actions for Provider Directories","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0161792812126979
"Section II Employer Group Waiver Plans","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0161565067592458
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Medicare Advantage MA Segmented Service Area Options",0.0160678423996621
"Section II Outpatient Observation Services","Section III Low Enrollment Plans Standalone PDPs only",0.0160375074774896
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section C  Part D Risk Sharing",0.0159890033472452
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Plans with Low Enrollment",0.0159092578298011
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Cost Plan Transition to MA under MACRA",0.0159053583939365
"Section II Part C Optional Supplemental Benefits","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0158964955622667
"Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.0158740203224684
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Tiered Cost Sharing of Medical Benefits",0.0158614750881373
"Section D  Retiree Drug Subsidy Amounts","Section II Transparency  Timeliness with Prior Authorization Processes",0.0157956005901641
"Section II Outpatient Observation Services","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0156675929621447
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Outpatient Observation Services",0.0155586676003112
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Medicare Advantage MA Segmented Service Area Options",0.0155276882332366
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section M  Medical Loss Ratio Credibility Adjustment",0.0154995734576076
"Section I Enforcement Actions for Provider Directories","Section I  ESRD Risk Adjustment Model for CY 2019",0.0154391629368984
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0153505157708041
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Health Related Supplemental Benefits",0.0153446442543824
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI",0.0151907983783258
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0151705040253038
"Section B  Encounter Data as a Diagnosis Source for 2019","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.0150208747447816
"Section I Enforcement Actions for Provider Directories","Section L  Normalization Factors",0.0148468931356049
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.0147731278924229
"Section K  Medicare Advantage Coding Pattern Adjustment","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0145866931230622
"Section I Enforcement Actions for Provider Directories","Section D  Retiree Drug Subsidy Amounts",0.0145661963821296
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section C  Part D Risk Sharing",0.0141888329181824
"Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs","Section D  Retiree Drug Subsidy Amounts",0.0141019241272864
"Section II Overview of CY 2019 Benefits and Bid Review","Section B  Encounter Data as a Diagnosis Source for 2019",0.0140120555538955
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section B  Encounter Data as a Diagnosis Source for 2019",0.0138379681204333
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Enhanced Disease Management EDM for Dual Eligible Special Needs Plans DSNPs and Institutional Special Needs Plans ISNPs",0.0136688445528907
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Per Member Per Month PMPM Actuarial Equivalent AE Cost Sharing Limits",0.0133972467579449
"Section III Specialty Tiers","Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA",0.0133924567844206
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section E  Clinical Trials",0.013212011034357
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Specialty Tiers",0.013166445673388
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0127551066522879
"Section II Medicare Advantage MA Segmented Service Area Options","Section B  Encounter Data as a Diagnosis Source for 2019",0.0127321402815846
"Section I Annual Calendar","Section B  Encounter Data as a Diagnosis Source for 2019",0.0126959179029756
"Section I Plan Corrections","Section L  Normalization Factors",0.0125573855705983
"Section K  Medicare Advantage Coding Pattern Adjustment","Section III Tier Composition",0.0125316038284655
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.0125262503477938
"Section II Special Needs Plan SNP Legislative Sunset Provision","Section E  Clinical Trials",0.0122510428803826
"Section II Rewards and Incentives for Completion of a Health Risk Assessment HRA","Section D  Retiree Drug Subsidy Amounts",0.0122182615663285
"Section B  Encounter Data as a Diagnosis Source for 2019","Section E  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0118939786037223
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Expanding the Part D OTC Program",0.0117679639012142
"Section A  Update of the RxHCC Model","Section I Audit of the Sponsoring Organizations Compliance Program Effectiveness",0.0113712478649596
"Section III LIS Enrollee Costsharing for OutofNetwork Part D Drugs","Section B  Encounter Data as a Diagnosis Source for 2019",0.0113624626161392
"Section B  Encounter Data as a Diagnosis Source for 2019","Section E  Clinical Trials",0.0113470872097149
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Special Needs Plan SNP Legislative Sunset Provision",0.0110263569283994
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Medicare Diabetes Prevention Program MDPP Services Clarification",0.0105722481681907
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Maximum OutofPocket MOOP Limits",0.0102341744807749
"Section M  Medical Loss Ratio Credibility Adjustment","Section III Tier Composition",0.00988726864885969
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.00987002754235028
"Section I New Medicare Card Project formerly the Social Security Number Removal Initiative SSNRI","Section M  Medical Loss Ratio Credibility Adjustment",0.00986671297454823
"Section I Enforcement Actions for Provider Directories","Section E  Estimated Total Covered Part D Spending at OutofPocket Threshold for Applicable Beneficiaries",0.00953568137742311
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Cost Plan Transition to MA under MACRA",0.0094525411033751
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.00883952537973033
"Section B  Encounter Data as a Diagnosis Source for 2019","Section II Improving Beneficiary Communications and Reducing Burden for Integrated DSNPs",0.00880377449816106
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.00855185153197859
"Section A  MA Growth Percentage","Section III Tier Composition",0.0084640126409258
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Outpatient Observation Services",0.00842331159532115
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment DME Supply Drugs",0.00814112011282295
"Section A  MA Growth Percentage","Section B  Encounter Data as a Diagnosis Source for 2019",0.00806019258851245
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section II Maximum OutofPocket MOOP Limits",0.00794541011023435
"Section II Special Needs Plan SNPSpecific Networks Research and Development","Section D  Retiree Drug Subsidy Amounts",0.00773823232534137
"Section III Benefit Review","Section K  Medicare Advantage Coding Pattern Adjustment",0.00733393311061072
"Section II Coverage of Supervised Exercise Therapy SET for Symptomatic Peripheral Artery Disease PAD","Section B  Encounter Data as a Diagnosis Source for 2019",0.0072480897005938
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Outpatient Observation Services",0.00721744224957368
"Section II Transparency  Timeliness with Prior Authorization Processes","Section B  Encounter Data as a Diagnosis Source for 2019",0.0070616585358254
"Section B  Encounter Data as a Diagnosis Source for 2019","Section I Innovations in Health Plan Design",0.00705724913262567
"Section H  CMSHCC Risk Adjustment Model for CY 2019","Section III Coordination of Benefits COB User Fee",0.00698873624533977
"Section II Outpatient Observation Services","Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.00678086886330393
"Section II Part C Optional Supplemental Benefits","Section K  Medicare Advantage Coding Pattern Adjustment",0.00623419104385162
"Section B  Encounter Data as a Diagnosis Source for 2019","Section III Expanding the Part D OTC Program",0.00620094178787804
"Section G  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Encounter Data Listening Forums Monitoring and Compliance Activities",0.00600313745919789
"Section F  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section B  Encounter Data as a Diagnosis Source for 2019",0.00487572893787391
"Section D  Retiree Drug Subsidy Amounts","Section B  Encounter Data as a Diagnosis Source for 2019",0.00356938040755267
"Section III Medication Therapy Management MTM Annual Cost Threshold","Section B  Encounter Data as a Diagnosis Source for 2019",0.00279170643422646
